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ABSTRACT 
 
Madhavan, Krishna (Ph.D., Mechanical Engineering) 
Design and development of multilayer vascular graft 
Thesis directed by Assistant Professor Wei Tan 
 
Vascular graft is a widely-used medical device for the treatment of vascular diseases such as 
atherosclerosis and aneurysm as well as for the use of vascular access and pediatric shunt, which are 
major causes of mortality and morbidity in this world. Dysfunction of vascular grafts often occurs, 
particularly for grafts with diameter less than 6mm, and is associated with the design of graft 
materials. Mechanical strength, compliance, permeability, endothelialization and availability are issues 
of most concern for vascular graft materials. To address these issues, we have designed a 
biodegradable, compliant graft made of hybrid multilayer by combining an intimal equivalent, 
electrospun heparin-impregnated poly-ε-caprolactone nanofibers, with a medial equivalent, a 
crosslinked collagen-chitosan-based gel scaffold. The intimal equivalent is designed to build 
mechanical strength and stability suitable for in vivo grafting and to prevent thrombosis. The medial 
equivalent is designed to serve as a scaffold for the activity of the smooth muscle cells important for 
vascular healing and regeneration. Our results have shown that genipin is a biocompatible 
crosslinker to enhance the mechanical properties of collagen-chitosan based scaffolds, and the 
degradation time and the activity of smooth muscle cells in the scaffold can be modulated by the 
crosslinking degree. For vascular grafting and regeneration in vivo, an important design parameter of 
the hybrid multilayer is the interface adhesion between the intimal and medial equivalents. With 
diametrically opposite affinities to water, delamination of the two layers occurs. Physical or chemical 
modification techniques were thus used to enhance the adhesion. Microscopic examination and 
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graft-relevant functional characterizations have been performed to evaluate these techniques. Results 
from characterization of microstructure and functional properties, including burst strength, 
compliance, water permeability and suture strength, showed that the multilayer graft possessed 
properties mimicking those of native vessels. Achieving these FDA-required functional properties is 
essential because they play critical roles in graft performances in vivo such as thrombus formation, 
occlusion, healing, and bleeding. In addition, cell studies and animal studies have been performed on 
the multilayer graft. Our results show that the multilayer graft support mimetic vascular culture of 
cells and the acellular graft serves as an artery equivalent in vivo to sustain the physiological 
conditions and promote appropriate cellular activity. In conclusion, the newly-developed hybrid 
multilayer graft provides a proper balance of biomechanical and biochemical properties and 
demonstrates the potential for the use of vascular tissue engineering and regeneration. 
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CHAPTER 1 
 
1. THE NECESSITY OF VASCULAR GRAFTS (LITERATURE REVIEW) 
 
Abstract 
 
Atherosclerosis is one of the major causes of human death. The failure of the kidney to function 
properly as a filtering system in the human body is also a major cause of death. Vascular grafts are 
currently used in the replacement of damaged blood vessels in bypass surgeries and as a vascular 
access in hemodialysis. There are a number of types of grafts available today including autologous 
grafts (saphenous vein, umbilical cord vein, right thoracic artery), synthetic grafts (extended 
Polytetrafluoroethylene, Dacron) and tissue engineered blood vessels (TEBV) produced by a wide 
variety of synthesis techniques. Current techniques of manufacturing TEBV include electrospinning, 
remodeling and assembly of extracellular matrix (ECM) by cells in bioreactors and common protein 
self-assembly methods with mechanical property improvement by reinforcements and crosslinking. 
There is a necessity to design a new material for replacement of small caliber blood vessels (diameter 
< 6mm) since current materials have some problems associated with them. The failure of small 
caliber vessels is generally caused by formation of intimal hyperplasia due to improper 
endothelialization, occlusion due to compliance mismatch and improper healing at the site of 
anastomosis. Proteins like collagen and elastin are the major components of the ECM which are 
commonly included in the design of materials for a vascular graft today. Chitosan closely resembles 
the other major components of the ECM, the glycosaminoglycans, and possesses superior 
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biomechanical and biochemical properties. The current study investigates the potential of the 
combination of these naturally occurring polymers as a substitute for small caliber blood vessels. 
 
1.1 Introduction 
 
The cardiovascular system is absolutely vital to the operation of the human body. This system 
consists of the heart and blood vessels which serve as pump and conduits respectively, which carry 
oxygen, carbon dioxide and nutrients to various parts of the body. A number of factors, including, 
age, genetics, stress, food habits, smoking and alcohol consumption are known to contribute to 
diseases and disorders associated with this system which are known as cardiovascular diseases 
(CVD). CVDs are among the most common reasons for death in this world today. One of the most 
common types of CVD is atherosclerosis (a.k.a. stenosis). Stenosis is the deposition of fat, 
cholesterol and other substances on blood vessels (or simply: formation of plaque). There were 
approximately 426,000 deaths in USA in 2006 due to stenosis, making it one of the main causes of 
death in USA alone [1]. The World Health Organization reports that there were at least 7,200,000 
deaths due to stenosis around the world in 2004 [2]. A variety of methods have been used for 
treatment, namely, prophylactic medication, angioplasty, atherectomy, use of stents and bypass 
surgery. Bypass surgeries are used in the replacement of chronically blocked blood vessels by 
replacing them with vascular grafts.  
 
In the kidney, the vascular system is involved in the removal of waste products such as creatine and 
urea from the blood. It is absolutely imperative for the elimination of such waste products to avoid 
adverse effects to the human body. At the same time, such elimination should be achieved in short 
periods of time. There are situations in which the kidney fails and the elimination of such waste 
3 
 
products becomes very difficult for the human body. Hemodialysis is, often, used for the removal of 
waste products in the case of such a renal failure.  Hemodialysis is carried out using an arteriovenous 
fistula, an arteriovenous vascular access graft or a venous catheter[3]. The most common type of 
procedure involves the vascular access graft, in which, the vascular graft is used to connect the artery 
to the vein and is placed right under the skin[3]. Since the graft acts as a vein, it can be immediately 
used for needle placement and blood access during hemodialysis.  
 
1.2 Anatomy of the human blood vessels [4] 
 
The circulatory system in a human body can, generally, be divided into two major sections: the heart 
and the blood vessels. The fluid medium of transport for the exchangeable entities such as nutrients, 
gases, hormones, electrolytes, immune-system cells, etc., is called blood. The heart is the muscular 
organ which pumps the blood towards the tissues where exchange takes place. The conduits which 
carry blood are called blood vessels. These blood vessels can further be divided into three types: the 
arteries, the veins and the capillaries. The arteries generally carry blood from the heart towards the 
organs where exchange takes place. Most of the arteries carry oxygenated blood except for 
pulmonary and umbilical arteries. They are classified based on the size of the artery and the 
constituent layers present. The largest of the arteries are the Elastic Arteries. The pulmonary arteries, 
the aorta, and its branches generally constitute the elastic arteries. The next set of arteries is muscular 
arteries which are smaller in diameter than the elastic arteries. Apart from this there is not much 
difference in their anatomies.  Some muscular arteries include the iliac artery, femoral artery, radial 
artery, renal artery, etc.  
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Elastic and muscular arteries, generally, consist of an inner layer called tunica interna (a.k.a intima), a 
middle layer of tunica media (a.k.a. media) and an external layer called tunica externa (a.k.a. 
adventitia). These layers not only act as barriers but also perform a vital function in maintaining 
homeostasis of the human body. The smallest type of artery is called the arterioles which basically 
consists of the intima and media. The major difference between arterioles and the other types of 
arteries is that there are only layers of cells present and no extracellular matrix. The veins are also 
classified similar to the arteries as venules, medium-sized veins and large veins. The major difference 
between the medium-sized and large veins and their counterparts in arteries is that the medial layer is 
thinner in veins. Capillaries are the smallest of the blood vessels situated the farthest away from the 
heart and this is where the (describe the exchange) exchange takes place. They are generally situated 
in major organs such as muscles, lungs, kidney and intestines. The blood vessels are further classified 
as systemic and coronary depending upon the delivery of blood. Systematic vessels transport blood 
to and from the organs in the body other than the heart. Coronary vessels transport blood to and 
from the various regions of the heart. 
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Figure 1.1: Human Circulatory System[4] 
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1.3 Sections of an artery [5] 
 
1.3.1 Tunica interna (Intima) 
 
Intima consists of the endothelium, the sub-endothelial layer and the fenestrated layer. The 
endothelium is a single layer of endothelial cells arranged longitudinally on a basal membrane parallel 
to the flow of blood. The function endothelium is to ensure hemocompatibility and to regulate 
blood pressure by vasoconstriction and vasodilation. It also produces nitric oxide (NO) which 
prevents occlusion and keeps the vessels patent (open). The sub-endothelial layer contains stellate 
cells (neurons and astrocytes with many dendrites) and connective tissue. This layer is a feature that 
is present only in large arteries. The third layer is a network of elastic fibers arranged principally in 
the longitudinal directions. Size of this layer is the largest in elastic arteries and decreases as the size 
of the arteries decreases. This layer also acts as a support to the underlying endothelium. Improper 
functioning of endothelium is a major factor causing occlusion leading to atherosclerosis.  
 
1.3.2 Tunica media (Media) 
 
Elastic and muscular arteries have a layer called the media which constitutes the bulk of the artery. 
The thickness of this layer is dependent on the size of the artery and the larger arteries have the 
thickest while the arterioles have pretty thin layers. This layer, generally, consists of smooth muscle 
cells (SMC) arranged concentrically (transversely) along with the ECM. The ECM consists of fibers 
such as collagen and elastin and proteoglycans (a.k.a glycosaminoglycans). The responsibility of this 
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layer is to aid in the transport of blood by the peristaltic movement by the contraction and the 
expansion of the SMCs based on various stimuli. 
 
1.3.3 Tunica externa (Adventitia) 
 
Adventitia is the outermost layer of the artery. It consists of longitudinal collagen fibers and 
fibroblasts (FB) embedded parallel to the fibers. The collagen fibers provide protection, support to 
the blood vessel by anchoring them to nearby organs and nutrient sustenance. The primary function 
of FB is to synthesize the ECM materials like collagen, elastin and glycosaminoglycans. In 
atherosclerosis, the thickening of the blood vessel is a common symptom and occurs due to the 
excessive production of ECM materials due to known factors (already listed in the previous section). 
 
 
Figure 1.2: Section of an Artery (A) and Vein (V) from the mucus membrane of the epiglottis of a 
child: a-adventitia, m-media, e-intima. [6] 
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1.4 Components of the extracellular matrix 
 
1.4.1 Collagen [7] 
 
Collagen is a major structural protein of the human body found in abundant quantities in the 
connective tissue. It is synthesized by fibroblasts and secreted into the extracellular matrix (ECM). 
Collagen constitutes nearly 35% of the human protein content. There are at least 29 types of 
collagen identified in the human body till date out of which type 1 collagen is the most common. 
Some of the important types of collage and their locations in the human body are listed in Table 1.1. 
Collagen type I is present in scar tissue which is the end product of tissue healing by repair. Another 
important type of collagen is type III collagen which is present in granulation tissue. These fibers are 
also called reticular fibers and they are produced by young fibroblasts before the more rigid collagen 
type I. Some types of collagen are attached to the cell membranes through fibronectin and integrin. 
 
The collagen molecule, the tropocollagen, is made up of three polypeptide chains arranged in a 
three-dimensional helical structure. Some of the major amino acids in the collagen molecule are 
glycine, proline, lysine, hydroxyproline and hydroxylysine. The content of these amino acids varies 
from one type of collagen to another. The precursor to tropocollagen, known as procollagen, is 
synthesized as a three-dimensional helical structure in the rough endoplasmic reticulum (RER) of 
fibroblasts through a series of steps. Then, the procollagen is transported to the golgi apparatus and 
secreted into the ECM by exocytosis. In the ECM, procollagen is converted into tropocollagen by 
procollagen peptidase and then assembled into cross-striated fibrils. This process is known as 
fibrillogenesis. Then, the self-assembled fibrils are further bundled to form collagen fibers. 
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Type Location in the Human Body 
I 
Tendons, skin, blood vessel walls, endomysium of myofibrils, 
fibrocartilage, organic part of bones and teeth 
II Hyaline cartilage, Vitreous humor of eye 
III Granulation tissue, blood vessel walls, skin, intestines, uterus 
IV 
basal lamina, eye lens, part of the filtration system in capillaries, 
glomeruli of nephron in kidney 
V most interstitial tissue, placenta 
VI most interstitial tissue 
VII dermal epidermal junctions 
VIII some endothelial cells 
IX Cartilage 
X hypertrophic and mineralizing cartilage 
XI Cartilage 
XIII transmembrane collagen, basement membranes 
XVII transmembrane collagen 
XVIII  source of endostatin 
 Table 1.1: Some types of Collagen and their location in the Human Body[7] 
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1.4.2 Glycosaminoglycans [8] 
 
Glycosaminoglycans (GAGs) or mucopolysaccharides (MPS) are long chain sugars with disaccharide 
as the monomeric unit. Generally the disaccharide consists of hexose (a sugar with carbon atoms, 
a.k.a hexonic acid) and its corresponding amine, hexamine joined together by a C-O-C bond known 
as the glycosidic linkage. There are number of GAGs and they are found in ECM of various 
connective tissue. Table 1.2 lists some of the well-known GAGs and their location in the human 
body. GAG is a crucial structural component of the human body but also aids in brain development, 
health of eye and vision, blood coagulation, and lubrication. These GAGs combine with 
glycoproteins to form proteoglycans (PGs). These proteoglycans have the ability to attract and bind 
ions like sodium (Na+), potassium (K+) and calcium (Ca+), and water (specifically, hydrogen (H+) and 
hydroxide (OH-)) moving through the ECM, thereby regulating the molecules moving through it. 
Due to this crucial property of bind water, glycoproteins give rise to the viscoelastic behavior of 
tissue under a load. Figure 1.3 illustrates some important cell-surface PGs and ECM PGs. 
Membrane proteoglycans either penetrate the plasma membrane or they are linked by a 
glycosylphosphatidylinositol anchor [9]. Some PGs are usually secreted into the ECM while some 
other PGs are cleaved and directly cast off from the cell surface into ECM [9]. Like collagen, GAGs 
and PGs are manufactured in the RER of fibroblasts, neurons, chondrocytes, osteocytes and 
lymphocytes. 
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Name Monomer Unit 
Location in the Human Body 
Chondroitin 
sulphate 
D-glucuronic acid and N-acetyl-D-
galactosamine-4 (or 6)-sulphate 
Cartilage, Bone, Heart valves 
Dermatan 
sulphate 
L-iduronic acid and N-acetyl-D-
galactosamine-4-sulphate 
Skin, Blood vessels, Heart valves, 
Tendons, Lungs 
Keratan 
sulphate 
galactose and N-acetyl-D-
glucosamine-6-sulphate  
Cornea, Cartilage, Bone, Central 
Nervous System  
Heparin 
L-iduronic acid-2sulphate and D-
glucosamine-6-sulfate 
Blood, Lungs, Liver, Skin, Sites of 
Tissue Injury  
Heparan 
sulphate 
L-iduronic acid-2sulphate and D-
glucosamine-6-sulfate (have less 
sulphate groups than Heparin) 
Blood, Lungs, Liver, Skin, Basement 
membranes, Sites of Tissue Injury 
and Vasculogenesis, Cell Surfaces 
Hyaluronan 
D-glucuronic acid and N-acetyl-D-
glucosamine 
Articular Cartilage, Skin, Epithelial 
Tissue, Neural Tissue Synovial 
Tissue, Vitreous Humor 
Table 1.2: Major GAGs and their location in Human Body [8] 
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Figure 1.3: Proteoglycans consist of a protein core (brown) and one or more covalently attached 
GAG chains (blue: Hyaluronan Sulphate; yellow: Chondroitin Sulphate/Dermatan Sulphate) [9] 
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1.4.3 Elastin [10] 
 
Elastin is the second major protein (after collagen) in the human body.  It is the protein which 
imparts elasticity to connective tissue. It is found is various tissues of the human body such as blood 
vessels (mainly arteries), lungs, ligamentum nuchae, skin, urinary bladder, elastic cartilage, 
intervertebral disc over the sacroiliac joint. Of all the known locations of elastin in the human body, 
it is present in the largest amounts in the large elastic arteries. In these elastic arteries, there is a layer 
of elastin right below the intimal layer which is responsible for sustaining the pressure wave through 
the artery developed during the pumping of blood by the heart. The primary amino acids in the 
elastin monomer, tropoelastin, are glycine, valine, alanine and proline. Tropoelastin is synthesized in 
the RER of both fibroblasts and SMCs and secreted out of the cell into the ECM by exocytosis after 
packing at the golgi apparatus. Though tropoelastin is highly soluble in water, elastin is insoluble in 
water due to the crosslinking to form a strong network. There are two important crosslinkers in the 
case of elastin, desmosine and isodesmosine which are both modification of lysine and it is 
desmosine which imparts the yellow color to elastin fiber after crosslinking.  
 
1.5 Criteria for new materials or constructs for vascular grafts [11-16] 
 
1.5.1 Physiological requirements 
 
1. Healing: Graft material should be capable of promoting healing or material should, at least, not 
hinder in healing. 
2. Toxicity: Graft material should not be toxic to the host being. 
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3. Antigenicity: Graft material should not produce its own antigen which might affect the immune 
system of the host being. 
4. Immunogenicity: Graft material should not produce any adverse immunogenic response inside 
the host cardiovascular system. 
5. Oncogenicity: Graft material should not generate any cells which may be oncogenic or 
cancerous in nature. 
6. Thrombogenicity: Graft material should not promote the formation of thrombus or blood clot. 
7. Microbial Contamination: Graft material should be resistant to pathogenic infection. 
8. Neointimal Hyperplasia: Graft material should not promote neointimal hyperplasia. Neointimal 
hyperplasia is an adverse condition in which the vascular smooth muscle cells from the 
adventitia of the vascular graft or native vessel migrate into the intima of the vascular graft 
thereby causing a thickening of the intima due to the detailed development of the extracellular 
matrix in the intima.  
9. Other Physiological Requirements: The graft should be able to fulfill physiological requirements 
like vasoconstriction and vasodilatation. It should also be permeable to the movement of white 
blood cells. 
 
1.5.2 Structural requirements 
 
1. Fibrous: The basic structure of the graft material matrix is expected to be fibrous like the 
extracellular matrix. 
2. Porosity: The graft material should be porous to promote the growth and movement of smooth 
muscle cells inside it. 
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3. Inclusion of Elastin: Researchers have shown that a missing path to a good vascular graft might 
actually be elastin and hence it should be included in the design. 
4. Remodeling of Matrix: The graft material should promote alterations of the artificial extracellular 
matrix by the host cells. 
 
1.5.3 Mechanical property requirements 
 
1. Burst pressure: Vascular graft should have at least a burst pressure of 1700 mmHg. The burst 
pressure of the saphenous vein is approximately 1680 mmHg. It would be advisable to design 
grafts with strength over this limit as to avoid the use of the saphenous vein during the bypass 
surgeries. 
2. Compliance: The graft must be compliant and elastic so that it is able to withstand the forces 
generated due to the blood flow to avoid formation of kinks. Compliance mismatch between the 
graft and the native vessel can cause adverse effects leading to occlusion as discussed in the 
earlier section. 
3. Fatigue Resistance: The graft should be capable of withstanding 30 days of in vitro cycling of 
systemic flow without noticeable radial dilation. 
4. Suturing: The graft material should be able to withstand the force exerted during and after 
suturing it to the native vessel. It should also promote easy suturing. 
 
1.5.4 Manufacturing requirements 
 
1. The graft should, preferably, be not synthesized in a complicated process so that it can be easily 
reproduced with the same accuracy. 
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2. The graft should have a short time for fabrication. 
3. The graft should be producible in different sizes, i.e., diameter and lengths. 
4. The graft, after production, should not require any extreme storing procedures. 
 
1.5.5 Optional requirements 
 
1. The graft should be capable of local drug release. 
2. The graft should be of low cost. 
 
1.6 State-of-the-art vascular graft technology  
 
1.6.1 Types of vascular grafts 
 
It appears that there are at least 35 patents for artificial blood vessels from the last 30 years [17]. 
Although these implants have had varying levels of accomplishments, none of them are close to 
satisfying all the requirements of the product [17]. Current materials for vascular grafts can be 
broadly classified into three categories based on graft size, construction and materials [18].  Further, 
the types of materials being used are either autologous, synthetic or bio-inspired [17]. Generally, 
grafts fall under three categories based on their size: large (7-30+ mm), small (6 or less mm) and 
coronary artery (1-4 mm) [18]. Table 1.3 lists all the types of vascular grafts being used today. In the 
following paragraphs we shall discuss the advantages and disadvantages of using the “State-of-the-
Art” grafts and materials available today. Ideal properties of a vascular graft, generally, include a 
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wide variety of features encompassing strength, viscoelasticity, biocompatibility, hemocompatibility, 
and bio stability [19]. 
 
1.6.1.1 Autologous Grafts  
 
The arteries or veins from the patient are the first choice for implantation. Though these are the best 
choice, in many cases, these vessels remain unavailable for implantation since they are diseased or 
were used in previous surgeries [20]. These grafts generally possess excellent biomechanical 
properties similar to the host vessels to be replaced. Patency or occlusion is defined as the state of 
quality of being open or unblocked. William Edwards [21] reported that the autologous saphenous 
veins generally have about 65% more patency than a glutaraldehyde tanned human umbilical cord 
vein first proposed by Dardik et al in 1979 [22]. There have been other instances, too, when these 
vessels failed to remain completely patent after implantation after a certain period [23]. These grafts 
readily replace small diameter blood vessels (<6mm) and coronary arteries (1-4 mm) [18].  
 
1.6.1.2 Synthetic Grafts 
 
In the absence of autologous grafts, synthetic grafts are the foremost choice for vascular implants 
[20]. Some of the commonly used synthetic grafts include extended-Polytetrafluoroethylene (e-
PTFE) and Polyethylene terephthalate (Dacron). Synthetic grafts possess some very good properties 
making them the most used grafts during bypass surgeries [17]. They are as follows:  
1. Simplicity of fabrication, 
2. High control over properties of the bulk material, 
3. Easy procurement,  
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4. Adaptability,  
5. Excellent load bearing capacity of the bulk material, 
6. Low probability of bacterial or viral contaminations, 
7. Low possibility of antigenicity due to the relative inertness of the material in large diameter 
applications, and, 
8. Rapid transmural-transanastomotic endothelialization in certain synthetic grafts [24, 25]. 
 
The following are some important drawbacks which arise due to the use of synthetic grafts: 
1. Failure of graft material (particularly e-PTFE and Dacron) due to modulus mismatch and 
compliance mismatch resulting in intimal hyperplasia and thrombogenicity [16, 17, 23], 
2. Higher occlusion rates in small caliber vascular grafts (particularly e-PTFE and Dacron and 
some polyurethane-based) due to failure of formation of endothelial layer either [16] 
a. from movement of cells from host native vessel to the graft at the site of suture, i.e., 
transmural-transanastomotic endothelialization, or, 
b. from fall-out cells from the blood stream, i.e., blood-borne endothelialization. 
3. Improper healing due to the same reasons abovementioned. 
 
Polyurethane-based grafts have reportedly been unstable due to one or more of the flowing reasons: 
1. Hydrolysis in acidic or basic conditions [26],  
2. Enzymatic attack [27],  
3. Oxidative environment [27],  
4. Stress [27], 
5. Lack of porosity [17], 
6. Poor attachment at the anastomotic site [28], and, 
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7. Thrombogenicity due to poor-run off or distal blockage [29]. 
 
In spite of these reasons, what baffles many researchers is that e-PTFE still remains to be one of the 
most sought-after vascular grafts today [16, 17]. 
  
1.6.1.3 Bio-inspired  vascular grafts 
 
With the increase in the number of subjects with failed synthetic implants, researchers have turned 
to an idea of mimicking the physiological systems, a process simply known as biomimicking. This 
has improved not only the design of the vascular graft but has also added a number of qualities to it, 
which makes the bio-inspired vascular graft superior to the synthetic vascular graft. Bio-inspired 
vascular grafts are better than synthetic grafts for the following reasons: 
1. Lower occlusion rates and neo-intimal layer formation [30], 
2. Good endothelialization of the inner surfaces [30], 
3. Degrades and promotes tissue growth inside and around it [31-34], and, 
4. Use of natural materials like collagen, elastin, chitosan, fibrin, etc., in as constructs leads to lesser 
rejection of implants.  
 
In spite of the superior qualities of these bio-inspired materials, researchers have pointed out certain 
important aspects due to which these materials fail as vascular graft prostheses. Some of them are as 
follows: 
1. Some biodegradable materials are either too fast (“premature”) or too slow in degradation 
leading to undesired results. [17] 
2. Some materials have shown very slow cell in-growth rate. [33] 
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3. Since there have been no human trials with biodegradable vascular grafts, there is no in vivo data 
available which may help us improve the designs. 
 
Generally bio-inspired grafts can be broadly classified under three groups: 
1. Tissue Engineered Grafts 
2. Bio-hybrid Grafts 
3. Biodegradable Grafts 
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Table 1.3: State-of-the-Art Blood Vessel Replacements [17, 18] 
 
 
 
S.No. Type Subtype Example 
1 Autologous 
Artery 
Internal Mammary, Iliac, 
Right Thoracic 
Vein Saphenous 
2 Synthetic 
Woven and Knitted Dacron 
Extruded E-PTFE 
Polyurethane (PU)-Based 
Polyester Based PU, 
Polyether based EU, 
Polycarbonate based PU 
Electrospun PLG-PLA, PEO-PLA 
3 Bio-Inspired 
Tissue Engineered Cellular and Acellular 
Bio-Hybrid (Combination of  
Synthetic and Natural) 
Composites, Collagen-based 
Biodegradable 
(Synthetic or Natural) 
PLG-PLA, PDO-Elastin, 
PEO-PLA 
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1.6.2 Tissue engineered vascular grafts 
 
One of the most essential features of tissue engineering is the ability to imitate the ECM constructs 
that physically support and direct cell behavior. The ECM contains specific biomolecules which are 
used to provide information to the cells present in the ECM through biochemical and biomechanical 
stimulations. With sufficient knowledge about the effects of these biomolecules present in the ECM 
on the fundamental cell processes and how they contribute to the biomechanical and structural 
deformations of the ECM, new and improved constructs can be designed for tissue repair and 
replacement. Researchers in the past have not only used natural materials but also synthetic materials 
in designing vascular grafts. Tissue engineering not only allows us to mimic natural ECM but also 
fine tune biomechanical, biochemical and micro-structural properties of constructs. This section 
discusses the design, the synthesis and the properties of tissue engineered materials which have been 
proposed for development into vascular grafts and some of the well-known tissue engineered grafts. 
 
1.6.2.1 History 
 
In this section, we shall discuss the design, synthesis and properties some of the famous vascular 
grafts from the last few decades when tissue engineering for vascular grafts evolved. Table 1.4 enlists 
some the finest examples of tissue engineered vascular grafts and materials synthesized for their 
design in detail.  
 
Weinberg and Bell [35] were the first set of researchers to demonstrate that porcine skin collagen 
can be reconstituted in vitro and cast in the form of a tube inside an incubator at 37˚C for 1 week.  
The vascular graft design involved the formation of two layers, an inner layer of collagen mixed with 
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bovine aortic SMCs and an outer layer of collagen mixed with bovine aortic fibroblasts. There was a 
layer of Dacron sheet in between the inner and the outer layer suspended to offer mechanical 
support to the tube. The tubes were also coated with bovine aortic endothelial cells (EC) by injecting 
a suspension of the ECs into the lumen and the tube was rotated about the flow axis at 1 rev/min 
for a week. Some tubes without the ECs were mechanically tested yielding a burst strength of 100 
mmHg. Though the model did not include elastin during synthesis, this model was able to 
demonstrate some important results, namely; 
1. collagen can be casted into tubes along with SMCs and ECs harvested earlier; 
2. the secretion of elastin by the SMCs over longer periods of culture; and  
3. the orientation of collagen and the SMCs toward the longitudinal axis of the tube. 
 
After Weinberg and Bell, there have been some significant advances made in the field of tissue 
engineering vascular grafts. L’Heureux et al [36] successfully demonstrated the first bioreactor 
method of tissue engineering a vascular graft. In this method, they used cellular sheets of human 
umbilical SMCs and human skin FBs as the medial and the adventitial layers. They used a non-
pulsatile semi-perfusion flow in the bioreactor which produced shear stresses and radial distention 
for 3 months.  They also seeded ECs in the vessel lumen. This process produced a small-caliber 
vascular graft with three distinct layers, a high burst strength of 2300 mmHg and ECM proteins like 
elastin. The authors report that implantation in dogs also produced desired results. Later in 2006 
[52], they improved the model with a similar bioreactor process. The burst strength increased to 
3500 mmHg after maturation for 4 months. The main difference with the graft from 1998 was that 
the graft in 2005 had a decellularized medial layer. They extended their implantation studies to nude 
rats and primates. The one point of concern for this model is that the compliance was about 1.5%, 
one-third of the native artery [37-39]. 
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Tranquillo et al [40] were the first ones to demonstrate that the orientation of the collagen I fibers 
can be controlled and aligned using a strong magnetic field during fibrillogenesis. Murine aortic 
SMCs were isolated and added to the collagen Pre-gel mixture. This SMC-collagen Pre-gel mixture 
was then gelled inside a special polycarbonate mold which rotated once every 5-10 minutes under 
the presence of a strong magnetic field. The total incubation time varied from about 1.5 hours to 5.5 
hours depending on the magnetic field alignment and the initial SMC concentration. They were able 
to ascertain the orientation of the fibers and cells by double refraction. They found the mechanical 
properties of the medial equivalent material varied drastically with the variation of the 
aforementioned parameters. With the increase in the orientation, the stiffness of the material 
increased while creep decreased in the circumferential direction of the vascular graft.  They also 
found that due to the magnet alignment of the collagen fibers and SMCs, the vascular graft material 
was able to compact faster and resist swelling due to internal pressure. 
 
Niklason et al [41] developed a graft from a biodegradable polyglycolic acid (PGA) scaffold which 
was cultured for two months in a bioreactor, under pulsatile radial stress, after been seeded with 
bovine aortic SMCs and ECs. This work established the effects of dynamical stresses on the 
remodeling of vascular grafts. The burst strength was in excess of 2000 mmHg and the suture 
retention force of over 90g. The SMCs were able to produce collagen and replace it in place of the 
degraded PGA fibers. The vascular graft was also able to respond to chemoattractants by 
contraction and remained patent up to 90% after a month of implantation in a porcine model. 
 
Berglund et al [42] demonstrated the use of crosslinking methods on improving the mechanical 
properties of a tissue engineered vascular graft. They strengthened collagen I gels with a 
glutaraldehyde or ultraviolet or dehydrothermal crosslinked biological supports. A two-layer 
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approach was adopted by the authors, in which the inner layer was the cross-linked layer of collagen 
I while the second layer was collagen I seed with neonatal human dermal FBs. Later they seeded the 
lumen with human coronary ECs. They reported substantial changes in the biomechanical properties 
of the uncross-linked grafts and the cross-linked grafts, particularly the burst strength improved 
from 100 mmHg to 650 mmHg. 
 
Roeder et al [43] performed uniaxial tensile tests on COL gels with varying concentrations and pH. 
They incubated the COL gels in dog bone-shaped molds procuring gels suitable for uniaxial tensile 
testing. They found that all COL gels had a characteristic tensile test stress-strain curve. They 
identified three distinct regions in the curve and named them toe, linear and failure region. They 
found that on an average these gels had a linear modulus of about 30 kPa, a failure stress of 10 kPa 
and a failure strain of 90%. They reported that acidic pH would produce fibrils of greater diameter 
than basic pH while basic pH would produce fibrils of greater length than basic pH. They did the 
fibril diameter measurement by confocal microscopy. They have also reported that the increase in 
concentration and pH showed an increase in the mechanical properties. 
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Table 1.4: Tissue Engineered Vascular Grafts-Synthesis Techniques (Arranged Chronologically) 
 
 
Reference Cells Scaffold 
Burst 
Strength 
Maturation 
Period 
Major Observations 
1 [35] 
Bovine aortic 
SMC, EC and 
adventitial FC 
Collagen gel 
supported by 
Dacron mesh 
100 mmHg 3 weeks 
Feasibility of 
generating triple 
layered structure with 
collagen 
2 [44] 
Canine jugular 
vein SMC and 
EC 
Collagen gel 
supported by 
Dacron mesh 
NA NA 
Implanted in canine 
models; 
Higher SMC seeding 
and lower initial 
collagen 
concentration 
induced more rapid 
and prominent 
shrinkage 
3 [36] 
Human 
umbilical vein 
SMC and EC 
and human 
skin FC 
None 
2300 
mmHg 
3 months 
Non-pulsatile semi-
perfusion producing 
shear stresses and 
radial distention; 
No Scaffold to start 
with, use a cell 
seeded membrane 
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4 [45] 
Polyester Graft 
cross-linked 
with gelatin 
NA NA NA 
Canine Bilateral 
carotid–femoral 
implantation; 
Biochemical analysis 
done by FTIR to 
study the effect of 
length of 
implantation 
5 [41] 
Bovine aortic 
SMC and EC 
Polyglycolic Acid 
2000 
mmHg 
2 months 
Pulsatile producing 
radial stress; 
Effects of dynamical 
mechanical stresses 
6 [46] None 
Collagen-Silicone 
Composite tubes 
NA NA 
Grafts were treated 
with Triton X-100, 
Neutralized Ovine 
Skin Collagen I, 
Heat-Denatured 
Ovine Skin Collagen 
I, Bovine Gelatin, 
Sheep Serum, Bovine 
Serum Albumin, 
Dexamethazone and 
heparin to study the 
various biological 
responses imparted 
after implantation. 
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7 [47] 
Adult Rat 
Aortic SMC 
Collagen I gels NA 8 days 
Pulsatile dynamic 
conditioning at 10% 
strain from 4-8 days; 
Cells were by 
attaching the 
collagen gel with cell 
seeded Silicon tubes 
dipped with Collagen 
I and Chitosan 
8 [48] 
Ovine carotid 
artery 
myofibroblasts 
and EC 
Polyglycolic Acid 
coated with P4HB 
(Human Gene) 
300 mmHg 1 month 
Pulsatile profusion in 
the lumen producing 
shear stresses and 
pressure indicated by 
the flow; 
Effect of pulsatile 
flow studied 
9 [49] Aortic rat SMC Fibrin NA NA 
Fibrin stimulates 
collagen production 
by SMC 
10 [50] 
Adult Human 
Aortic SMC 
Collagen Gels NA 2 months 
Effect of Ascorbic 
and Retinoic Acid 
were studied. 
Biochemical analysis 
helps understand 
biomechanical 
properties and 
changes. 
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11 [42] 
Neonatal 
human dermal 
FC and human 
coronary EC 
Collagen gel 
supported by 
cross-linked 
collagen film 
650 mmHg NA 
Feasibility of cross-
linked collagen to 
support gels 
12 [51] 
Rat Aortic 
SMC 
Collagen-Fibrin 
Gel 
NA NA 
TGF-β strongly 
inhibited cell 
proliferation and 
increase SMA 
expression especially 
in the presence of 
mechanical strain 
13 [52] 
Ovine 
Umbilical SMC 
from near-term 
fetal lambs 
Fibrin Tubes NA 2 Weeks 
Effect of aprotonin 
concentration 
variation, 
thromboxane and 
endotheline was 
studied;  
Similarity to 
collagen-elastin 
scaffold in vascular 
remodeling and 
fibrogenesis have 
been reported. 
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14 [53] Rabbit SMC 
Poly(lactide-co-
caprolactone) 
NA NA 
Pulsatile profusion in 
the lumen producing 
shear stresses and 
pressure indicated by 
the flow; 
Rubber-like scaffold 
beneficial in 
delivering mechanical 
signals to cells 
15 [54] 
Human 
umbilical vein 
SMC 
Bovine Achilles 
Tendon Collagen I 
and Equine 
Ligamentum 
Nuchae Elastin 
gels crosslinked 
with EDAC/NHS 
NA 2 weeks 
Dynamic 
conditioning 
stimulates SMC to 
orient collagen fibers 
in the direction of 
force 
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16 [55] 
Human 
umbilical vein 
SMC and EC 
and human 
skin FC 
None 
3500 
mmHg 
4 months 
Non-pulsatile semi-
perfusion producing 
shear stresses and 
radial distention; 
Implanted in Canine, 
Nude Rat and 
Primate Models; 
No Scaffold to start 
with, use a cell 
seeded membrane. 
Decellularized medial 
layer. Abundant 
elastin production 
has been reported. 
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17 [56] NA 
Pullalan-Dextran 
Hydrogels with 
acellularized 
Wistar rat aorta 
tubes attached to 
the ends 
NA NA 
Implanted in Wistar 
Rats Models as a 
replacements for 
abdominal aorta; 
Polysaccharide gels 
capable of 
withstanding 
pressures and remain 
patent under 
physiological 
conditions;  
in vivo cell 
colonization and 
vascular 
reconstruction 
observed 
18 [57] 
New Born 
Wistar Rat 
Cardiac EC, 
Vena Cava 
SMC and 
Bladder SMC 
Porcine Collagen 
Membrane cross-
linked with 
Glutaraldehyde 
NA 7 days 
Rat inferior vena 
cava completely 
regenerated from 
cell-seeded collagen 
absorbable guide in 
12 weeks and 
smooth surface due 
to cell seeding caused 
less thrombosis 
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1.6.2.2 Improvement of Biomechanical Properties by Cross-linking 
 
Since the first demonstration of a COL construct for a vascular graft various researchers have used 
cross-linkers like glutaraldehyde [59], formaldehyde [59], carbodiimides [60], succinimides [60] & 
physical treatments methods including ultraviolet radiation [59], freeze-drying [59], heating during 
the process of COL gel formation [59]. This has allowed them get COL constructs with better 
mechanical properties and better cell-adhering capabilities. Other researchers [61-63] have all studied 
the effect of cross-linkers on the COL gel and their mechanical properties. Orban et al [61] 
demonstrated vascular graft material crosslinked with transglutaminase which had 30 mmHg higher 
burst pressures than pure COL graft. Gildner et al [62] reported a 5-fold and a 13-fold increase in 
the ultimate strength and the toughness of the COL gels when they were cross-linked by 
polymerizing fibronectin along with the gels. They reported that the GAGs increased the strength 
19 [58] None 
Salmon Collagen 
gels ethanol 
shrunk and  cross-
linked with EDAC 
1500 
mmHg 
1 day 
Implanted in Wistar 
Rats Models 
Collagen gels were 
dehydrated in 
ethanol and then 
cross-linked with 
EDAC. No Cells 
have been used. No 
adverse biological 
effects were seen 
during and after 
implantation in rats. 
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and toughness while the fibroblasts decreased it. Osborne et al [63] studied the effect of cross-
linking agents like the water-soluble 1-ethyl-3-(3-diaminopropyl) carbodiimide (EDAC), and 1,1-
carbonyldiimidazole (CDI), on COL gels with and without chondroitin sulphate and GAGs. They 
reported that the addition of chondroitin sulphate and GAGs to the COL gel and cross-linking the 
COL gel with EDAC and CDI increased the ultimate strength and modulus. They however 
suggested that the CDI would inhibit the infiltration and proliferation of FBs. 
 
1.6.2.3 Chitosan [64] 
 
Chitosan is a linear long chain sugar composed of D-glucosamine (deacetylated unit) and N-acetyl-
D-glucosamine (acetylated unit) distributed arbitrarily. It is commercially manufactured by 
deacetylation of chitin, which can be obtained from the exoskeleton of crustaceans like crabs, 
shrimps, etc. Since chitosan has an acid dissociation constant of about 6.5, it is positive charged and 
dissolves in acidic to neutral solutions. The amount of dissolutions depends up on the pH of the 
solvent and the degree of chitin deacetylation. Chitosan closely resembles mammalian GAGs and 
hence has been a preferred substitute for GAGs due to the ease of availability, ease of production 
and better biomechanical properties.  Due to the cationic nature of chitosan, it can attract anions 
and water thereby contributing to the mechanical properties of the scaffold.  
 
Over years of research, chitosan has developed into one of the favorite materials in tissue 
engineering of vascular grafts because it promotes bioactivity due its high biocompatibility with 
mammalian cells. Zhu et al [65] used a chitosan/heparin complex bound to the inner lumen of an e-
PTFE graft which promoted reduced platelet adhesion and longer duration of good patency in a 
canine model. Chupa et al [66] demonstrated that a GAG-Chitosan scaffold controlled SMC and EC 
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migration and proliferation. They also reported that these scaffold promoted their attachment to the 
scaffold which in turn reduces the risk of and SMC hyperplasia and incomplete endothelialization 
leading to intimal hyperplasia. Okamoto et al [67] and Mori et al [68] have demonstrated the 
promotion of migration of fibroblasts by chitosan and hence improved healing.  
 
Tan et al [69] studied the potential nature of the collagen-chitosan as a bioengineered vascular 
scaffold. They found that the scaffold was stable under pulsatile flow and the matrix integrity 
improved with the concentration of chitosan in the scaffold. They also reported the influence of 
chitosan on the crosslinking and the pore size of the collagen matrix. They demonstrated that the 
decrease in the proliferation and increase in the cytokine activity of K562 cells was influenced by the 
increase of chitosan in the scaffold. Hence, the superior properties of chitosan, as shown by other 
researchers [65-69], have given it a boost as a potential component of the vascular graft scaffolds. 
 
1.7 Necessity for a new vascular graft 
 
We have already discussed the various issues associated with present day vascular grafts in section 6 
of this chapter. Here, we summarize, not going into details, some of the key problems associated 
with the graft which is of importance to this study. These reasons justify the selection of materials 
and the methodology for the development and characterization of a new vascular graft material. 
 
1.7.1 Small caliber grafts 
 
Small caliber grafts are vascular grafts with an inner lumen diameter less than 6mm. Most tissue 
engineering today is concentrated around designing a suitable vascular graft for replacement of small 
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arteries like the coronary arteries in bypass surgeries. Large arteries can easily be replaced by the 
saphenous vein and synthetic grafts like e-PTFE and Dacron. Since there are not many 
commercially available grafts for small caliber vessel replacement, there is a necessity to design a 
graft for less than 6mm inner diameter. 
 
1.7.2 Occlusion 
 
Occlusion is the failure of a vascular graft to remain open. For good functioning of the graft as the 
replacement to a blood vessel, it is necessary for the graft to remain patent, i.e. open, after 
implantation. It is reported [16] that higher occlusion rate is due to two important reasons. 
 
1.7.3 Compliance mismatch  
 
This is due to the difference in the mechanical properties of the graft and the target vessel at the site 
of suturing. 
 
1.7.4 Improper healing  
 
Another factor which influences occlusion is the healing of the graft at the site of suturing. This is 
contributed by the construct-cell interaction at the site of anastomosis. The abovementioned 
compliance mismatch also contributes to improper healing by inhibiting cell migration at the site of 
anastomosis. 
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1.7.4.1 Long time of manufacture  
 
The average time of synthesis of a tissue engineered graft has been around 6-8 weeks, since most 
Sresearchers prefer a long time of maturation in a bioreactor. This increases the risk for patients who 
may urgently require a vascular graft for bypass surgery or hemodialysis. 
 
1.8 Conclusions 
 
Currently, there are no good designs for small caliber grafts (diameter < 6mm). Higher occlusion 
rates are reported due to compliance mismatch and improper healing. The time of synthesis of 
present day grafts is to be reduced to improve the accessibility and availability of these grafts to heart 
and kidney patients. Hence, it is necessary to design, develop and characterize a new material with 
suitable biomechanical properties and cellular compatibility. 
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CHAPTER 2 
 
2. EVALUATION OF COMPOSITION AND CROSSLINKING EFFECTS ON 
COLLAGEN-BASED COMPOSITE CONSTRUCTS 
 
Abstract 
 
Vascular grafts are widely used for a number of medical treatments. Strength, compliance, 
endothelialization and availability are issues of most concern for vascular graft materials. With 
current approaches, these requirements are difficult to satisfy simultaneously. To explore an 
alternative approach, the present study has engineered the collagen gel construct by incorporating 
mimetic components and crosslinking the construct with different crosslinkers. The effects of 
component additives, such as chitosan and elastin, have been evaluated in terms of their mechanical 
and biological properties. Results demonstrate that the incorporation of chitosan and/or elastin alter 
stress-strain curves in the low stress loading region, and significantly improve the stretching ratio 
and ultimate stress of gel constructs compared to collagen constructs. Electron microscopy results 
suggest that the mechanical improvements might be due to microstructural modifications by 
chitosan sheets and elastin fibers. The effects of crosslinkers, such as formaldehyde, genipin and 
ethyl-(dimethyl aminopropyl) carbodiimide hydrochloride (EDAC) have also been evaluated. Results 
demonstrate that formaldehyde, EDAC and genipin employ different mechanisms to crosslink 
collagen-based constructs, and use of genipin as a construct crosslinker exhibits improved 
elongation and endothelial coverage as compared to formaldehyde and EDAC. In addition, 
extending gelation time increased the elastic modulus but not the ultimate strength. Therefore, this 
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study suggests that the mimicry of natural vessel tissues with properly crosslinked biopolymer 
composites could be a potential material design strategy for vascular graft materials.  
 
2.1 Introduction 
 
Vascular grafts are widely used for a number of medical treatments including bypass surgery for 
atherosclerosis and vascular access for hemodialysis. Often these vascular grafts are made up of 
synthetic polymers such as expanded polytetrafluoroethylene (e-PTFE) and Dacron (polyethylene 
terephthalate) [70]. Though these inert, stiff polymeric grafts successfully replace large arteries, 
problems arise with small-diameter (< 6mm) vessels resulting in high occlusion rates [23, 71]. Major 
pathogenic factors leading to occlusion include compliance mismatch [16, 23] and lack of 
endothelialization [16, 72]. Alternatively, native blood vessels such as saphenous veins have been 
used. For many patients such as those with diabetes complications, these veins are not suitable for 
implantation. In the past two decades, many new approaches including tissue-engineered blood 
vessels and compliant synthetic materials such as polyurethane have emerged. In particular, tissue 
engineering approaches, which induce cells to produce collagen, elastin or other matrix components, 
have evolved into a highly promising strategy to address complications associated with current grafts 
[55]. Several obstacles still must be overcome before this enormous engineering feat can be realized. 
Most concerned are clinical-related issues including time and efforts involved, possibility of 
contamination and quality control over the long course of in vitro production [55]. Thus, an alternative 
approach to achieving proper strength, compliance and endothelialization for vascular structure could 
involve engineering biopolymer materials to mimic structural, mechanical and biological properties of 
natural vessels. The present study explored this approach by employing multiple equivalent 
40 
 
components of the vascular extracellular matrix (ECM) to construct vessel substitutes and different 
types of crosslinkers to strengthen the constructs.  
 
Collagen type I is the most abundant protein in the human body where it constitutes the majority of 
the ECM and is the essential structural and mechanical building block of various physiological 
systems. Collagen has many advantages including its high density of the RGD sequence and other 
functional sequences for cell adhesion and cell differentiation [51, 69, 73]. The ability of collagen to 
polymerize into a three-dimensional fibrous matrix makes it an appealing material for extensive 
therapeutic applications including medical implants [53, 74-76]. However, collagen matrix constructs 
lack desired mechanical properties for vascular grafts [77]. Hydrated reconstituted collagen matrices 
are mechanically weak and stiff [43, 63, 77, 78]. They thus need to be modified for high compliance 
and elongation as vessel substitutes and be strengthened to be ready for in vivo use. The ECM of 
natural vessels is a collagen-based composite consisting of fibrous proteins such as collagen and 
elastin, and proteoglycans containing long chain polysaccharides, glycosaminoglycans (GAGs). 
GAGs such as chondroitin-6-sulphate play an important role in tissue elasticity and interacting with 
functional proteins [63, 78, 79]. Chitosan or “poly D-glucosamine”, a natural polysaccharide, is 
characterized by excellent biocompatibility and structural similarity to gags. Our prior study used 
chitosan in conjugation with collagen to make constructs that can control cell growth [69]. 
Additionally, elastin is another indispensable component contributing to high elasticity in natural 
vessels and engineered vessels [13]. Solubilized elastin is able to markedly promote elastin synthesis 
and tissue regeneration [80, 81]. Thus, if properly bound, addition of elastin and/or GAG-equivalent 
components into the collagen matrix is expected to increase compliance and elongation as well as 
biological properties.  
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To increase collagen strength, two strategies are generally implemented - crosslinking [78, 82, 83] 
and reinforcement [51, 69, 73]. Crosslinking involves the use of physical or chemical crosslinkers 
such as glutaraldehyde [84, 85], formaldehyde [85-87], N-ethyl-N’-(3-dimethyl-aminopropyl) 
carbodiimide hydrochloride (EDAC) [63, 82], and genipin [78, 88]. These crosslinkers form covalent 
bonds between characteristic chemical groups on biopolymers. Reinforcement involves the addition 
of mechanically stronger components to the collagen matrix [73]. This process, if precisely 
controlled, might increase the ultimate strength of the matrix. The main advantage of using 
crosslinking or reinforcement to gain mechanical strength is reducing the manufacture time required 
for a strong vascular graft. Previous studies often used one crosslinker or one reinforcement 
component, and thus the relative potentials of these matrix-strengthening approaches are not 
known. Comparative studies to evaluate the efficiency of different approaches in terms of their 
capability of strengthening collagen-based constructs and inducing cytotoxicity are critical to future 
studies and use of collagen materials in various biomedical applications. To this end, the present 
study has investigated mechanical, structural and biological properties of the materials that are 
constructed from mixtures of collagen, chitosan and/or elastin, and are crosslinked with EDAC, 
formaldehyde or genipin, in order to evaluate their potentials in vascular graft applications. 
 
2.2 Materials and methods 
 
2.2.1 Synthesis of collagen-based gel constructs 
 
All types of experimental collagen-based constructs were prepared in dog-bone shaped molds which 
were designed by modifying the ASTM D638-03 standard. The whole design was scaled down by 
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half. Two strips of polyurethane mesh were placed at both ends of the mold to improve gripping. 
All collagen-based gel constructs were prepared at 3.0 mg/ml collagen concentration. Denatured rat 
tail collagen (type I) in 0.02N acetic acid (pH 4.0) at 9 mg/ml (BD Biosciences Inc., San Jose, CA) 
was transferred to a tube. Then, 10X Hank’s balanced salt solution (HBSS) containing phenol red 
and 0.1 M sodium hydroxide were added to the collagen solution. The pH of the pre-gel mixture 
was adjusted to 7.3. Finally, the mixture was finally topped off with 1X HBSS to achieve the desired 
volume. The final mixture was poured into molds with care to avoid bubble formation. To further 
remove bubbles which influence mechanical properties by introducing void defects and high 
variations in gel constructs, the pre-gel solution was placed at room temperature for five minutes 
before it was transferred into the incubator. Finally, the molds were transferred into a cell culture 
incubator at 37°C to initiate gel formation.  
 
Chitosan (Molecular Weight = 100,000-300,000 g/mol, 90% deacetylation, Milan Panic Biomedicals 
Inc., Solon, OH)  was dissolved in 1% acetic acid resulting in a chitosan suspension of 10 mg/ml 
concentration with a viscosity of 2000-3000 mPa.s. The elastin suspension was prepared by 
suspending elastin (Elastin Products Co., Owensville, MI) in 0.2 M Tris solution (pH 8.8) with 
Triton X100 surfactant, which was followed by filtering and washing the elastin suspension with 0.2 
M Tris solution (pH 8.8) without surfactant. The elastin solution was finally resuspended in 0.2 M 
Tris solution at a concentration of 20 mg/ml. Preparation of all the pre-gel mixtures of various 
collagen-based constructs, including collagen (COL), collagen-chitosan (COL-CHI) and collagen-
chitosan-elastin (COL-CHI-ELN), followed a similar procedure as explained above. The samples for 
mechanical, chemical, structural and biological characterization underwent gelation for 3 hours.  The 
final concentrations of the collagen, chitosan and elastin in the collagen-based constructs were 3 
mg/ml, 3.5 mg/ml and 7 mg/ml, respectively. 
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2.2.2 Crosslinking of collagen-based gel constructs 
 
After gelation, the constructs were removed from the molds and placed in a crosslinker bath for 5 
hours to promote crosslinking by diffusion. The COL, COL-CHI and COL-CHI-ELN constructs 
were crosslinked with 10 mg/ml EDAC (Sigma Aldrich Inc., St. Louis, MO), 4% formaldehyde 
(Mallinckrodt Baker Inc., Phillipsburg, NJ) or 10 mm genipin (Wako Chemicals USA Inc., 
Richmond, VA). These concentrations of the crosslinkers chosen for this study have been 
commonly used in literature [89-91]. After crosslinking, all the constructs were retrieved and stored 
in 1X Dulbecco’s Phosphate Buffered Saline (DPBS). Constructs crosslinked with genipin exhibited 
greenish-blue color while other crosslinkers did not cause any color changes. 
 
2.2.3 Fourier transform infrared spectroscopy for biochemical characterization 
 
Uncrosslinked and crosslinked COL, COL-CHI and COL-CHI-ELN constructs were frozen in 
liquid nitrogen (~195˚C), following which they were dried in a critical-point drying chamber 
(Labconco, Kansas City, MO) for approximately 48 hours. The biochemical compositions and the 
crosslinking mechanisms were studied using an attenuated total reflectance Fourier transform 
infrared (FTIR-ATR) spectrometer, Nicolet 4700 (Thermo Fisher Scientific Inc., Waltham, MA). 
Comparisons were made between samples and pure collagen constructs to study the effect of 
various matrix components and the effect of crosslinkers. OPUS software (Bruker Optik gmbh, 
Ettlingen, Germany) was used to find the peaks and to calculate the areas under the peak. 
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2.2.4 Uniaxial tensile testing for mechanical characterization 
 
All of the experimental gel constructs were subjected to uniaxial tensile tests employing the same 
testing protocol. An MTS Insight electromechanical testing system (MTS Systems Corp., Eden 
Prairie, MN) was used. Testing was performed in a 1X DPBS bath at room temperature. A special 
set of grips in delrin was used to avoid corrosion. One of the grips was loaded on the lower end of 
the instrument while the other grip was mounted under a 5 N load cell (MTS Systems Corp., Eden 
Prairie, MN) attached to the other end of the instrument. Samples were loaded and the dimensions 
of thickness, gauge length and width were measured using a vernier caliper. Only crosslinked 
constructs were tested at a strain rate of 1% per second. All the samples were tested until failure. 
The stress-strain curves were plotted for each of the samples to determine peak stress, strain at 
break and linear elastic modulus. These curves were fit with a 5th order polynomial using Matlab 
(MathWorks Inc., Natick, MA). With this fit data, the curvature of the stress-strain (-) curve was 
plotted against the strain. The curvature was calculated using the general curvature formula, 
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where k is the curvature, y is the abscissa (stress - ) and x is the ordinate (strain - ). On the 
curvature-strain curve, the strain value at the largest local maximum was taken to be the transition 
point. Using the transition point and peak stress, the toe, the linear and the failure regions were 
determined. The toe region was characterized as the region on the stress-strain curve up to the 
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transition point. The linear elastic modulus was slope of the straight line fit in the region between 
transition point and peak stress. Data collected were statistically analyzed using the one-way 
ANOVA test. Student’s t test was then used to compare the means of each individual group. The 
level of significance was set at α = 0.05 for 95% statistical significance. Error bars on all the 
histogram charts represent the standard error of the mean (SEM) based on the total number of the 
samples. 
 
2.2.5 Biocompatibility testing for biological characterization 
 
Biocompatibility testing was performed on the experimental constructs using the Live/Dead 
Viability Kit (Molecular Probes-Invitrogen Detection Technologies, Carlsbad, CA) to determine the 
construct cytotoxicity. COL, COL-CHI and COL-CHI-ELN constructs were gelled and crosslinked 
directly in 24-well culture plates. In order to remove crosslinker residues, samples were washed 
thoroughly in 1X DPBS 4 times in addition to being stored overnight in 1X DPBS. Then, bovine 
pulmonary arterial endothelial cells (BPAECs) were seeded onto each of the gel samples and the 
empty wells of the cell culture plate were used as controls. After one-day culture, samples were 
washed thoroughly in 1X DPBS. Then, the stain from the cytotoxicity test kit, consisting of a 
mixture of calcein-AM (live cell stain) and ethidium bromide homodimer-1 (dead cell stain) in 1X 
DPBS was applied to each of the gel samples by following the protocol provided by the 
manufacturer. Finally, samples were imaged under a Zeiss Axiovert S-100 fluorescence microscope 
(100X magnification) and the images were captured with a Zeiss Axiocam camera (Carl Zeiss Inc., 
Thornwood, NY). Images were then analyzed using NIH ImageJ software to determine cell 
numbers.  
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2.2.6 Field emission scanning electron microscopy for structural characterization 
 
Crosslinked COL, COL-CHI and COL-CHI-ELN constructs, gelled in polystyrene clone cylinders 
(11mm height x 1mm thickness x 2 mm in diameter), were frozen in liquid nitrogen (~195 ˚C) 
following which they were dried in a critical chamber for approximately 48 hours. These samples 
were sectioned parallel to the circular cross section. Then, they were examined using a field emission 
scanning electron microscope (FESEM, JSM-7401F, Jeol Ltd., Tokyo, Japan). 
 
2.3 Results 
 
2.3.1 FTIR-ATR characterization results showing the incorporation of component additives in 
collagen gel matrix and the effects of different crosslinkers  
 
The characteristic peaks derived from the stretching vibrations of N-Hx (x=1, 2), O-H, C-Hy (y=1-
3), C-O-C, C=O, and the bending vibrations of N-H, C-O-C, C-H, are exhibited in the FTIR 
spectra of various biopolymer matrices, as shown in Figure 2.1 and Figure 2.2. Areas under the 
peaks calculated by integration are presented in Table 2.1. Figure 2.1 demonstrates the spectrum of 
each matrix component and the spectra of the different types of collagen-based matrices, showing 
the incorporation of component additives. For the spectra of collagen (Curve 2.1A) and elastin 
(Curve 2.1C), two main typical peaks derived from amide I (C=O stretching at 1630 cm-1) and amide 
II (N-H bending at 1550 cm-1) are clearly present. For the spectrum of chitosan (Curve 2.1B), a 
strong broad peak attributed to the mixed stretching and bending vibrations of the C-O-C bond 
(1150 cm-1-970 cm-1) appears. The spectra of uncrosslinked COL-CHI (Curve 2.1D) and COL-CHI-
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ELN (Curve 2.1E) can both be interpreted as linear combinations of the individual collagen, 
chitosan, and elastin spectra. With the additions of chitosan and/or elastin, both the absorbance 
frequencies and intensities of amide I and amide II shift slightly. Additionally, compared to Curve 
2.1B, the C-O-C peak areas in Curves 2.1D and 2.1E have considerably decreased from 42.85 to 
9.71 and 2.08, respectively, due to the addition of collagen and/or elastin. The addition of chitosan 
does not appreciably change the ratio of AN-H (area of N-H bending) to AC=O (area of C=O 
stretching), while the addition of chitosan and elastin to the COL scaffold cause this ratio to change 
from 51.40 % in COL to 39.56 % in COL-CHI-ELN.  
 
 
Figure 2.1: ATR-FTIR spectra for material comparison. (A) Uncrosslinked COL; (B) CHI; (C) 
Uncrosslinked COL-CHI; (D): ELN; (E): Uncrosslinked COL-CHI-ELN 
 
Figure 2.2 demonstrates the effects of the three crosslinkers, EDAC, formaldehyde and genipin, on 
the gel matrices. Curve 2.2B shows that the intensity of the N-H bending peak appreciably increases 
after the matrix is crosslinked with EDAC; thus the ratio of AN-H to AC=O increases from 51.40% to 
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57.77%. There is no significant change in this ratio when the matrix is crosslinked with 
formaldehyde (Curve 2.2C). But this spectrum shows a double peak of C-O-C bond with an area is 
8.51. The spectrum of the genipin-crosslinked matrices (Curve 2.2D) shows a weak peak at 1740 cm-
1, which is attributed to an ester group of C-O-O from genipin, and an increase in C=O group, 
which reduces the ratio of AN-H to AC=O from 51.40% to 46.46%. Because the FTIR spectra of 
crosslinked COL-CHI and COL-CHI-ELN matrices are complicated and show mixed effects of 
component and crosslinking, the data are not shown here. However, these results are in good 
agreement with the data shown in Figures 2.1 and 2.2.    
 
 
Figure 2.2: ATR-FTIR spectra for crosslinker comparison. (A) Uncrosslinked COL; (B) COL with 
EDAC; (C) COL with formaldehyde; (D): COL with genipin 
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2.3.2 Typical stress - strain curves for crosslinked collagen-based constructs 
 
The characteristic stress-strain curves of crosslinked collagen-based constructs are shown in Figure 
2.3. The curves exhibit the three regions, namely the toe, the linear and the failure regions. These 
regions are typical for vascular tissues and collagen-based reconstituted tissue. The shape of the 
curves, characterized by the extension of each of the three regions, varies according to the 
composition in the construct matrix. In general, COL constructs have a short toe region, typically 
within the low strain range (< 15%). In comparison, COL-CHI and COL-CHI-ELN constructs 
displayed much longer toe regions which extend to high strains up to 30% and 40% respectively. 
Additionally, COL constructs fail instantaneously, while COL-CHI and COL-CHI-ELN constructs 
yield after attaining the peak stress. The slope of the linear region in the curve is used to determine 
the linear elastic modulus. Experiments have been performed on samples crosslinked by different 
crosslinkers, and it is found that the shape of the stress-strain curves is not dependent on the 
crosslinker used, although the extension of the linear region and the linear modulus vary with the 
crosslinker. 
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Area AC=O AN-H AN-H/AC=O 
(%) 
AC-O-C 
Wave # Range (cm-1) 1790-1580 1580-1470 1150-940 
COL 7.49 3.85 51.40 - 
CHI - - - 42.85 
ELN 17.52 12.00 68.49 - 
COL-EDAC 4.12 2.38 57.77 - 
COL-FLN 5.76 2.94 51.04 8.51 
COL-GPN 15.77 7.32 46.46 - 
COL-CHI 9.18 4.88 53.15 9.71 
COL-CHI-ELN 6.85 2.71 39.56 2.08 
Table 2.1: Evaluations of C=O, N-H, C-O-C peak areas due to addition of different components 
and crosslinking 
 
Figure 2.4 demonstrates the quantitative results from uniaxial tensile testing performed on the 
collagen-based constructs crosslinked with EDAC. Figure 2.4 shows that COL-CHI and COL-CHI-
ELN constructs are characterized by significantly higher peak stress and strain at the break as 
compared to COL constructs. With the addition of chitosan to the collagen matrix, the strain at the 
break (or the elongation percent) significantly increases from 29% to 47%. Further, the addition of 
elastin to the COL-CHI matrix significantly improves the strain at the break by an additional 6%. 
The peak stresses of COL-CHI-ELN and COL-CHI constructs are about two-fold of that of COL 
constructs. Additionally, the COL-CHI-ELN construct has significantly higher elastic modulus than 
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the other constructs. No significant differences in the linear elastic modulus are observed between 
crosslinked COL and COL-CHI constructs.   
 
 
Figure 2.3: Typical stress - strain curves of crosslinked COL based constructs. Point T on each of 
the graphs shows the end of the toe region and Point U shows end of the linear region. Beyond the 
linear region lies the failure region. The determination of Effect of matrix composition on 
mechanical properties of collagen-based constructs 
 
 
 
52 
 
 
 
 
  
Figure 2.4: Effect of material composition (CHI, ELN) of COL-based constructs on their 
mechanical properties with (A) Peak stress, (B) Failure Strain and (C) Modulus. Note: * - statistically 
significant difference in comparison to COL gel, † - statistically significant difference in comparison 
to COL-CHI gel for a statistical significance of p < 0.05 in Student’s t test. †† - Indicates statistical 
difference between the COL-CHI and COL-CHI-ELN for p < 0.1. The error bars indicate the 
standard error mean. 
 
 
(A) (B) 
(C) 
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2.3.3 Effect of chemical crosslinkers on mechanical properties of collagen-based constructs 
 
Three different crosslinkers, EDAC, formaldehyde and genipin, were used to strengthen the 
collagen-based constructs. Results of mechanical testing are shown in Figure 2.5. Genipin-
crosslinked constructs have significantly higher strain at break than EDAC-crosslinked and 
formaldehyde-crosslinked constructs. Genipin-crosslinked constructs also have significantly higher 
peak stress (p<0.05) and modulus (p<0.1) than formaldehyde-crosslinked constructs. Although 
EDAC-crosslinked constructs and formaldehyde-crosslinked constructs do not show significant 
differences in peak stress and failure strain, their moduli are significantly different. Similar results 
have also been found in the other collagen-based constructs including COL-CHI and COL-CHI-
ELN constructs crosslinked by these crosslinkers.  
 
2.3.4 Effect of gelation time on mechanical properties of collagen constructs 
 
The effect of gelation time has been studied by using 3, 5, 10, 15, 20 and 25 hours of gelation time 
with subsequent crosslinking in EDAC for 5 hours. As shown in Figure 2.6, improvement in the 
modulus is significant as it changes from 261 kPa after 3 hour gelation to about 417 kPa after 25 
hour gelation, while the strain at break decreases slightly. The ultimate tensile strength does not 
significantly change over the gelation time. 
 
 
 
 
54 
 
 
 
 
Figure 2.5: Effect of chemical crosslinkers on mechanical properties of COL constructs with  
(A) Peak stress, (B) Failure Strain and (C) Modulus. Note: * - statistically significant difference in 
comparison to EDAC crosslinked COL gel and † - statistically significant difference in comparison 
to formalin crosslinked COL gel for statistical significance of p < 0.05 in Student’s t test.  
†† - Indicates statistical difference between the formalin crosslinked COL gel and genipin 
crosslinked COL gel for p < 0.1. The error bars indicate the standard error mean. 
 
 
 
 
(A) (B) 
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Figure 2.6: Effect of gelation time on collagen constructs 
 
2.3.5 Biocompatibility testing results on collagen-based constructs 
 
Figure 2.7 shows the images of cells stained using the Live/Dead Assay. The images combine green 
fluorescence (for living cells) and red fluorescence (for dead cells). The cytotoxicity test reveals that 
EDAC-crosslinked or genipin-crosslinked constructs are more favorable for endothelial adhesion 
than formaldehyde-crosslinked constructs which might contain toxic residues that lead to significant 
cell death even after thorough washing steps as described in the method section. Additionally, 
genipin-crosslinked constructs show higher endothelial coverage percent than EDAC-crosslinked 
constructs, suggesting better biocompatibility. Our results also show that the crosslinkers have more 
significant effects on cell compatibility of constructs than the construct compositions. Regardless of 
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the composition, formaldehyde-crosslinked constructs are always characterized by significant cell 
death while genipin-crosslinked constructs are always the most compatible ones.  
 
 
Figure 2.7: Cytotoxicity test results using live-dead assay on following constructs:  
(A) control - culture petri dish; (B) EDAC-crosslinked COL; (C) formalin-crosslinked COL;  
(D) genipin-crosslinked COL; (E) EDAC-crosslinked COL-CHI-ELN;  
(F) formalin-crosslinked COL-CHI-ELN; and (G) genipin-crosslinked COL-CHI-ELN.  
Note: Green fluorescence shows living cells and red fluorescence shows dead cells. 
 
2.3.6 Field emission scanning electron microscopy results on collagen based constructs 
 
Figure 2.8 shows the microstructure of collagen-based constructs as viewed under FESEM. Collagen 
is characterized as a fibrous protein in Figure 2.8A. With addition of chitosan or elastin in collagen 
constructs, the formation of collagen fibers is not affected. Chitosan is generally known to 
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polymerize into thin sheets in the space between the collagen fibrils forming a highly porous 
interpenetrating structure [92-94] . The FESEM images Figures 2.8B-C for COL-CHI and COL-
CHI-ELN constructs also suggest the same. COL-CHI and COL-CHI-ELN basically have similar 
structural features that are characterized by thin sheets along with interfibrils. The COL-CHI-ELN 
constructs clearly showed an increase in the fiber density which also could possibly due to the 
addition of elastin. Though it is difficult to distinguish between collagen and elastin fibers, larger 
fiber bundles are seen in COL-CHI-ELN. As suggested by a previous study [78], it is possible that 
elastin forms thicker fiber bundles than collagen.   
 
 
Figure 2.8: FESEM images of (A) COL, (B) COL-CHI, and (C) COL-CHI-ELN constructs 
 
2.4 Discussion 
 
This study has explored approaches to improve mechanical and biological properties of collagen-
based materials for vascular constructs. It is demonstrated that the incorporation of chitosan and/or 
elastin altered stress-strain curves in the low stress loading region, and significantly improved the 
stretching ratio and peak stress of gel constructs compared to pure collagen constructs. It also 
(A) (B) (C) 
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demonstrated that formaldehyde, EDAC and genipin employ different mechanisms to crosslink 
collagen-based constructs and the use of genipin as a construct crosslinker exhibits improved 
elongation and endothelial coverage as compared to formaldehyde and EDAC.  
 
Mechanisms of mechanical improvements through the construct composition should consider the 
interplay among microstructural components. The incorporation of chitosan and/or elastin in the 
collagen network is confirmed by the presence of C-O-C bonds and changes in the ratio of AN-H to 
AC=O in the FTIR curves (Figures 2.1C and 2.1E) while the FESEM images in Figure 2.8 also suggest 
the same. It is known that collagen fibrils are characterized with low elongation (about 3% 
elongation for individual fibril [95]) and high stiffness with elastic modulus of 10mpa [96], but 
collagen gel constructs are often weak and show non-linear stress-strain relationship because they 
are biphasic materials with the solid phase, the fibril, bearing the majority of the force under tensile 
loading [97]. Similar to the structure and mechanics of pure collagen gel matrices [43], COL-CHI 
and COL-CHI-ELN show biphasic structure and three regions (toe, linear and failure) in the stress-
strain curves. The toe region can be attributed to the rotation of wavy collagen fibers in the 
reconstituted tissues, which store some energy and release upon initial tension, towards the direction 
of force [98]. The microstructure of the collagen matrix changes with the addition of chitosan by the 
formation of chitosan sheets amongst the collagen fibers as suggested by Figure 2.8B. The viscous 
nature of chitosan possibly increased the water retention in the matrix making COL-CHI more 
stretchable than the COL as well as reinforcing it to improve the ultimate strength and the linear 
modulus. This is probably why the toe region in the COL-CHI scaffold is longer than that in COL. 
Our results of COL-CHI mechanics are consistent with previous study [99]. The further extension 
of the toe region with the addition of elastin might be attributed to the potential formation of an 
interpenetrating network of elastin with collagen fibers as suggested by FESEM Figure 2.8C. 
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Although elastin is similar in fiber structure to collagen, these fibers have much lower strength and 
higher elongation. Our results on COL-CHI-ELN mechanics, to some extent, are comparable with 
the mechanics results of natural vessels demonstrated in prior studies. These studies showed that 
elastin in a natural vessel affected the toe region and contributed to the modulus in the low stress 
region [100-102]. Furthermore, our results show that the addition of elastin in COL-CHI constructs 
affects the linear region besides the toe region while the addition of chitosan in the collagen do not 
significantly change the linear region. The exact mechanisms of this reinforcement of elastin need 
further explorations. Therefore, this study has shown that compositional and structural modification 
of collagen-based constructs using ECM-equivalent components is an effective way to simulate 
mechanical performances of native blood vessels whose high stretching ratio, non-linear stress-strain 
curve and viscoelasticity are largely dependent on viscous polysaccharides, elastin fibers and highly 
tortuous, wavy collagen fibers. 
 
 
 
(B) 
(A) 
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Figure 2.9: Biopolymer crosslinking mechanisms (A) EDAC, (B) Formaldehyde & (C) Genipin 
(Note: BM = Biomolecule) 
 
Hydrated collagen-based constructs are often very weak in vitro. Crosslinkers such as glutaraldehyde 
have been used to increase the strength of these constructs. However, the drawbacks are the 
potential of glutaraldehyde to high levels of toxicity and immunogenicity, as well as high stiffness 
which was associated with adverse cell responses [84]. More recently, EDAC, formaldehyde and 
genipin have been used as glutaraldehyde substitutes due to their lower toxicity [103, 104]. This 
study has evaluated the effects of these crosslinkers on mechanical behaviors and endothelial 
coverage of hydrated collagen-based constructs because these properties are major considerations in 
vascular grafts. Genipin-crosslinked constructs seem to be promising for these applications because 
genipin-crosslinked constructs show a higher elongation percent and are more biocompatible than 
formaldehyde- and EDAC- crosslinked ones. Formaldehyde-crosslinked constructs showed 
significant cytotoxicity after thorough washing. This was possibly due to the presence of the residues 
from crosslinkers which might be difficult to remove and were slowly released from the constructs 
over time [84]. Though EDAC is more cytocompatible than formaldehyde, endothelial coverage on 
EDAC-crosslinked gels are lower than that on genipin-crosslinked ones. This might be because 
EDAC more effectively reduces RGD sequences by crosslinking them in the biopolymer matrices. 
EDAC toxicity has also been demonstrated by Kataropoulou et al [105].  The differences among 
(A) 
(C) 
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these crosslinkers might be explained by their crosslinking mechanisms. In agreement with previous 
reports [104, 106, 107] the crosslinking mechanisms suggested by our FTIR results are demonstrated 
in Figure 2.9. EDAC, a zero-length carbodiimide crosslinker, crosslinks the carboxyl and amine 
groups presented in the biopolymer matrix, forming stable amide bonds (Figure 2.9A). The 
consumption of the amine group is confirmed by an increase in the intensity of amide II peak (1550 
cm-1) and the ratio of AN-H to AC=O (Figure 2.2B). Formaldehyde, on the other hand, in neutral 
solutions reacts with the hydroxyl group presented in the biopolymer matrix, forming -C-O-C- 
bonds (Figure 2.9b). This is confirmed by an increase in the intensity of the -C-O-C- stretch (1150 
cm-1-970 cm-1) in Figure 2C. There is no change in the intensity of the amide II peak and in the ratio 
of AN-H to AC=O, indicating that formaldehyde does not attack carboxyl or amine groups. Genipin 
forms a dimer or a longer oligomer [106, 107] with itself and forms two hemiaminal bonds with 
collagen during crosslinking [108] (Figure 2.9C). The insertion of genipin in the collagen network 
after crosslinking is confirmed by Figure 2.2C in that the decrease in the ratio of AN-H to AC=O is due 
to the carboxyl group from genipin and a weak peak at 1740 cm-1 is due to the ester group from 
genipin. The formation of the genipin dimer or oligomer possibly explains why genipin-crosslinked 
constructs yield a higher elongation percent than EDAC- or formaldehyde- crosslinked ones. It 
should be noted that this study has been focusing on investigating how the different chemical 
crosslinkers involve different crosslinking mechanisms and attack different functional sites on the 
biopolymer matrices, rather than comparing how the crosslinking density or efficiency influences the 
constructs. Thus, one limitation in this study must be acknowledged: crosslinking density was not 
taken into account. Nevertheless, in spite of having different concentrations (or crosslinking density) 
the crosslinker, both EDAC and formaldehyde imparted very similar peak stress and failure strain to 
COL while EDAC and genipin imparted similar linear elastic modulus.  
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2.5 Conclusions 
 
Results from this study have demonstrated that the properties of collagen constructs are tunable 
with the addition of mimetic components and the selection of crosslinkers. Chitosan and elastin 
improve the strength, elongation and stretchability of collagen-based gel constructs. Crosslinkers 
impart critical effects on the strength and modulus of the constructs as well as cell compatibility. 
Constructs crosslinked with genipin demonstrate higher elongation and endothelial coverage without 
reducing strength compared to EDAC and formaldehyde. In addition, extending gelation time 
increased the modulus but not the ultimate strength or the elongation at the break. Therefore, the 
constructs composed of a combination of collagen, chitosan and/or elastin and crosslinked with 
genipin, hold potential for superior performance in both mechanical properties and biological 
properties. This study has given important implications to engineering collagen-based gel matrix 
materials for vascular graft applications.  
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CHAPTER 3 
 
3. COMBINATION OF GENIPIN CROSSLINKING AND BIOACTIVE MOLECULES IN 
COLLAGEN-CHITOSAN-ELASTIN MATRIX FOR VASCULAR MEDIA 
EQUIVALENT 
 
Abstract 
 
The vascular media layer, containing smooth muscle cell (SMC), is often a target functional tissue in 
the construction of artificial blood vessels, because it has major contribution to mechanical 
properties and other important vascular functions such as contraction of the vessel and regulation of 
endothelial functions. The present study aimed to construct mechanically strong and stable, 
biologically functional scaffold for vascular media equivalents. To this end, a biocompatible 
crosslinker genipin was used to crosslink collagen-chitosan-elastin (CCE) constructs, and the effects 
of genipin concentration on the mechanical properties, SMC activity and degradation of collagen-
chitosan-elastin (CCE) constructs were examined. Results revealed that mechanical strength, 
stiffness and stability of CCE gel constructs increased with the addition of genipin and with its 
concentration increasing from 1mM to 25mM, but genipin significantly inhibited SMC contraction 
of and invasion in the CCE gels. No SMC contraction or invasion was observed in the gels 
crosslinked with genipin at a concentration of 5mM or above. These results were shown to be 
correlated with the chemical characterization results from ATR-FTIR. Since cell activities become 
increasingly important for regenerative medicine, the incorporation of soluble factors in insoluble 
structural matrices is crucial for regenerating biological activities of cells. We thus incorporated 
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several growth factor conditions in the genipin-treated CCE constructs and evaluated their effects 
on SMC activities. These conditions include heparin, platelet-derived transforming growth factor 
(PDGF), high-concentrated fetal bovine serum (h-FBS) and their combinations. Results showed that 
the addition of h-FBS in genipin-crosslinked gels significantly increased SMC contraction and 
invasion, PDGF increased SMC invasion while heparin reduced this PDGF effect, and the 
synergetic effects of h-FBS and PDGF stimulated SMC invasion more significantly than a single 
factor. Thus, the use of combination of h-FBS and PDGF with 1mM genipin-crosslinked CCE 
constructs might potentially achieve a vascular media equivalent with superior performances. Our 
study suggests that designing a suitable engineering equivalent to blood vessels which allow 
immediate implantation and encourage tissue regeneration in vivo should employ an appropriate 
combination of crosslinking condition and soluble biomolecule factors, striking a balance between 
mechanical and biological properties. 
 
3.1 Introduction 
 
Synthetic vascular grafts or artificial blood vessels are widely used for a number of medical 
treatments including bypass surgery for atherosclerosis and vascular access for hemodialysis. Often 
these vascular grafts are made from synthetic polymers such as expanded polytetrafluoroethylene (e-
PTFE) and Dacron (polyethylene terephthalate)[70]. Though these inert, stiff polymeric grafts 
successfully replace large arteries, problems arise with replacement of small-diameter (< 6mm) 
vessels, which results in high occlusion rate[23, 71]. To overcome these problems, more recent 
efforts have been focusing on tissue engineering approaches. In the general paradigm of tissue 
engineering, vascular cells are often seeded in vitro on a synthetic or biological porous scaffold, and 
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are allowed to proliferate and produce matrices before final implantation. Recent successes in this 
area have demonstrated the use of bioreactor, imposing appropriate biochemical and/or mechanical 
stimuli on cell-scaffold, to reproduce architecture and function of a blood vessel, simulating part or 
all of its multiple layers, namely intima, media and adventitia L’Heureux, 1998 [41] L’Heureux, 2006.  
These approaches often start with mechanically weak extracellular matrix (ECM) materials or 
biodegradable polymers and, through a few weeks of culture in a bioreactor, result in a mimetic 
vascular structure with high tensile modulus and strength L’Heureux, 2006  [53]. However, due to 
the weak initial tensile properties of the engineered constructs, the main problem encountered with 
these approaches is the time, cost and effort necessary to prepare the biological grafts [17]. A long 
culture time is not suitable for many grafting procedures requiring an immediate replacement.  Also, 
due to lack of elastic lamina in these constructs, long-term implants showed dilation of vessel[13]. 
Furthermore, harvesting vascular cells from patients and then culturing them could be 
problematic[17, 20]. An alternative approach omits in vitro cell culture by chemically crosslinking 
decellularized or acellular extracellular matrix scaffolds using glutaraldehyde to enhance mechanical 
properties for immediate implantation and allow cells to migrate and form tissues in vivo [22, 93]. But 
cytotoxicity and host response are major concerns when a chemical crosslinker such as 
glutaraldehyde is in use [84]. To that end, our previous study evaluated the biological, mechanical 
and structural properties of collagen-based constructs which were crosslinked with more 
biocompatible crosslinkers such as formaldehyde, ethyl-(dimethyl aminopropyl) carbodiimide and 
genipin [109]. Results demonstrated that genipin-crosslinked materials had comparatively favorable 
mechanical properties and cell compatibility.  
 
The vascular media layer, containing smooth muscle cell (SMC), is often a target functional tissue in 
the construction of artificial blood vessels, because it has major contribution to mechanical 
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properties and other vascular functions such as contraction of vessel and regulation of endothelial 
functions [98]. The extracellular matrix (ECM) of vascular media is a composite consisting of fibrous 
proteins such as collagen and elastin, proteoglycans formed by glycosaminoglycan polysaccharides, 
and biomolecules such as growth factors. Both collagen and elastin fibers are indispensable 
components in native and engineered vessels, due to their critical roles in maintaining strength and 
elasticity meanwhile promoting matrix synthesis and tissue regeneration[81, 102]. Chitosan or “poly 
D-glycosamin” is a natural polysaccharide derived from chitin and is characterized by structural 
similarity to glycosaminoglycan and excellent biocompatibility. We have thus chosen collagen, 
chitosan and elastin as structural components of the scaffold material for a vascular media 
equivalent.  In addition to structural components, various growth factors are also present in vascular 
media to support the cellular processes necessary for optimal functions of the tissue. Thus, the 
present study is to construct mechanically strong and biologically functional vascular media 
equivalents composed of a combination of structural components and growth factors and properly 
crosslinked with genipin. We first examined the effects of genipin concentration on the mechanical 
properties, SMC activities and matrix degradation of collagen-chitosan-elastin (CCE) constructs. 
Then, we incorporated several growth factor conditions in the genipin-treated CCE constructs and 
evaluated their effects on SMC activities. Heparin and platelet-derived transforming growth factor 
(PDGF) are substances known to influence vascular cells and are often incorporated or analyzed in 
the vascular graft device. Also, standard fetal bovine serum (FBS) provide nutrients to cells and has 
a rich content of growth factors like transforming growth factor-β (TGF-β) and PDGF. Therefore, 
heparin, PDGF, high-concentrated FBS (h-FBS), and their combinations are used for biomolecule 
conditioning in the study. This study is important to our ultimate goal of producing an engineering 
equivalent to blood vessels, which may allow immediate implantation and encourage tissue 
regeneration in vivo. 
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3.2 Materials and methods 
 
3.2.1 Preparation of CCE gel constructs 
  
Collagen-chitosan-elastin (CCE) gel constructs were prepared according to the following procedure:  
First, the Pre-gel mixture was prepared on an ice bath under sterile conditions.  After agitation, 3ml 
of elastin solution (in 0.2M Tris, at a concentration of 20mg/ml) was placed in a 50ml centrifuge 
tube.  Then, 1ml of 10x Hank’s Balanced Salt Solution (HBSS) containing phenol red was added.  
This was followed by addition of 3.6ml of collagen (at a concentration of 8.4mg/ml), 1.5ml of 
chitosan (at a concentration of 10m/ml), 100µl of 7% NaHCO3, and then 30µl of 1M NaOH.  At 
this point, the solution was agitated to ensure a homogeneous mixture.  Then, a pH paper was used 
to confirm the pH of the solution (~ 7.4).  Finally, 850µl of nanopure water was added to bring the 
solution to a final volume of 10ml.  The final concentration of collagen, chitosan, and elastin were 
respectively: 3mg/ml, 3.5mg/ml, and 7mg/ml. Pre-gel solutions were cast into 12-well or 24-well 
plates and allowed to polymerize 1 hour in a cell culture incubator at 37˚C. They were then 
crosslinked with 0mM (no crosslinking), 1mM, 5mM, 10mM and 25mM genipin.  After five hours, 
the genipin solutions were aspirated, replaced with 1ml of PBS per well. The culture plate was then 
maintained overnight at room temperature. The next day, the gels were washed 6 times with 30 
minutes each wash using sterile PBS.   
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3.2.2 Treatment of CCE constructs with growth factors 
 
The heparin growth factor solution was prepared by dissolving 100 units of heparin per mL of 1X 
PBS. The platelet-derived growth factor (PDGF) solution was obtained by mixing 400ng of PGDF 
per mL of 1X PBD. A solution with a combination of heparin and PDGF was prepared by 
dissolving 100 units of heparin and 400ng of PDGF per mL of 1X PBS. Highly concentrated fetal 
bovine serum (h-FBS) solution was prepared by dissolving 75% FBS, 24% DMEM, and 1% 
Penicillin/Streptomycin/Amphotericin per mL of 1X PBS. A solution with a mixture of h-FBS and  
PDGF was prepared by dissolving 75 % FBS and 400ng PDGF per mL of 1X PBS. The CCE 
constructs were soaked in each of the solution for 1 hour to allow the growth factors to get embed 
in the matrix by diffusion. 
 
3.2.3 Fourier transform infrared spectroscopy for biochemical characterization 
 
The CCE gel constructs were frozen in liquid nitrogen (~195˚C), following which they were dried in 
a critical-point drying chamber (Labconco, Kansas City, MO) for approximately 48 hours. The 
biochemical compositions and the crosslinking mechanisms were studied using an attenuated total 
reflectance Fourier transform infrared (ATR-FTIR) spectrometer, Nicolet 4700 (Thermo Fisher 
Scientific Inc., Waltham, MA). Comparisons were made between samples and pure collagen 
constructs to study the effect of various matrix components and the effect of crosslinkers. OPUS 
software (Bruker Optik GmbH, Ettlingen, Germany) was used to find the peaks and to calculate the 
areas under the peak. 
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3.2.4 Uniaxial tensile testing for mechanical characterization 
 
All of the experimental gel constructs were subjected to uniaxial tensile tests employing the same 
testing protocol. An MTS Insight electromechanical testing system (MTS Systems Corp., Eden 
Prairie, MN) was used. Testing was performed in a 1X DPBS bath at room temperature. A special 
set of grips in delrin was used to avoid corrosion. One of the grips was loaded on the lower end of 
the instrument while the other grip was mounted under a 5 N load cell (MTS Systems Corp., Eden 
Prairie, MN) attached to the other end of the instrument. Samples were loaded and the dimensions 
of thickness, gauge length and width were measured using a vernier caliper. All the samples were 
tested at a strain rate of 1% per second until failure. The stress-strain curves were plotted for each of 
the samples to determine peak stress, strain at break and linear elastic modulus. These curves were 
fit with a 5th order polynomial using Matlab (MathWorks Inc., Natick, MA). Data collected were 
statistically analyzed using the one-way ANOVA test. Student’s t test was then used to compare the 
means of each individual group. The level of significance was set at α = 0.05 for 95% statistical 
significance. Error bars on all the histogram charts represent the standard error of the mean (SEM) 
based on the total number of the samples. 
 
3.2.5 Cell culture, adhesion, viability and proliferation assay 
 
The SMCs freshly separated from bovine pulmonary arteries were cultured and cells between 
passages three and six were used in all biological assays. Cells were cultured in Dulbecco’s Modified 
Eagle’s Medium (DMEM) supplemented with 10% FBS, 2% L-Glutamine, and 1% penicillin-
streptomycin at 37˚C and 5% CO2, unless otherwise stated. SMCs were cultured until approximately 
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90% confluence before cell seeding. All the cell assays were carried out after the removal of genipin 
and thorough washing steps. 
 
For cell viability and proliferation assay, the SMCs were seeded in 12-well plates (cell concentration 
= 235,700 cells per mL per well, which is approximately 50% confluence), covered with 1ml of cell 
culture medium and incubated for one day before the gel were plated. After the gels were 
polymerized and crosslinked, the gels were thoroughly washed in PBS and transferred into the 12-
well plates seeded with SMCs; this was referred to as day 0. For cell adhesion assay, the SMCs were 
directly seeded onto the gel constructs. On the next day (day 1), cell viability assay (LIVE/DEAD 
kit obtained from Invitrogen Corporation, Carlsbad, CA) was performed. After aspirating the 
medium and five washes with D-PBS, 500µl of LIVE/DEAD staining solution (obtained by mixing 
20µl of 2mM ethidium homodimer-1 stock solution followed by 5µl of 4mM calcein AM stock 
solution in 10 mL of D-PBS) was added to each well. Plates were then incubated at room 
temperature for 40 minutes. The staining solution was then aspirated and the gels were washed five 
times with D-PBS and covered with cell culture medium. The cells were then viewed under a Zeiss 
Axiovert S100 inverted fluorescent microscope, six photographs per well were taken. The applied 
stain presented by live cells was green (calcein) while the nuclei of dead cells were stained red 
(ethidium). The obtained images were then analyzed using ImageJ software (NIH, Bethesda, MD) to 
determine cell counts. The percentage of viable cells was determined by the number of live cells and 
the total number of cells including live and dead cells. Similar viability assay was again carried out on 
the same plates on day 4 to determine cell number and thus the cell proliferation was determined by 
the increase percentage of the live cell number from day 1 to day 4.  
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3.2.6 Cell contraction assay 
 
Pre-gel solutions were cast into 24-well plate wells and allowed to polymerize 1 hour in a cell culture 
incubator at 37˚C.  They were then crosslinked with 0mM (no crosslinking), 1mM, 5mM, 10mM and 
25mM genipin.  After five hours, the genipin solutions were aspirated, replaced with 1ml of PBS per 
well and then the culture plate was maintained overnight at room temperature. The next day, the 
gels were washed 6 times with 30 minutes each wash using sterile PBS.  The gels were then covered 
with fresh PBS and were left in the cell culture hood under UV light for 1 hour.  Following 
sterilization with UV light, the gels were covered with culture media (DMEM containing 10% FBS, 
2% L-Glutamine, and 1% penicillin/streptomycin/amphotericin) and incubated at 37˚C and 5% 
CO2 for 1 hour. Gels were then seeded with 200µl of SMCs, incubated at 37˚C and 5% CO2 for one 
hour to allow cell adhesion.  After seeding, the gels were covered with 1ml of cell culture medium, 
allowed the cells to attach to the gels for 1 hour, and then detached from the culture plate wells by 
running a pipette tip around the circumference of the gel.  SMC seeded gels were then cultured at 
37˚C and 5% CO2 for 72 hours, with medium being changed every 24 hours.  The seeded gels were 
subsequently photographed at 24-, 48-, and 72-hour time points. The gels were placed on a light box 
and were photographed using a Nikon Coolpix 995 camera at full optical zoom at a height of 
approximately 40cm above the light box.  The images were then processed using ImageJ software to 
determine gel area.  Gel areas were calculated for each of these time points and compared to the 
original gel area. Gel contraction was determined by the comparison ratio.   
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3.2.7 Cell invasion assay  
 
After performing gel contraction experiments, the gels that were used to determine contraction were 
used to evaluate cell invasion.  After the 72-hour time point, they were washed once with PBS.  Gels 
were then immersed with formalin for 10 minutes.  The formalin solution was then replaced with 
PBS.  The gels were then embedded in paraffin, sectioned and then stained with hematoxylin and 
eosin to examine histology.  Nine total sections per gel were made, with three on one edge, three in 
the center of the gel, and three on the opposite edge of the gel.  The sections were then viewed 
using a Zeiss Axiovert S100 microscope at 100x magnification and photos were taken of the gel 
sections.  Using Zeiss Axiovision software, photos of gel sections that exhibiting SMC invasion were 
analyzed for invasion depth.  This was done by measuring the distance, in micrometers, from the 
gels top surface (seeding surface) to the location of the cells inside the gel. 
 
3.2.8 Gel degradation assay  
 
CCE gel constructs were prepared and polymerized as described above.  The gels were then 
crosslinked using 0mM (no crosslinking), 1mM, 5mM, 10mM and 25mM genipin solutions.  Gels 
were then washed three times in PBS for 30 minutes each, three times in culture medium for 30 
minutes each, and again three times in PBS for 30 minutes each.  Gels were then detached and 
removed from the 24-well plates and placed on glass slides which were placed in a vacuum oven 
(room temperature, -18 inHg) for 48 hours to dry.  Air was allowed to leak in to prevent water vapor 
buildup and to facilitate drying.  After gels were dried, they were carefully scraped off the slides 
ensuring that they stayed intact using a razor blade.  The gels were then weighed, and their masses 
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recorded.  The gels were then placed in 1.5ml microfuge tubes, to which 1ml of collagenase type I 
(100µg/ml) solution was added.  The gels were then incubated at 37˚C for 4, 8, 12, and 24 hours.  At 
each time point, gels from each crosslinking condition were removed from the incubator and placed 
on ice for 5 minutes to arrest digestion.  The supernatant from each microfuge tube was aspirated 
and the gels were again dried in a vacuum oven, and then weighed.  The percentage of degradation 
was then determined based on the mass loss of the gel. 
 
3.3 Results 
 
3.3.1 Effect of genipin concentration on the mechanical properties of CCE constructs 
 
First, the influence of the concentration of genipin applied on the mechanical properties of CCE 
constructs was studied. Figure 3.1 demonstrates quantitative results from uniaxial tensile testing 
performed on the CCE constructs crosslinked with genipin at various concentrations. The figures 
shows that compared to uncrosslinked constructs, the peak stress and linear modulus of any 
genipin-treated construct significantly increase. Uncrosslinked samples have peak stress (or failure 
strength) of 18.01 ± 6.48 kPa and modulus of 84.75 ± 26.45 kPa. Crosslinking the construct with 
1mM genipin increases the peak stress to 47.1 ± 15.38 kPa, and the linear modulus to 294.68 ± 
75.12 kPa. Thus, the 1mM genipin-crosslinked CCE samples demonstrate mechanical improvement 
around 2-3 times over the uncrosslinked samples, but they show no significant difference in strain at 
break from the uncrosslinked ones. As the concentrations of genipin crosslinker increase to 5mM, 
10mM, and 25mM, the peak stresses increase to 49.17 ± 16.01 kPa, 54.3 ±11.59  kPa, and 61.34 ±  
18.81  kPa, respectively, and the moduli increase to 365.41 ± 148.57 kPa, 393.07 ±94.82  kPa, and 
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400.22 ±  78.5  kPa, respectively. Compared to 1mM genipin-treated samples, 25mM genipin-treated 
samples show significant mechanical improvements in peak stress and linear modulus, increasing by 
about 30% and 36%, respectively. Compared to 1mM genipin-treated samples, 5mM and 10mM 
genipin-treated samples did not show any significant improvement (4% and 13%) in mechanical 
strength but they increased the linear modulus by 24% and 33%, respectively. Uncrosslinked 
samples fail at 31.35 ± 10.49% strain, while samples crosslinked with genipin concentrations of 
1mM, 5mM, 10mM and 25mM reduce the strain at break by 5%, 6%, 8% and 7%, respectively. 
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Figure 3.1: Results from uniaxial tensile test showing the effects of the genipin concentration on 
mechanical properties of CCE constructs.  (A) Peak Stress (B) Strain at break and (C) Linear 
modulus.  For statistical significance, p < 0.05 in Student’s t-test, “*”and “†”respectively represent 
significantly different (p < 0.05) from uncrosslinked constructs (0mM) and 1mM genipin crosslinked 
constructs; “**” and “††”respectively represent possibly different (0.05 < p < 0.1) from 0mM and 
1mM. The error bars indicate the standard error mean 
 
 
 
(A) (B) 
(C) 
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3.3.2 ATR-FTIR characterization results showing the incorporation of genipin and the effect of 
genipin concentration 
  
Since crosslinking CCE constructs with genipin change the construct mechanical properties, we 
asked whether changes in the mechanical properties are due to the chemical structure changes with 
the crosslinking conditions. ATR-FTIR was used to characterize the chemical changes in the 
construct. Figure 3.2 demonstrates the spectra of genipin (Curve 3.2A), uncrosslinked CCE samples 
(Curve 3.2B) and genipin-crosslinked samples (Curves 3.2C-3.2E) showing the incorporation of 
genipin and the effect of genipin concentration. The spectrum of uncrosslinked samples 
demonstrate the incorporation of all component additives, as it can be interpreted as linear 
combinations of the individual collagen, chitosan, and elastin spectra [109]. Compared to the 
spectrum of uncrosslinked samples, the changes in the ATR-FTIR spectra of the genipin-crosslinked 
CCE samples are described as followings: (1) The spectra of all the genipin-crosslinked samples 
show a decrease in the characteristic peak derived from amine (-NH2) stretch between 3500 cm
-1-
3200 cm-1. With the increase in the concentration of genipin from 1mM to 5, 10 or 25mM, this peak 
further decreases slightly. This can be attributed to the usage of the amine (-NH2) group during the 
formation of the hemiaminal group. (2) The amide II peak (N-H bend at around 1550 cm-1) shifts to 
the right by about 15 cm-1-20 cm-1. This may be due to the consumption of N-H and the covalent 
addition of carbon-carbon structures such as C–C in–ring stretch and -C=C- stretch, whose peaks 
are stronger than the amide (-NH-) peak. This can be attributed to the aromatic and alkene 
structures in the genipin molecule. (3) There is also a substantial change in the range of -C-O-C- 
stretch (1170 cm-1-950 cm-1). A new peak at around 1105 cm-1 shows up in the crosslinked samples. 
This change may be due to the incorporation of genipin oligomer in the crosslinked structure and 
thus some genipin molecules retain -C-O-C- group. Therefore, the ATR-FTIR characterization 
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results demonstrate the incorporation of genipin in the CCE constructs and demonstrate the slight 
increase in the crosslinking density with the increase in the genipin concentration. 
 
 
Figure 3.2: ATR-FTIR spectra demonstrate the incorporation of genipin in the CCE constructs. 
Genipin; (B) Uncrosslinked constructs; (C) 1mM genipin-treated constructs;  
(D) 5mM genipin-treated constructs; (E) 25mM genipin-treated constructs. 
The spectrum of 10mM genipin-treated constructs is the same as that of 5mM. 
 
3.3.3 Effect of the genipin concentration on SMC activities 
 
The materials for vascular media equivalent should not only be mechanically strong but also provide 
amiable environment to SMCs. The most concern with chemical crosslinkers is the cell toxicity and 
other unfavorable influence on cell activities. We thus used SMCs to examine cell viability, 
proliferation and invasion in the genipin-treated CCE constructs. Cell viability assay has shown that 
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there are no significant differences among uncrosslinked samples and all the genipin-crosslinked 
samples (Figures 3.3A and 3.3B). It also shows that the number of cells attached onto the surface of 
CCE constructs is not significantly affected by the concentration of genipin solution. Additionally, 
cell proliferation study shows that there are no significant differences between the uncrosslinked 
samples and the genipin-crosslinked samples except 25mM genipin-crosslinked samples which 
significantly reduce cell proliferation by entirely preventing the cells from growing (Figure 3.3C).  
 
Cell contraction assay is an assay to evaluate the cell-matrix interaction, particularly the contractile 
function of SMCs on the gel matrix. Here, it was determined by comparing the gel area after 24-, 48- 
or 72- hour cell seeding to the original gel area. Contraction assay results (Figure 3.4) show that only 
the uncrosslinked samples and the 1mM genipin-crosslinked samples exhibited contraction by 
SMCs, while the samples that were crosslinked with higher concentrations of genipin did not. The 
average contraction percentages of 0mM (uncrosslinked samples) and 1mM genipin-crosslinked 
samples after 24 hours were 61.75% and 13.34%, respectively. The gel contractions after 48 hours 
and 72 hours did not show significant differences as compared to those after 24 hours. In addition, 
cell invasion assay showed that cells did not migrate into all the genipin-crosslinked samples 
including 1mM, 5mM, 10mM and 25mM genipin treated samples (data not shown).  
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Figure 3.3: (A) Representative images from SMC viability assays on the CCE constructs crosslinked 
with genipin at different concentration (0mM, 1mM, 5mM, 10mM and 25mM). Live cells showed 
green stain and dead cells showed red stain. (B) Quantitative results of SMC viability assay; (C) 
Results from SMC proliferation assay. 
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Figure 3.4: (A) Representative images from contraction assay showing SMC contraction of 
uncrosslinked (0mM) and crosslinked gel constructs (1mM, 5mM, 10mM and 25mM) after 24hr as 
compared to those just detached from the bottom (0hr). (B) Quantitative measurements of the gel 
contraction which changes with the genipin concentrations. “*” and “†” represent significantly 
different from 0mM and1mM, respectively. 
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Figure 3.5: (A) Representative images from contraction assay showing the effect of h-FBS on SMC 
contraction of uncrosslinked and crosslinked gel constructs after 24hr and after 72 hr.; (B) 
Quantitative measurements of the changes in gel contraction with genipin concentrations after 24hr. 
“*” and “†” represent significantly different from 0mM and 1mM, respectively. 
 
3.3.4 Effect of growth factor conditions on SMC activities 
 
As demonstrated in 3.3.3, the genipin crosslinking significantly inhibits SMC-matrix interactions and 
SMC activities, such as contraction and migration, but it does not significantly affect cell adhesion, 
viability and proliferation except for the concentration of 25mM. To overcome this inhibition effect, 
several growth factor conditions, including h-FBS, PDGF, heparin, mixture of h-FBS and PDGF 
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and mixture of heparin and PDGF, were designed in the present study. Heparin, PDGF, and h-FBS 
are known to have the ability to stimulate vascular cell proliferation and/or chemotaxis. Solutions 
containing growth factors were used to condition crosslinked gel constructs. Figure 3.5 illustrates the 
effect of h-FBS on SMC contraction of the gels. Compared to Figure 3.4, this result shows that the 
increased concentration of FBS, a mixture of nutrients and low-concentrated growth factors, 
increased SMC contraction of all the genipin-crosslinked CCE gel constructs except 25mM, while 
the h-FBS condition did not significantly influence SMC contraction of uncrosslinked gels. 
However, the gel contractions of crosslinked samples were still significantly lower than the gel 
contraction of the uncrosslinked samples. Also, the gel contraction of 1mM genipin-crosslinked 
samples was significantly higher than that of 5mM or 10mM genipin-crosslinked samples. 
 
These studies indicated that higher genipin crosslinking conditions, 5mM and above, significantly 
inhibit SMCs in spite of growth factor conditioning. Therefore, we further examined the effects of 
growth factors on SMC traction and invasion using only two types of COL-CHI-ELN constructs, 
uncrosslinked and 1mM genipin-crosslinked ones. Figure 3.6 shows the results of cell contraction 
assays performed on the 0mM and 1mM genipin-crosslinked samples with different biomolecule 
conditions including heparin, PDGF, h-FBS, a combination of heparin and PDGF and a 
combination of h-FBS and PDGF. The results are shown in comparison to the “null” condition 
which use only standard 10% FBS with no additional growth factors. For 1mM genipin-crosslinked 
samples, the addition of h-FBS or a combination of h-FBS and PDGF significantly increased the gel 
contraction when compared to the null condition.  For uncrosslinked samples, only the addition of a 
combination of h-FBS and PDGF significantly increased the gel contraction when compared to the 
null condition. 
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Figure 3.6: Effects of soluble factors on SMC contraction of uncrosslinked and crosslinked gel 
constructs. “*” and “†”respectively represent significantly different from null  
condition at 0mM and null condition at 1mM. 
 
The SMC invasion assay results are demonstrated in Figure 3.7. SMCs invaded deep into the 
uncrosslinked gel constructs, and the use of h-FBS did not significantly influence SMC invasion. 
Without the use of h-FBS or the addition of biomolecules, the cellularity in the gel constructs was 
limited to the periphery of the 1mM genipin-crosslinked CCE construct, with almost no cells found 
in the center of the construct. The use of h-FBS significantly increased the SMC invasion depth, and 
a combination of h-FBS and PDGF further increased SMC invasion in the crosslinked construct. 
The addition of PDGF also increased SMC invasion, but the addition of heparin together with 
PDGF into the crosslinked construct showed reduced SMC invasion in comparison to PDGF alone. 
This indicated that heparin has inhibitory effects on PDGF-induced SMC invasion into the 
crosslinked constructs. 
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Figure 3.7: Effects of soluble factors on SMC invasion in uncrosslinked and crosslinked gel 
constructs. (A)  The relationship between cell invasion depth and the conditioning of soluble factors 
and crosslinker concentration. “*”represent significantly different from the null condition (1mM). 
(B) Representative images from the histology study. 
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3.3.5 Effect of genipin crosslinking on the degradation of CCE matrices 
 
Crosslinking of the gel matrix is also expected to increase its stability after implantation. We thus 
examined the degradation of genipin-crosslinked CCE matrices in response to collagenase (Figure 
3.8). Uncrosslinked constructs showed gradual degradation, with an average degradation of 4.5% at 
4hr to an average of 20% at 24hr.  Genipin-crosslinked CCE matrices showed much slower 
degradation. With the increase of genipin concentration, the degradation rate of the matrix 
constructs decreased. The 10mM-crosslinked CCE matrices did not demonstrate significant 
degradation within the first 24 hours. No differences in construct degradation were found among 
samples crosslinked with 5, 10 and 25mM genipin. 
 
 
Figure 3.8: Degradation of different CCE gel constructs over time. The degradation curves of 5mM 
and 25mM genipin-treated constructs are similar as that of 10mM. 
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3.4 Discussion 
 
Vascular media equivalents require sufficient mechanical strength, stability and amiable 
environments for SMC function. In general, cell environment is composed of several factors which 
fall into one of two categories: insoluble cues such as the composition and stiffness of the ECM and 
soluble cues such as growth factors [110]. Thus, the present study has demonstrated the effect of the 
concentration of genipin, a natural-derived crosslinker, on the mechanical strength, stiffness and 
stability (resistance to biodegradation) of CCE gel constructs, and further explored the use of 
soluble growth factors in the genipin-crosslinked CCE matrices to enhance SMC activities. We 
found that mechanical strength, stiffness and stability of the gels increased with the addition of 
genipin and with its concentration increasing from 1mM to 25mM, but genipin significantly 
inhibited SMC contraction of and invasion in the CCE gels. No SMC contraction or invasion was 
observed in the gels crosslinked with genipin at a concentration of 5mM or above. We thus 
incorporated soluble growth factor conditions, including h-FBS, PDGF, heparin and their mixtures 
in the genipin-crosslinked gels. The addition of h-FBS in the 1mM genipin-crosslinked gels 
increased SMC contraction and invasion, PDGF increased SMC invasion, heparin reduced this 
PDGF effect, and the synergetic effects of h-FBS and PDGF stimulated SMC invasion more 
significantly than a single factor. This study suggests that the use of combination of h-FBS and 
PDGF with 1mM genipin-crosslinked CCE constructs could potentially achieve a vascular media 
equivalent with improved performances. 
 
Several previous studies have determined mechanical properties and degradation of collagen and 
collagen-chitosan gel materials. Compared to a study done an earlier study, our results showed that 
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uncrosslinked CCE constructs were mechanically stronger (~50% higher in strength) and degraded 
more slowly (20% vs. 90% of degradation after 24 hours). In addition to the matrix composition, 
our results also showed that addition of a low concentrated (1mM) genipin solution significantly 
increased stiffness, strength and stability. Furthermore, the mechanical strength, stiffness and 
stability slightly increased with the concentration, but the differences in the mechanical property 
between genipin with 1mM concentration with those at higher concentrations were not proportional 
to the fold-increase in the concentration, and no significant difference in the mechanical property 
and stability was found among the three high crosslinker concentrations (e.g. 5mM, 10mM and 
25mM). This could be explained by the changes in functional groups and density by the genipin 
crosslinking. FTIR data suggested that increase in the genipin solution concentration influenced the 
crosslinking density only to a small degree, which might be caused by the saturation of the 
crosslinking sites.       
 
Crosslinking conditions also influenced SMC activities. In agreement with previous studies [109], we 
found that genipin crosslinking imposed no cytotoxicity on SMCs as cell viability and adhesion were 
not significantly affected by the genipin concentration. And cell proliferation was also not 
significantly affected by the genipin concentration except for 25mM genipin. Additionally, we found 
that directly adding 1mM genipin in cell-containing CCE constructs significantly reduced the cell 
viability after 24 hr. incubation (~10%) compared to uncrosslinked samples (data not shown here). 
This finding is different from the study performed by Sundararaghavan et al[91] who reported that 
directly adding 1mM genipin in cell-containing collagen matrix did not significantly affect fibroblast 
viability compared to uncrosslinked ones. This might be due to the difference in cells as immortal 
cell lines were used in that study while primary cells were used here. Our study suggests that cell 
seeding must be performed after the removal of genipin even though it is one of the most 
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biocompatible crosslinkers for collagen-based matrix gels. Additionally, we found that crosslinking 
reduced SMC-matrix interactions and reduced SMC contraction and invasion. Increased crosslinking 
density further reduced these SMC activities. This was likely caused by the mechanical and 
biochemical changes crosslinking brought to the gel constructs, altering the microenvironments for 
SMCs. In particular, genipin crosslinking increased the gel stiffness and might decrease the number 
of RGD peptide sequences on collagen. The critical role of matrix stiffness in regulating cell 
behaviors has received great attention recently. Mechanical testing results showed that 1mM genipin 
significantly increase the stiffness of CCE gel and higher genipin concentration resulted in higher 
matrix stiffness. A previous study reported that normal epithelial cells and fibroblasts migrated faster 
on softer substrates than stiff substrates, because softer substrates resulted in more focal adhesions 
in cells and thus higher forces generated by myosin contraction. As a biomaterial, collagen I has 
many advantages including its high density of the RGD sequence and other functional sequences for 
cell attachment and cell differentiation. Genipin-crosslinking among functional peptides inhibits 
cellular recognition and interaction with the construct by crosslinking the primary amine found on 
the end of the arginine R-group of the RGD integrin binding sequence. The consumption of NH2 
was also shown by the FTIR characterizations in this study. 
 
To enhance or induce SMC contraction of and invasion in the crosslinking-strengthened constructs, 
soluble cues such as growth factors were introduced in the ECM gel. We selected factors that were 
often used or studied in vascular grafting to stimulate SMC activity. Results showed that balancing 
mechanical and biological properties can be achieved by adding h-FBS and PDGF in 1mM genipin-
treated CCE matrix. PDGF is a well-known SMC chemoattractant. The PDGF molecules in the 
crosslinked gels stimulate SMC migration. It is known that FBS contains an array of soluble factors 
including PDGF, TGF-β, and adhesion molecules such as fibronectin. The addition of h-FBS likely 
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stimulated the matrix deposition by SMCs which may provide an intermediate way for the cells to 
interact with the crosslinked constructs which exhibited a reduced number of RGD sites, thus 
stimulating contraction. Heparin is often incorporated on the vascular graft to prevent thrombosis. 
It is also well known as an endothelial growth factor. However, it inhibited SMC growth, 
differentiation and other activity. Our results suggested that heparin should be localized on the 
luminal surface of an engineered vascular construct, instead of being uniformly distributed 
throughout the construct or presented in the media equivalent which should encourage SMC 
growth, invasion and remodeling during the initial stage of implantation.  
 
Optimization of mechanical properties and SMC environments are important for vascular media 
equivalents and for vascular graft constructs that facilitate immediate use and in vivo cell seeding. 
The present study suggests that we may strike a balance between mechanical and biological 
properties, by selecting a low concentration (1mM) of biocompatible crosslinker (genipin), together 
with insoluble biomimetic matrix (CCE) and soluble chemoattractants and differentiators (PDGF 
and h-FBS). The two sets of cues, the soluble medium and the insoluble matrices, should be co-
optimized for the best results, since they may affect same signaling pathways through crosstalk as 
suggested by previous studies. Proper designs of scaffold compositions, its stiffness, and molecular 
presentation to the cell may significantly improve the biological relevance of constructs to cells since 
the cell acts and looks far more like its in vivo counterpart.   
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3.5 Conclusion 
 
Results from this study have demonstrated the effects of genipin concentration on the mechanical 
properties, SMC activity and degradation of genipin-crosslinked CCE constructs. Though the 
mechanical properties of the CCE constructs improved with the increase in genipin concentration, 
SMC activity (contraction and invasion) on the CCE constructs greatly reduced. The degradation of 
the matrix also depended on the concentration of genipin making the crosslinked sample more and 
more resistant to degradation. The addition of growth factors to the scaffold had a positive effect to 
scaffold contraction by SMCs. The 1mM crosslinked scaffolds showed a remarkable amount of 
contraction with the presence of heparin, PDGF, a combination of heparin and PDGF, h-FBS, and 
a combination of h-FBS and PDGF in that order. With the presence of growth factors, it was also 
seen that that the invasion depth of SMCs in the low concentration crosslinked scaffold varied with 
h-FBS, a combination of heparin and PDGF, a combination of h-FBS and PDGF and PDGF in 
that order. Hence, by balancing the mechanical and biological properties and in the presence of 
growth factors such as PDGF, low concentration crosslinked CCE scaffolds can act as a suitable 
medial layer in tissue engineered vascular grafts. 
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CHAPTER 4 
 
4. MECHANICAL AND BIOCOMPATIBLE CHARACTERIZATIONS OF A READILY 
AVAILABLE MULTILAYER VASCULAR GRAFT 
 
Abstract 
 
There is a considerable need for alternatives to autologous vein or artery tissues for vascular graft 
uses; synthetic graft materials such as polytetrafluoroethylene have not matched the efficacy of 
native tissues, mainly due to their low compliance and limited capability of regenerating tissues. 
Considering the graft availability to surgery, the required physical and mechanical properties, and the 
potential for vascular regeneration, we aimed to design a readily-available, strong and compliant graft 
consisting of layer-specific matrices that respectively define environments for different vascular cells. 
This study thus focused on developing and characterizing multilayered biodegradable constructs, in 
which heterogeneous materials and structures were integrated to offer properties for readily grafting 
and environments for culture or ingrowth of diverse vascular cells. The multilayer constructs 
consisted of a thin, dense, nanofibrous layer composed of stiff poly-ε-caprolactone (PCL) materials, 
and a thick, highly-porous layer of genipin-crosslinked collagen-chitosan (GCC) hydrogel. Because 
of large differences in physiochemical properties of the layer materials, the material interface was 
identified as an important determinant to the graft integrity and property. The interface 
modifications for improving the layer adhesion, including physically increasing porosity of the PCL 
surface and chemically increasing hydrophilicity or crosslinking were studied. Microscopic 
examination as well as results of graft physical properties showed increasing porosity of the PCL was 
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an effective way of providing layer adhesion for successful construct integration, and offering 
desired graft permeability (528 mL/cm2/min), required implant burst strength (695mmHg) and 
suture strength (2.38N),  and high compliance (4.5%) for graft implant applications. Results also 
showed that PCL mainly contributed to the biomechanical properties such as burst strength, 
compliance and suture strength, while GCC reduced the water permeability. In addition to the 
complementary function in physical and mechanical properties, the two-layer design also provided 
layered structure for cell seeding or ingrowth in vitro and in vivo. Acellular multilayer constructs were 
readily implantable to replace abdominal aorta in rabbits, resulting in rapid cell ingrowth, flow 
reperfusion and free of thrombosis. The engineered constructs capable of sustaining physiological 
conditions and promote appropriate cellular activity could serve as a platform for future 
developments of regenerative vascular grafts.  
 
4.1 Introduction 
 
There is a considerable need for alternatives to autologous vein and artery tissues for vascular 
reconstructive uses [17, 70], including coronary bypass, lower limb bypass, hemodialysis access, and 
arteriovenous shunt. Until now, synthetic materials such as polytetrafluoroethylene (PTFE) have not 
matched the efficacy of native tissues, particularly in the small-diameter vessel (<6mm) applications 
[23, 111]. In the past decade, impressive progress in vascular tissue engineering has demonstrated 
the possibility of using a living biograft as a blood vessel substitute [36, 41, 42, 55, 112-114]. The 
biograft is often characterized by a multilayer structure mimicking intima, media or adventitia of 
native vessels and is capable of withstanding physiological stresses. In these in vitro engineered 
vascular biografts, synthetic or natural biomaterials are used as three-dimensional (3D) scaffolds to 
provide temporary mechanical support for culture of cells which are stimulated to synthesize matrix 
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components for the formation of vascular structure and property. However, the clinical potential of 
current approaches is thought to be tempered by time-consuming, labor-intensive preparations, 
complicated storage requirements and rigorous culture regulation [36, 41, 55]. Development of 
vascular replacement demands further investigations into engineering technologies that not only 
provide regenerative growth of blood vessels without immunogenic, thrombogenic or inflammatory 
responses, but also consider the availability, ideally “off-the-shelf”, to vascular surgeons [17, 19]. 
These require that grafts should not only provide layer-specific microenvironments supporting 
regenerative activities of diverse vascular cells, but also possess physical and mechanical properties 
to sustain graft remodeling under hemodynamic conditions in vivo. 
 
A long-standing challenge in the development of synthetic vascular grafts is the balance between 
mechanical strength of a vascular graft to withstand physiological stresses and its compliance to 
provide appropriate hemodynamic environments to cells. On one hand, robust physical and 
mechanical properties, including burst strength, water permeability and suture strength, are required 
for graft implantation. On the other hand, high compliance or low stiffness is desired, since 
compliance mismatch at the site of anastomosis between a vascular graft and neighboring arteries is 
a major cause of graft failure, because disturbed blood flow at the junction of mismatched 
compliance leads to adverse cell responses and/or pro-inflammatory milieu [16, 17, 23]. Compliance 
mismatch generally results from high stiffness of grafts [16], or the lack of optimal pore sizes [115]. 
Pore sizes, however, also alter water permeability and cell synthesis [116]. 
 
From the tissue regeneration point of view, an ideal scaffold is to provide microenvironments for 
ingrowth and proliferation of vascular cells, vascular endothelial cells (ECs) and smooth muscle cells 
(SMCs) [12, 19]. The artery exhibits a multilayer structure with layer-specific matrix 
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microenvironments for specific cell or tissue functions [20]. Considering the availability to surgery, 
the required physical and mechanical properties as well as vascular regenerative potential, we will 
need a strong, compliant scaffold with thromboresistant surface and layer-specific matrices that 
respectively define environments for ECs and SMCs to guide vascular regeneration in vivo. This 
study thus focuses on developing multilayered biodegradable constructs, in which heterogeneous 
structures are integrated to offer properties for the “off-the-shelf” implant, as well as high 
compliance and layer-specific scaffolding materials to provide physiological microenvironments for 
vascular cells. The multilayer constructs consisting of a thin, dense, nanofibrous layer composed of 
strong poly-ε-caprolactone (PCL) materials, and a thick, highly-porous layer of genipin-crosslinked 
collagen-chitosan (GCC) hydrogel, aim to provide properties for immediate grafting and structural 
guidance for cell growth. We previously have demonstrated the GCC scaffold as a vascular medial 
equivalent due to its structural, mechanical and biochemical properties as well as its function of 
supporting SMC growth and contraction [109, 117]. We have also shown that electrospun PCL 
constructs possess mechanical strength for vascular applications [118]. Additionally, both GCC and 
PCL are biodegradable, and hence can be readily remodeled by cells. However, the water affinity, 
structure and physiochemical properties of PCL and GCC are quite opposite. Thus, an important 
design challenge of using these materials for multilayer vascular grafts is interface engineering. 
Herein, we have developed several interface strategies to integrate the layers, and studied their 
influences on structural adhesion, graft integrity, as well as biomechanical and physical properties. 
Finally, evaluation of the multilayer vascular grafts was performed in vitro with vascular cells and in 
vivo as grafts interpositioned in infrarenal abdominal aorta of rabbits. 
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4.2 Materials and methods 
 
4.2.1 Materials  
 
Poly-ε-caprolactone (  ̅̅ ̅̅ =80,000 g/mol) and polyethylene oxide (  ̅̅ ̅̅ =500,000 g/mol) were 
purchased from Sigma Aldrich Inc. (St Louis, MO). Dry porcine skin collagen type I was purchased 
from Elastin Products Co. (Owensville, MO). Acetonitrile (ACN) and 1, 1, 1, 3, 3, 3 – hexafluoro – 
2 – propanol solution (HFIP) was obtained from Sigma Aldrich. N, N-Dimethylformamide (DMF, 
minimum purity 99.9%) and dichloromethane (DCM, minimum purity 99.5%) were purchased from 
Mallinckrodt Chemicals (Phillipsburg, NJ). The electrospinning apparatus comprised of a Gamma 
High Voltage Research ES30P-10W power supply (Gamma High Voltage Research Inc., Ormond 
Beach, FL), a pair of syringe pumps (Pump 11 Plus - Harvard Apparatus, Crisel Instrument, Rome, 
Italy), a cylindrical aluminum collector with 4.76mm in diameter, a brushless rotating electric motor 
(BLF230C-A Oriental Motor,  Italia S.R.L., Milan, Italy), 5 ml polystyrene syringes to dispense the 
polymer solutions, stainless-steel 18G blunt-ended needles and flexible PTFE tubing. Oxygen 
plasma treatment apparatus consisted of a Plasmod Plasma Etcher (March Instruments Inc., 
Concord, CA), comprising of an etcher, a pump and oxygen-flow system.  
 
4.2.2 Electrospinning fabrication and surface modification of the inner core  
 
PCL was dissolved in a 5:3:2 mixture of DCM, DMF and a heparin-methanol solution to obtain an 
8% by weight PCL solution. Heparin, a thromboresistant molecule and EC attractant [119], was 
dissolved in the methanol to obtain a heparin-methanol solution (8% wt) and the total heparin 
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concentration in the resulting PCL solution was 0.5% by weight. PEO was dissolved ACN to obtain 
a PEO solution (4.5% wt). Collagen (COL) was dissolved in HFIP to obtain a COL solution (8.3% 
wt). Single-polymer nanofibrous materials were fabricated by a single electrospinning apparatus 
(Figure 4.1A). Rotation speed was set at 400 rpm. To facilitate detachment of scaffold materials 
from the collector and protect the scaffold lumen surface, the collector was tightly wrapped with a 
thin aluminum foil with an ultrathin PEO layer covering its surface. PEO fibers electrospun prior to 
PCL were dissolved in DI water, which released PCL fibers from the foil. PCL fibers were collected 
with a needle-collector distance of 22cm. The voltage and flow rate for collecting the PCL fiber were 
set to 27kV and 1mL/hr, respectively. PCL was spun up to a thickness of 120µm with or without 
the surface modifications.  
 
To enhance the interface interactions and thus the integration between the layers, three surface 
modification strategies of PCL fibers were introduced: (a) creating high porosity (HP) at the surface, 
(b) forming double-spun collagen/PCL layer (DC) on the surface, and (c) using oxygen plasma (OP) 
to activate the surface. PCL(HP) and PCL(DC) fiber scaffolds were fabricated by collecting PCL 
nanofibers until the point where the thickness of the tube reaches approximately 100µm. After that, 
PEO or COL was simultaneously spun with PCL, forming interwoven nanofibers on the collector 
for the next 20µm (Figure 4.1B). Thus, the single-fiber segment and the two-fiber segment were 
structurally integrated through a continuous spinning process. The production of interwoven fiber 
networks was based on our previously established double-electrospinning technique [118]. The 
voltage and collector distance for collecting the PEO or COL fibers were set to 30kV and 18cm, 
respectively. The flow rates of PCL and PEO or COL were programmed to vary with time, 
according to Figure 4.1C. The PCL scaffold was cut into small tubes of uniform length of about 
30mm. To create PCL(HP) scaffolds, PCL scaffolds with PCL/PEO surface were soaked for an 
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hour in deionized or ultrapure water to eliminate the PEO component and solvent residuals, thus 
increasing higher porosity on the surface. PCL(DC) fiber scaffolds were fabricated by first obtaining 
unmodified PCL samples (120µm), removing them from the aluminum foil, and then placing them 
in the vacuum chamber of an etcher at 0.2 Torr by applying oxygen plasma for 5 minutes. The 
oxygen flow rate and the RF power were set to 0.5 cm3/min and 5.0W, respectively. It was shown 
that oxygen plasma activated PCL surfaces by introducing hydroxyl and carboxyl groups [120, 121].  
As the reactive species were not stable, the treated materials were used immediately.  
 
 
Figure 4.1: Illustration of the graft fabrication process: (A) Illustration of the double electrospinning 
apparatus used to spin PCL with PEO or COL on a rotating aluminum collector; (B) Schematic 
illustration of the multilayer vascular graft design; (C) Feed rate for spinning of 120µm PCL tube 
with a 20µm-thick mixed fiber layer with PEO or COL; (D) Mold used to produce multilayer grafts;  
(E) Illustration of a one-layer PCL graft (top) and a multilayer graft (bottom). 
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4.2.3 Preparation of multilayer vascular grafts 
 
Preparation of the gel for the outer shell was followed the protocol we developed previously [117]. 
Briefly, rat tail collagen (type I) in 0.02N acetic acid (pH 4.0) at 9 mg/ml (BD Biosciences Inc., San 
Jose, CA) was first transferred to a centrifuge tube. Then, 1X Dulbecco’s Phosphate Buffered Saline 
(DPBS, Invitrogen Corporation, Carlsbad, CA) and 10X Hank’s balanced salt solution containing 
phenol red was added to the solution, followed by the addition of chitosan suspension. Chitosan 
(Molecular Weight = 100,000-300,000 g/mol, 90% deacetylation, Milan Panic Biomedicals Inc., 
Solon, OH) was dissolved in 1% acetic acid resulting in a chitosan suspension of 10 mg/ml 
concentration with a viscosity of 2000-3000 mPa.s. The pH of the pre-gel mixture was adjusted to 
7.3 by the careful addition of 1M NaOH. Finally, the mixture was finally topped off with 1X DPBS 
solution to achieve the desired volume. The final concentrations of the COL and chitosan in the 
collagen-chitosan constructs were 3mg/ml and 3.5 mg/ml, respectively. The inner core 
manufactured by the electrospinning process was slid over a dry glass rod. This rod was then placed 
in the vascular graft mold. The neutralized collagen-chitosan mixture was slowly poured into the 
graft mold (Figure 4.1D) around the PCL tube. To further remove bubbles which influence 
mechanical properties by introducing void defects in gel constructs, the pre-gel solution was placed 
at room temperature for five minutes before it was transferred into the incubator. Finally, the mold 
was transferred into an incubator to initiate gelation at 37 °C.  After 10 hours of gelation, the outer 
shell was crosslinked by diffusion with 1mM or 2.5mM genipin in 1X DPBS for 10 hours. The 
crosslinker concentration was determined by our previous study [117], according to its effect on 
SMC migration. The samples were washed 5 times in 1X DPBS to remove an excess unreacted 
genipin. The PCL tubes without the outer GCC shell and have thicknesses of 120µm and 240µm 
were referred to as PCL(120µm) and PCL(240µm), respectively. The multilayer grafts using 
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PCL(HP) for the inner core were denoted as PCL(HP)-GCC, those using PCL(DC) as PCL(DC)-
GCC, and those using PCL(OP) as PCL(OP)-GCC. Figure 4.1E demonstrated a one-layer graft and 
a multilayer graft after fabrication. 
 
4.2.4 Structural characterizations  
 
Small graft-sections were obtained from all the samples in hydrated and dehydrated conditions. Cut 
sections (~10mm length) of the graft samples were frozen in liquid nitrogen (~195 ˚C) following 
which they were dried in a critical chamber for approximately 48 hours. The outer surfaces of PCL 
(120µm) without and with surface modifications were imaged. Both dry and hydrated grafts were 
frozen in liquid nitrogen and dried in a critical-point drying chamber (Labconco, Kansas City, MO). 
All of these graft samples were embedded in a cryo-optimum-cutting-temperature compound 
(Andwin Scientific, Schaumburg, IL), and then sectioned in a cryostat.  These samples were 
sectioned transversely in parallel to the cross-section. Resultant 15-µm thick histological sections 
were placed on glass slides. The slides were then stained with Van Gieson stain or modified Movat’s 
Pentachrome stain, and observed under a light microscope (Zeiss Axiovert S100, Carl Zeiss, 
Germany) at 20X magnification. The graft samples were also imaged under a field emission scanning 
electron microscope (Zeiss FESEM Supra40, Carl Zeiss, Germany).  
  
4.2.5 Fourier transform infrared spectroscopy (FTIR) analysis 
 
Transverse cross-sections of unmodified PCL, uncrosslinked collagen scaffold and PCL(DC) were 
frozen in liquid nitrogen (~195°C), following which they were dried in a critical-point drying 
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chamber (Labconco, Kansas City, MO) for approximately 48 h. The incorporation of collagen 
nanofibers in the PCL nanofibrous matrix was studied using an attenuated total reflectance fourier 
transform infrared (ATR–FTIR) spectrometer, Nicolet 4700 (Thermo Fisher Scientific, Waltham, 
MA). Comparisons were made between samples. IGOR software (WaveMetrics Inc., Tigard, OR) 
was used to identify the peaks and to calculate the areas under the peaks. 
 
4.2.6 Physical and biomechanical characterizations of vascular grafts 
 
Water permeability, burst strength, compliance and suture retention strength of the vascular grafts 
were determined according to the method prescribed in ANSI/AAMI/ISO 7198:1998/2001/(R) 
2004 (Cardiovascular Implants:  Tubular Vascular Prostheses).  
 
Water Permeability: Tube adapters were inserted on both ends of the multilayer graft. Suture 
threads were used to secure the graft on the adapters. The graft was, then, cannulated by connecting 
one end of the graft to a water reservoir and closing the other end using a flow valve. Air, 
pressurized at 16kPa (120mmHg), was forced on the water column in the reservoir. Due to the 
pressure, water permeated through the membrane. Once the flow became steady, the permeate fluid 
was collected in a beaker and the volume of water collected in 1 minute was measured. The 
permeability of the graft (mL/cm2/min-1) was determined using the equation:  
   
 
 
  
where, τ was the scaffold’s permeability, Q was the fluid volume passing through the scaffold, A was 
the cross sectional area of the aperture in the sample holder. 
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Burst Strength: To perform burst strength on hydrated grafts, a thin latex tube was slid into the 
lumen of the tubular graft and the tube adapters were inserted on both ends. Suture threads were 
used to secure the graft on to the latex tube near the adapters. The tubular graft was, then, 
cannulated with CO2 being pumped in through one end of the graft, using PTFE tubing, while 
closing the other end using a flow valve. Due to the increase of CO2 flow in to the latex tube, the 
latex tube expanded causing the vascular graft outside to expand. The expansion was allowed until 
graft failure occurred. The pressure at which this failure of the vascular graft occurs is recorded as 
burst strength or burst pressure of the graft.  
 
Compliance: For compliance tests, the tubular graft was cannulated with the insertion of a latex 
tube similar to the burst strength test. The graft was then loaded onto a custom-made fixture and 
connected to a flow network via pressure gauges on both ends of the graft (Figure 4.2). The pressure 
in the graft was controlled using varying speed of a water pump from 0mmHg to 160 mmHg, with 
an increment of 10mmHg. At each pressure point, images of the graft dilatation were taken using a 
Canon EOS 450D camera (Canon Inc., Tokyo, Japan). These images were analyzed using a 
customized script in Matlab® (MathWorks Inc., Natick, MA) to measure the graft diameter at each 
pressure point. Then, the compliance of the graft (% mmHg x 102) was determined with the 
following equation,  
   
     
  
     
      
where R is the radius of the graft at pressure P.  
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Figure 4.2: Schematic illustration of the system setup for vascular graft compliance test 
 
Suture Retention Strength: To determine the suture retention strength, the vascular graft was cut 
normal to the long axis into small strips of dimensions (10mm X 5mm). A suture was inserted 2 mm 
from the end of the stretched strip of the graft through the wall of the graft to form a half loop and 
the other end of the graft was attached to the lower end of the MTS Insight electromechanical 
testing system (MTS Systems Corp., Eden Prairie, MN). The other end of the suture was attached to 
a 2000N load cell (MTS Systems Corp., Eden Prairie, MN). The suture was pulled at the rate of 150 
mm/min. The force required to pull the suture through the graft or cause the wall of the graft to 
rupture were recorded. In this study, the suture retention strengths of PCL(120µm) and PCL(HP)-
GCC were compared. 
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4.2.7 Vascular cell characterization  
 
Vascular grafts were frozen in liquid nitrogen and dried in a critical-point drying chamber 
(Labconco, Kansas City, MO) prior to seeding of cells into them. PCL(HP)-GCC grafts were used 
for cell characterization. To seed a 4.76mm multilayer vascular graft with bovine pulmonary artery 
ECs, the multilayer graft, suture strings and adapters were sterilized in 100% ethanol for 1 hour. All 
jackets and plugs used in the seeding process were autoclaved for 20 minutes. Seeding ECs onto the 
surface of the graft lumen was done by adapting protocols developed previously [122, 123]. The 
vascular grafts were then rehydrated by soaking into sterile 1X DPBS. One end of the graft was then 
secured with an adapter plug with sutures. For seeding, the EC suspension with a density of 1 x 106 
cells/ml was obtained in the cell culture medium which contains 10% fetal bovine serum and 1% 
penicillin-streptomycin in Dulbecco’s Modified Eagle Medium (DMEM). After filling the space in 
the graft lumen with ECs, the other end of the graft was secured with an adapter plug. Custom-
made jacket rings were then wrapped around the graft to fit it into a centrifuge tube and adapter 
spacer rinds were placed around both the adapters. The fully assembled centrifuge tube was then 
placed in the center of a centrifuge. The tube was aligned perfectly to the center to avoid any 
wobbling or uneven spinning. Then, the system was allowed to spin at 2000 rpm for 5 minutes. 
After centrifuge seeding, the graft secured with the adapters was allowed to sit for about an hour 
before carefully removing the adapters. After seeding ECs in the lumen, bovine pulmonary artery 
SMCs were seeded onto the outer shell of the grafts. The SMC suspension was prepared in the 
similar medium and with the same cell density as ECs. The liquid on the outer shell of the grafts was 
removed by gently and quickly rolling the graft on cotton gauge. The SMC suspension (1mL) was 
then allowed to be absorbed by the outer shell layer. Finally, the tube containing the graft seeded 
with ECs and SMCs was incubated for about an hour. The graft was transferred into a centrifuge 
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tube filled with fresh medium, which was put onto a rotator placed inside an incubator set at 37ºC 
and 5% CO2.  Graft samples were collected after culture for 1 hour, 3 days and 6 days, respectively. 
Samples were fixed in 10% formaldehyde. Samples were directly stained with DAPI and observed 
under a fluorescent microscope at 20X magnification. Samples were also cryo-sectioned and 
histological sections were stained with hematoxylin and eosin stain and observed under a light 
microscope at 20X magnification. Additionally, EC morphology on the graft lumen was imaged 
under a field emission scanning electron microscope (FESEM Supra40 Zeiss, Carl Zeiss – Advanced 
Imaging Microscopy, Germany). These samples were cut transversely in parallel to the cross section 
for en face imaging. 
 
4.2.8 Short-term implantation in rabbit models 
 
Four New Zealand white rabbits were premedicated with subcutaneous injections of Medetomidin 
(210 mcg/kg), Midazolam (0.5 mg/kg) and Morphine (1 mg/kg). An intravenous catheter was 
placed in a vein in the ear and propofol (5 to 8 mg/kg) was used to induce anesthesia.  After 
intubation, anesthesia was maintained with Isofluran in 100% oxygen. At the time of induction, 
rabbits receive Enrofloxacin at a dose of 5mg/kg. The rabbits were placed on dorsal recumbency.  
The abdomen was clipped with a #40 blade and prepared with chlorhexidine for surgery.  After 
draping the abdomen with sterile surgical drape, a midline incision was performed. The colon was 
retracted medially and the infrarenal aorta exposed.  They were ligated with 5-0 polypropylene 
suture.  Heparin was administered at the dose of 200 U/kg intravenously. After dissection of the 
infrarenal aorta over 2 cm, vascular clamps were applied to isolate the infrarenal aorta.  The aorta 
was transected between the clamps. An acellular PCL(HP)-GCC graft with a 3mm inner diameter 
was anastomosed in an end to end fashion with two continuous 7-0 polypropylene sutures.  After 
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completion of the anastomosis the clamps were removed and the anastomosis inspected for leakage 
and patency.  The abdominal incision was then closed in a routine fashion.  The animals received 
buprenorphine (0.05mg/kg subcutaneously twice a day for 3 days) and meloxicam (0.3 mg/kg 
subcutaneously twice a day for 3 days). After one day, the graft and the distal and proximal aortal 
sections were explanted and fixed in 10% formaldehyde, cryo-sectioned and stained with 
hematoxylin and eosin. These stained sections were observed under the light microscope at 20X 
magnification. 
 
4.2.9 Ultrasound sonography 
 
Ultrasound images of the grafts, the upstream and downstream neighboring artery, were taken after 
1-Day of implantation to visualize any thrombus formation or narrowing of the graft.  
 
 
4.2.10 Data analysis and statistics 
 
Data were statistically analyzed using the one-way ANOVA test. Student’s t test was then used to 
compare the means of each individual group. The level of significance was set at α = 0.05 for 95% 
statistical significance. Error bars on all the histogram charts represent the standard error of the 
mean based on the total number of the samples. 
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4.3 Results 
 
4.3.1 Structure and interface characterization 
 
The histological sections of the multilayer grafts, as observed under an optical microscope (Figure 
4.3), clearly demonstrate the adhesion between the inner core and the outer shell under dehydrated 
and hydrated conditions. Consistency of adhesion was dependent on the method of surface 
modification. The multilayer adhesion in PCL(OP)-GCC and PCL(HP)-GCC was more stable than 
PCL(DC)-GCC. It was also clear that hydration plays an important role to maintain the graft 
integrity. The surface modifications of the PCL inner core were examined using scanning electron 
micrographs (Figure 4.4). PCL layer is a porous network of fibers (Figure 4.4A) whose porosity can 
be increased by electrospinning and removal of PEO (Figure 4.4B). The SEM micrograph of the 
oxygen-plasma treated PCL fibers (Figure 4.4D) showed that some of the fibers have melted away 
causing the pores to be filled with the melted PCL. It is difficult to distinguish between electrospun 
COL and PCL fibers in the SEM images since they are similar in the structure (Figure 4.4C). But we 
were able to confirm the collagen component by performing FTIR spectroscopy analysis on the 
PCL(DC)-GCC samples. 
 
4.3.2 FTIR-ATR characterization results showing the incorporation of electrospun collagen fibers 
in the electrospun PCL matrix 
 
The characteristic peaks derived from the symmetric and asymmetric stretching vibrations of CH2, 
C=O, C-O, C-C, CO-C and C-O-C, in the crystalline and amorphous phases, are exhibited in the 
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FTIR spectra of the PCL and the PCL(DC) fiber matrices. The characteristic peaks derived from the 
stretching vibrations of N–Hy (y = 1, 2), O–H, C–Hy (y = 1–3), C–O–C, C=O, and the bending 
vibrations of N–H, C–O–C, C–H, are exhibited in FTIR spectra of the Collagen and the PCL(DC) 
fiber matrices. The peaks which are common to PCL, COL and PCL(DC) are presented in Table 
4.1. Figure 4.5 demonstrates the spectrum of each matrix component and the spectra of the 
different types of collagen-based matrices, showing the incorporation of component additives. For 
the spectra of COL (Curve 4.5B) and PCL(DC) (Curve 4.5C), typical peaks are derived from amide I 
(C=O stretching at 1630 cm-1), amide II (N–H bending at 1550 cm-1) and the mixed stretching and 
bending vibrations of the C–O–C bond (1150–970 cm-1)are clearly present. For the spectra of 
PCL(Curve 4.5A) and PCL(DC) (Curve 4.5B), the typical peaks are derived from asymmetric CH2 
stretching (2949 cm-1), symmetric CH2 stretching (2865 cm
-1), C=O stretching (1727 cm-1), C–O and 
C-C stretching in the crystalline phase (1293 cm-1), asymmetric COC stretching (1240 cm-1), OC–O 
stretching (1190 cm-1), symmetric COC stretching (1170 cm-1) and C–O and C-C stretching in the 
amorphous phase (1157 cm-1). 
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Figure 4.3: Optical microscopy images of the hydrated and dehydrated samples after freeze-drying 
process. (A) Hydrated PCL(HP)-GCC; (B) Dehydrated PCL(HP)-GCC; (C) Hydrated PCL(DC)-
GCC; (D) Dehydrated PCL(DC)-GCC; (E) Hydrated PCL(OP)-GCC; (F) Dehydrated PCL(OP)-
GCC. (G) Hydrated PCL(HP)-GCC under dark field. Scale bar: 100µm 
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Figure 4.4: SEM images of graft interfaces. (A) PCL without any surface modifications; (B) PCL 
double electrospun with PEO which was removed by dissolution in DI H2O; (C) PCL double 
electrospun with COL; (D) PCL treated with oxygen-plasma. Scale bar: 10µm 
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Figure 4.5: Fourier Transform Infrared Spectroscopy on (A): PCL; (B): Collagen  
and (C): PCL Double Electrospun with Collagen. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
111 
 
 
Position(cm−1) 
PCL 
2949 
Asymmetric CH2 Stretching 
2865 
Symmetric CH2 Stretching 
1727 
C=O Stretching 
1293 
C–O and C-C Stretching in the Crystalline Phase 
1240 
Asymmetric COC Stretching 
1190 
OC–O Stretching 
1170 
Symmetric COC Stretching 
1157 
C–O and C-C Stretching in the Amorphous Phase 
Position(cm−1) 
Collagen 
3500-2800 
O-H Stretching 
3500-3450 
N-Hy Stretching 
3100-2800 
C-Hy Stretching 
1790-1580 
C=O Stretching 
1580-1470 
N-H bending 
1150-940 
C-O-C Stretching 
Table 4.1: FTIR Curve Analysis: Incorporation of Collagen in PCL Matrix 
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4.3.3 Physical and biomechanical characterizations of multilayer grafts 
 
Physical and biomechanical properties of vascular grafts play critical roles in maintaining structure 
and function of the grafts in vivo and thus are included in the FDA standards. Herein, we determined 
several essential graft properties including permeability, burst strength, compliance and suture 
strength, and studied the effects of graft structure designs on these properties.  
 
Water Permeability: Results from water permeability tests showed that the mean permeability 
value of single layer 120µm-thick PCL grafts without outer shells was 2380mL/cm2/min (Figure 
4.6A). With the addition of an outer shell using various surface modification strategies on the PCL 
inner core (120µm), the mean water permeability values were found to be 528mL/cm2/min, 
1112mL/cm2/min, and 553mL/cm2/min for the PCL(HP)-GCC, PCL(DC)-GCC and PCL(OP)-
GCC grafts, respectively. The water permeability values of PCL(HP)-GCC and PCL(OP)-GCC 
showed four times reductions when compared to the PCL(120µm) samples. The water permeability 
value of PCL(DC)-GCC samples was significantly higher than PCL(HP)-GCC and PCL(OP)-GCC, 
and about two times reductions when compared to the PCL(120µm) samples. In addition, we 
respectively varied the design parameters of the PCL layer and the GCC layer, the inner core 
thickness and the crosslinking condition of the outer shell, to examine their influences on water 
permeability (Figure 4.6B). Results showed that the mean permeability value of the single layer 
240µm-thick PCL grafts was 1030mL/cm2/min. There was a significant decrease in the mean 
permeability value with the increase of PCL thickness; about two times reduction in permeability 
with two times increase in the PCL thickness. We also found that the permeability value for the graft 
with outer shells of a high crosslinking density, 10mM (264mL/cm2/min), decreased two times, 
when compared to the multilayer grafts with outer shells of lower crosslinking densities, 1mM 
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(609mL/cm2/min) and 2.5mM (528mL/cm2/min).  We previously determined the effects of these 
crosslinking conditions on the crosslinking density [117]. Our results here, thus, demonstrated that 
engineering the integration of a multilayer structure, in addition to the individual layer designs such 
as varying PCL thickness or GCC crosslinking density could significantly influence the water 
permeability values of the vascular grafts.  
 
  
 
Figure 4.6: Graft water permeability. (A) Single-layer PCL grafts showed higher permeability than 
multilayer grafts with various interfacing strategies. * - p<0.05 w.r.t. PCL (120µm), and  ‡ -  p<0.05 
w.r.t. PCL(HP)-GCC. (B) Graft permeability varies with the thickness of PCL inner core (black bars) 
or the crosslinking condition of outer shell (grey bars). * - p<0.05 w.r.t. PCL (120µm),  
¶ -  p<0.05 w.r.t. PCL(240µm), † - p<0.05 w.r.t. PCL(HP)-GCC(1mM),  
and ** - p<0.05 w.r.t. PCL(HP)-GCC(2.5mM).   
 
Burst Strength: Results from burst strength tests showed that the mean burst strength values of 
PCL scaffolds (Figure 4.7A) without an outer shell were 684 and 1172mmHg, for the 120µm- and 
240µm- thick samples, respectively. Burst strength was significantly improved by increasing the inner 
core PCL thickness. The burst strength values of multilayer grafts with different interfaces or 
(A) (B) 
* 
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integration strategies, PCL(HP)-GCC, PCL(DC)-GCC and PCL(OP)-GCC, were found to be 695, 
638, and 611 mmHg,  respectively. No significant differences in burst strength were found among 
these three multilayer grafts or between any multilayer graft and single layer graft with the same PCL 
thickness (120µm). Additionally, there was no significant difference in burst strength between the 
multilayer grafts with differently crosslinked outer shells (Figure 4.7B).  
 
  
Figure 4.7: Graft burst strength. (A) Burst strength of PCL grafts and multilayer grafts with various 
interfacing strategies; (B) Burst Strength of grafts with varied thickness of PCL inner core (black 
bars) or varied crosslinking condition of outer shell (grey bars). 
*- p<0.05 statistical difference w.r.t. PCL (inner core alone). 
 
Compliance: Results from compliance tests between 80-120mmHg of cannulation pressure showed 
that PCL (120µm) had an average compliance of 5.3%, while the multilayer grafts, PCL(HP)-GCC, 
PCL(COL)-GCC, and PCL(OP)-GCC possessed average compliance values of 4.5%, 4.2% and 
3.8%, respectively (Figure 4.8). PCL(240µm) exhibited a lower compliance of 2.7%. The compliance 
of unmodified PCL was significantly higher than that of PCL(240µm), PCL(HP)-GCC, PCL(COL)-
GCC and PCL(OP)-GCC, respectively.  
 
(A) (B) 
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Figure 4.8: Compliance (%mmHg x 102) of PCL grafts and multilayer grafts with various interfacing 
strategies. *- p<0.05 w.r.t PCL (120µm), †- p<0.05 w.r.t PCL(240µm)  
and ††- p<0.1 w.r.t PCL(240µm). 
 
Suture Strength: The suture retention strength of PCL(120µm) and PCL(HP)-GCC were found to 
be 2.05N and 2.38N, respectively, with no significant difference between them. This value was 
comparable to previously reported values of other PCL-based synthetic graft [113, 124], though it 
was lower than saphenous vein (~4N), and PTFE graft (4.9-6.7N). 
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Graft Average Suture Retention Strength (N) 
PCL (120µm) 2.1±0.3 
PCL(HP)-GCC 2.4±0.1 
Saphenous Vein [124] 4 
e-PTFE [124] 4.9-6.7 
PCL-COL-ELN [124] 0.9-3.5 
PCL-COL [113] 3-5 
Table 4.2: Suture Retention Strength 
 
4.3.4 EC and SMC activities on the graft in vitro 
 
Results from graft characterization with cells have demonstrated the utility of the multilayer graft for 
fast cellularization and cell proliferation to form engineered blood vessel in vitro. The successful 
seeding of both ECs and SMCs in the multilayer scaffold was shown by the histological sections 
stained with hematoxylin and eosin stain (Figure 4.9). The SEM micrographs clearly indicate the 
formation of a more confluent layer of ECs with the increase in cell density due to proliferation after 
3 days (Figure 4.9B), compared to the initial cell density (Figure 4.9A). There was further cell 
proliferation and higher level of cell confluency after 6 days of cell-seeding (Figure 4.9C). Optical 
images of histological section of the cell-seeded grafts also demonstrated similar EC proliferation in 
the lumen (Figure 4.9D-E). In addition, these images also showed the increase in SMC number in 
the GCC outer core of the graft. The fluorescence imaging using DAPI also demonstrated seeding 
of ECs and SMCs in the different layers of the grafts (Figure 4.9F).  
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Figure 4.9: Microscopic examination of cell-seeded grafts. SEM images of EC-seeded graft lumen 
after 1 hour (A), 3 days (B), and 6 days (C) of cell seeding. Optimal microscopy images of the 
transverse cross-section of cell-seeded graft after 1 hour (D) and 6 days (E) of cell seeding. 
Fluorescent microscope image of DAPI-stained cells after 3 days of cell seeding (F).  
Scale bar for A-C: 20µm and for D-F: 100µm 
 
4.3.5 Short-term implantation evaluation results 
 
Acellular grafts were used in this initial in vivo evaluation of vascular grafts. Figure 4.10A shows the 
implanted 3mm multilayer vascular graft replacing the abdominal aorta of a rabbit with anastomosis 
covered with gauge to stop bleeding. There were no unfavorable inflammatory or thrombogenic 
reactions produced by the graft. Explanted vascular grafts revealed a clean lumen with no blood 
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clots or platelet adhesion (Figure 4.10B). The sectioned and stained explanted graft showed cell 
invasion at the site of anastomosis (Figure 4.10C). These cells exhibited preference to invade the 
GCC layer and not the PCL layer. Additionally, these cells were stained negatively with monocyte 
marker, suggesting that they are not inflammatory cells and could be myofibroblasts or SMCs 
migrating from the surrounding tissues. Additionally, ultrasonic evaluation of the post-implantation 
blood flow through the graft revealed reperfusion of the grafts with pulsatile blood flow (Figure 
4.10D). 
 
4.4 Discussion 
 
This study reported the development and characterization of robust, compliant, biodegradable 
multilayer constructs for vascular graft applications. The developed grafts were made from a 
densely-packed fibrous PCL membrane and a porous GCC gel, respectively to model the matrix 
environments in the vascular intima and media. Importantly, various interfacial designs were 
examined here to enhance the integration of the layers with drastically different structures and 
physiochemical properties to prevent delamination. Effects of the interfacial design on the material 
structure as well as physical and mechanical properties (i.e. permeability, burst strength, and 
compliance) under the physiological flow pressure were characterized. Results showed that the 
PCL(HP)-GCC graft with increased porosity at the interface provided layer adhesion for successful 
construct integration, desired graft permeability, required implant strength and high compliance 
(4.5%) for graft implants. Additionally, the multilayer construct supported culture and growth of 
vascular cells in vitro, and are readily implantable to replace artery in vivo resulting in cell ingrowth, 
flow reperfusion and free of thrombosis.  
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Figure 4.10: Biocompatibility evaluation of vascular grafts in vivo with a rabbit model. (A) Multilayer 
vascular graft Implanted 3mm replacing the abdominal aorta of a rabbit with anastomosis covered 
with gauge that stop bleeding; (B) Open-lumen of an explanted 3mm multilayer vascular graft with 
adjoining arteries, showing no thrombosis or occlusion in the lumen of the graft; (C) Optical image 
of H&E stained, histological section of explanted graft, showing the migration of cells from 
surrounding tissue mainly into the GCC layer rather than the PCL layer; (D) Ultrasonic image 
showing blood reperfusion through the graft and the lumen with no stenosis. Scale Bar for C: 
100µm. 
PCL is highly hydrophobic, stiff and strong, whereas GCC is highly hydrophilic, elastic and 
mechanically weaker. The combination of the biomaterials with drastically different properties made 
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the formation of a multilayer graft a challenging process. Without any surface modifications, GCC 
easily slipped over the PCL surface. Herein, the adhesion between the two layers was designed using 
a physical or a chemical attachment process. The physical process involved the entanglement of 
collagen-chitosan gel in the large pores of PCL fibers near the interface between the two materials. 
During the outer shell formation, the collagen-chitosan pre-gel mixture could more readily enter 
larger pores. After the gelation, the collagen-chitosan gel with a fiber-sheet structure [109] might 
interact with PCL fibers with physical entanglement. Within the physiological stresses used for 
physical and mechanical testing in this study, the multilayer constructs maintained integral structure. 
The chemical attachment process involved the formation of the covalent chemical bonds between 
the PCL and GCC layers. This was achieved by two methods. In the first method, PCL was double 
electrospun with collagen at the interface, and then genipin crosslinker could crosslink the collagen 
in the double-electrospun PCL-collagen with the collagen and chitosan component in the GCC 
outer shell [109]. However, this method resulted in excessive shrinkage or expansion of the inner 
layer during hydration and dehydration process, which could introduce separation and cracking.  
The second method involved oxygen plasma treatment of an unmodified pure PCL tube [120, 121]. 
During this process, new reactive oxygen groups were introduced on the surface of the PCL fibers, 
thereby forming a stable bond between the two layers. The major problem using this process was 
the appropriate amount of RF power and flow rate in the oxygen plasma process, which was limited 
to 5.0W and 0.1cm3/min, respectively. This limit was imposed due to the melting of the inner core 
at higher RF powers and flow rates, even though higher powers have been used in previous studies 
[120, 121]. Even under the limited power and flow rate, the SEM image showed melted PCL fibers 
that filled the pores.   
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Water permeability is a critical graft function test. Values above 800ml/cm2/min are generally 
considered high and preclotting must be applied before implantation, while values below 
600ml/cm2/min are considered low for molecule transport affecting graft healing [125, 126]. By 
virtue of being a nanofibrous material with connected pores, a thin PCL layer (120µm in this study) 
allows large quantities of water to permeate under the physiological flow pressure. Yet with the 
addition of the outer shell, the permeation was reduced considerably when the interface between the 
two layers showed good adhesion. PCL(DC) and GCC did not form as good adhesion as PCL(HP)-
GCC and PCL(OP)-GCC at the interface (Figure 4.3B-C), and thereby permeability of PCL(DC)-
GCC significantly higher than that of PCL(HP)-GCC and PCL(OP)-GCC (Figure 4.6A). Due to 
good adhesion which maintains structural integrity under flow, the GCC layer forms an effective 
barrier to reduce permeability. The reduction in the permeation can be attributed to the decrease in 
the water pressure difference across the cross-section of the graft as well as the increase in the 
thickness of the cross-section. Darcy’s law of diffusion states that the permeability of a porous 
membrane or slab is directly proportional to the pressure gradient across the membrane or slab and 
inversely proportional to the thickness of the membrane or slab. The equation of the relationship is: 
    
  
 
 
where, q is the amount of water permeated through unit area in unit time, KD is the permeability 
constant, ΔP is the pressure change, and t is the thickness of the membrane or slab. With the 
addition of the GCC layer, not only the thickness t increases, but also the pressure gradient across 
the graft decreases because the hydrophilic GCC matrix has sites for binding of water molecules, 
thereby reducing the pressure gradient and mass transfer across the graft.  
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In addition to permeability, compliance and burst strength are both important determinants to graft 
functioning in vivo, but achieving the balance between them as shown by native arteries is a long-
standing issue [19]. Herein, our strategies combine two types of materials: PCL, a strong yet stiff 
material [118] and GCC, a compliant scaffold [117]. The PCL inner core determines both burst 
strength and compliance of the multilayer graft, while the importance of a GCC layer in reducing 
permeability has been elaborated above. The multilayer graft can thus possess adequate permeability 
and burst pressure (five times the higher end of physiological pressure), for immediately 
implantation. Furthermore, due to a thin PCL inner core, the compliance value of PCL(HP)-GCC 
(4.5%) is comparable to those of native vessels such as saphenous vein (4.5%) and umbilical vein 
(4%), and much higher than those of synthetic PTFE and Dacron grafts (2%) [23]. Compared to 
PCL(HP)-GCC, the compliance value of PCL(OP)-GCC is lower. This can be attributed to the 
melting of PCL fibers during oxygen plasma treatment. PCL-based grafts used in previous studies 
were characterized by much higher thicknesses, resulting in higher burst strength and lower 
compliance [113, 114, 124, 127]. As compliance plays an essential role in cell activity and graft 
healing, due to its influence on hemodynamics at the site of anastomosis [16], Salacinski et al. have 
used the graft compliance to predict the graft patency [23]. They demonstrated a nearly linear 
relationship between the graft compliance and the graft patency after one month of implantation. 
Using this patency-compliance relationship (Table 4.3), we expect that the one-month patency rate 
of our grafts will be over 75%. The burst strength of the grafts, though low, is also adequate for in 
vivo functioning. One key reason why the burst strength is lower than previously reported values for 
PCL fiber grafts [113] is the difference in the PCL layer thickness (almost three times our model). 
Nevertheless, the in vivo evaluation demonstrated the graft robustness for the use as artery implants. 
Studies in rabbit models showed that there was no unfavorable thrombosis or inflammatory 
reactions. Also, we found that cells preferentially invaded into the GCC layer and not the PCL layer; 
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immune cells were not recruited to the lumen (Figure 4.10C). This may be due to the higher porosity 
and lower elastic modulus of the GCC in comparison to the PCL layer. Therefore, in addition to the 
complementary function in physical and mechanical properties, the two-layer design also provided 
layered structure for cell seeding or ingrowth in vitro and in vivo. 
 
Graft Compliance Patency 
 
% mmHg x 102 % 
PCL (120µm) 5.2±0.6 
 
PCL (240µm) 2.7±1.5 
PCL(HP)-GCC 4.5±0.6 
Host artery 5.9 ± 0.5 
Saphenous vein [128] 4.4 ± 0.8 75 
Umbilical vein [22, 128] 3.7 ± 0.5 60 
Bovine heterograft [128] 2.6 ± 0.3 59 
Dacron [128] 1.9 ± 0.3 50 
e-PTFE [128] 1.6 ± 0.2 40 
Table 4.3: Compliance vs. Patency – A Prediction 
 
4.5 Conclusion 
 
This paper reports design and characterization of multilayer vascular grafts which are synthesized 
with a combination of electrospun PCL fibers and collagen-based scaffolds. Results have identified 
the design of the material interface as an important determinant to the graft integrity and stability. 
Results have also shown PCL as graft inner core mainly contributes to the biomechanical properties 
such as burst strength, compliance and suture strength, while GCC as graft outer shell reduces the 
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water permeability. Additionally, the PCL core and the GCC shell respectively provide a surface for 
EC proliferation and support cell ingrowth or 3-dimensional cell culture. Also, the graft when 
implanted into animal models does not produce any unfavorable inflammatory or thrombogenic 
reactions. In the future, molecular environments mimicking those in the native blood vessels will be 
further designed and incorporated into the structure-mimic vascular grafts demonstrated here, and 
long-term implantation evaluation will be performed.  
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CHAPTER 5 
 
5. OVINE IMPLANT MODEL FOR A NOVEL MULTILAYER VASCULAR GRAFT 
CONSISTING OF AN ELECTROSPUN INNER CORE AND A COLLAGENOUS 
OUTER SHELL 
 
Abstract 
 
Vascular grafts are a common response to a number of different diseases. To achieve long-term 
function for small diameter vascular grafts, tissue engineering has been identified as a possible 
solution. Mechanical and chemical signaling has large effects on cell proliferation and migration. In 
this study, we replaced the carotid arteries in a sheep with two multilayer grafts, with an inner core 
made of an electrospun intimal equivalent (poly-ε-caprolactone) and an outer shell made of a 
collagenous medial equivalent (genipin-crosslinked collagen-chitosan), for a duration of one month. 
The endothelial cell chemoattractant, heparin, was embedded in the inner core during the process of 
electrospinning. During the one-month period, ultrasound sonography images were obtained which 
were used to calculate the changes in the lumen diameter and the wall thickness during each week. 
The graft was explanted after one-month implantation. During the explantation, it was observed that 
the graft had fully integrated with the neighboring artery. Sections of the graft, the suture sites and 
the neighboring artery were then subjected to cryo-sectioning for histological staining. The 
ultrasound images revealed minimal changes to the graft diameter as well as significant changes to 
the graft wall thickness during the four weeks. The increase in thickness of the graft wall in vivo is 
due to the integration of the graft with the neighboring artery as well as the formation of the 
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neointimal hyperplasia. The formation of the neointimal hyperplasia, was also shown in optical 
images of the stained histological sections. There was no recruitment of endothelial cells in the 
intimal possibly due to the recruitment of the smooth muscle cells onto the intimal equivalent. The 
smooth muscle cells and the extracellular matrix were found to have no orientation in the medial 
equivalent while they were aligned circumferentially in the neointimal hyperplasia. Additionally, the 
ultrasound sonography images as well as the histological sections confirm that no unfavorable 
immunogenic response or thrombosis or stenosis occurred in vivo during the implantation. With all 
the superior physiological properties along with some methods to develop in vivo endothelialization, 
this multilayer graft has the potential to serve as a suitable vascular graft scaffold providing the right 
biomechanical properties and the micro-environments suitable to promote vascular cell migration 
and proliferation as well as tissue remodeling. 
 
5.1 Introduction 
 
The use of substitutes to treat diseases such as atherosclerosis, and conditions such as congenital 
defects, damaged blood vessels and hemodialysis access is a very common approach today [17, 70]. 
In spite of the number of options, such as synthetic and autologous grafts, available to surgeons, 
most vascular grafts today are not suitable in applications where diameter of the replaced blood 
vessel is less than 6mm (small-caliber vessels) [23, 111]. During the last few decades there has been a 
considerable progress made in tissue engineering such vessel substitutes which are able to favorably 
mimic structure and function of a native blood vessel [36, 41, 42, 55, 112-114]. The emphasis of 
such research has been directed toward designing a three dimensional (3-D) nanofibrous matrix 
which is capable of not only being a regenerative blood vessel available readily (i.e. off-the-shelf) to 
vascular surgeons but also not cause any unfavorable immunogenic, thrombogenic and/or 
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inflammatory responses in vivo [17, 111, 129]. Though it has been difficult to reproduce a design 
which perfectly replicates a layered structure of a blood vessel, research has been dedicated in 
developing micro-environments which encourage vascular cells to promote remodeling as well as in 
imparting appropriate mechanical and physiological properties which will ensure the tissue 
engineered blood vessel (TEBV) will be able to withstand such remodeling under hemodynamic 
conditions in vivo. Some of the critical reasons of failure during the use of common used grafts as 
small-caliber substitutes include compliance mismatch, detrimental cellular activity at the site of 
anastomosis, and lack of endothelialization in the inner surface of the graft [16, 17, 23]. Most of 
these factors lead to occlusion and neointimal hyperplasia, thereby making the graft less patent in 
vivo. It is well established that the compliance of a graft at the site of anastomosis greatly contributes 
to the regenerative activity of the vascular cells. Salacinski et al [23] were able to establish a linear 
relationship between the compliance of the graft and the in vivo patency. Less compliant grafts 
greatly reduce smooth muscle cell (SMC) and fibroblast (FB) migration at anastamosa, thereby 
causing poor or no remodeling, which leads to occlusion, and, hence, reduction in the patency [16]. 
This project focuses on studying the in vivo properties of one such TEBV which serves as a potential 
for a suitable grafting materials. The TEBV consists of an electrospun inner core and collagenous 
outer shell. We have previously established that the inner has core biomechanical properties, 
particularly compliance, and the outer shell has similar physiological properties similar to native 
carotid artery. 
 
An ideal blood vessel surrogate is expected to provide a suitable micro-environment for the 
proliferation and migration of vascular cells such as smooth muscle cells and fibroblasts which will 
ensure appropriate remodeling in vivo. TEBV models are generally multilayered since native artery 
has three distinct layers – intima, media and adventitia [20]. The inner layer or the intimal equivalent, 
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which comes in direct contact with blood, is generally expected to be a thromboresistant surface and 
also act the surface for the attachment of endothelial cells (ECs). The other layer(s) is (are) expected 
to provide the necessary scaffolding for the migration for SMCs and FBs which are involved in the 
remodeling of the TEBV matrix [12, 19]. In one of our previous studies [118], poly (ε-caprolactone) 
(PCL) has been established as a suitable intimal equivalent, since it is a biodegradable and allows the 
formation of a confluent layer of ECs in vivo. Also, in another study [117], we have been able to 
establish that a genipin-crosslinked collagen-chitosan scaffold (GCC) acts a suitable medial 
equivalent since it is not only biodegradable but the collagen fibers also possess RGD sites which 
provide attachment sites to SMCs thereby allowing their proliferation and migration. With 
completely different affinity to water, the intimal and the medial equivalents demanded special 
interface modifications which control the stability of the multilayer graft (Chapter 4).  In this study, 
we have brought forward the physical modification process by increasing the PCL surface pore size. 
 
Previous research has shown that the formation of a confluent layer of ECs is critically to the 
stability of the graft in vivo [16, 20]. Non-native arterial tissue generally lacks any inherent property or 
molecule which can attract ECs in form such confluent layers in vivo. This is generally achieved by 
embedding heparin in the PCL fibers. At an optimal concentration, heparin can attract ECs in 
forming a confluent layer [130, 131]. Heparin can be also released over a time from the fibers, 
thereby, resisting the formation of thrombus [130, 131]. The formation of the ECs layer is critical 
since recruitment of ECs would stop any SMC from migrating on to the inner surface of the intimal 
equivalent [132, 133], thereby, circumventing any chances of the formation of neointimal 
hyperplasia. Heparin molecule, by itself is known to control the proliferation and migration of SMCs 
on to the inner core. Based on our previous study [117], the outer shell with a low crosslinking 
density, is suitable for promoting SMC activity and tissue remodeling. Addition of chemotaxants 
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such as platelet-derived transforming growth factor and high-concentration fetal bovine serum has 
shown to improve the SMC activity in the medial equivalent [117]. In this study, we have studied the 
release of heparin from the PCL fibers as well as evaluated the in vitro performance of these 
multilayer grafts with a sheep carotid grafting model. 
 
5.2 Materials and methods 
 
5.2.1 Materials for inner core 
 
Poly-ε-caprolactone (  ̅̅ ̅̅ =80,000 g/mol), polyethylene oxide (  ̅̅ ̅̅ =500,000 g/mol) and Acetonitrile 
(ACN) were purchased from Sigma Aldrich (St Louis, MO). N, N-Dimethylformamide (DMF, 
minimum purity 99.9%) and dichloromethane (DCM, minimum purity 99.5%) were purchased from 
Mallinckrodt Chemicals (Phillipsburg, NJ). The electrospinning apparatus comprised of a Gamma 
High Voltage Research ES30P-10W power supply (Gamma High Voltage Research Inc., Ormond 
Beach, FL), a pair of syringe pumps (Pump 11 Plus - Harvard Apparatus, Crisel Instrument, Rome, 
Italy), a cylindrical aluminum collector with 5.56mm in diameter, a brushless rotating electric motor 
(BLF230C-A Oriental Motor,  Italia S.R.L., Milan, Italy), 5 ml polystyrene syringes to dispense the 
polymer solutions, stainless-steel 18G blunt-ended needles and flexible PTFE tubing. 
 
5.2.2 Electrospinning of inner core 
 
The protocol for electrospinning of PCL has be described in our previous studies [118]. Briefly, PCL 
was dissolved in a 5:3:2 mixture of DCM, DMF and a heparin-methanol solution to obtain an 8% by 
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weight PCL solution. Heparin, a thromboresistant molecule and EC attractant [119], was dissolved 
in the methanol to obtain an 8% by weight heparin-methanol solution and the total heparin 
concentration in the resulting PCL solution was 0.5% by weight. PEO was dissolved ACN to obtain 
a 4.5% by weight PEO solution. The mandrel rotation speed was set at 400 rpm. To facilitate the 
detachment of the scaffold materials, the collector was tightly wrapped with a thin aluminum foil 
and an ultrathin layer of PEO was electrospun on its surface to avoid PCL fibers sticking to the 
collector. PCL fibers were collected with needle-collector distance of 22cm. The voltage and flow 
rate for collecting the PCL fiber were set to 27kV and 1mL/hr., respectively. PCL was spun up to a 
thickness of 120µm. The enhancement of the interface interactions and thus, the integration 
between the layers, was achieved by creating high porosity (HP) at the surface. PCL-PEO scaffolds 
were fabricated by collecting PCL nanofibers until the point where the thickness of the tube reaches 
approximately 100µm, and then simultaneously spinning PEO with PCL and forming interwoven 
nanofibers on the collector for the next 20µm with the protocol described in chapter 4. We have 
previously established double-electrospinning of two fibers as a means of modifying the surface 
[118]. The PCL scaffold was cut into small tubes of uniform length of about 30mm. To create 
PCL(HP) scaffolds, PCL scaffolds with PCL-PEO surface were soaked for an hour in deionized or 
ultrapure water to eliminate the PEO and the solvent residuals, before they were removed from the 
aluminum foil.  
 
5.2.3 Preparation of outer shell 
 
Preparation of the gel for the outer shell was followed the protocol we developed previously [109]. 
Briefly, rat tail collagen (type I) in 0.02N acetic acid (pH 4.0) at 9 mg/ml (BD Biosciences Inc., San 
Jose, CA) was first transferred to a centrifuge tube. Then, 1X Dulbecco’s Phosphate Buffered Saline 
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(DPBS, Invitrogen Corporation, Carlsbad, CA) and 10X DPBS (Invitrogen Corporation, Carlsbad, 
CA) was added to the solution, followed by the addition of chitosan suspension. Chitosan 
(Molecular Weight = 100,000-300,000 g/mol, 90% deacetylation, Milan Panic Biomedicals Inc., 
Solon, OH) was dissolved in 1% acetic acid resulting in a chitosan suspension of 10 mg/ml 
concentration with a viscosity of 2000-3000 mPa.s. The pH of the pre-gel mixture was adjusted to 
7.3 by the careful addition of 1M NaOH. Finally, the mixture was finally topped off with 1X DPBS 
solution to achieve the desired volume. The final concentrations of the collagen and chitosan in the 
collagen-chitosan constructs were 3mg/ml and 3.5 mg/ml, respectively. The inner core 
manufactured by the electrospinning process was slid over a dry glass rod. This rod was then placed 
in the vascular graft mold. The neutralized collagen-chitosan mixture was slowly poured into a 
cylindrical graft mold around the PCL tube on the glass rod. To further remove bubbles which 
influence mechanical properties by introducing void defects and high variations in gel constructs, the 
pre-gel solution was placed at room temperature for five minutes before it was transferred into the 
incubator. Finally, the mold was transferred into an incubator to initiate gel formation at 37 °C.  
After 10 hours of gelation, the outer shell was crosslinked by diffusion with 2.5mM genipin in 1X 
DPBS for 10 hours. The crosslinker concentration was determined by our previous study [117] 
according to its effect on SMC migration. The samples were washed 5 times in 1X DPBS to remove 
an excess unreacted genipin. The multilayer grafts have been designated as PCL(HP)-GCC for 
simplicity. 
 
5.2.4 Heparin release test 
 
Heparin impregnated unmodified PCL scaffolds were cut in pieces (25mm x 5 mm x 0.15 mm, 
approximate weight 60 mg). Each one was soaked in 5 ml of DPBS), at 37°C, under constant mild 
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shaking on a shaker table. After 12h, and 1, 4, 7, 10, 13, 16, 23 and 30 days 150µl were extracted for 
heparin content measure and replaced with fresh DPBS. The Biophen heparin Anti-Xa 
Assay/Detection Kit (HYPHEN BioMed, Mason, OH) was used to detect the amount of heparin 
released during each time point. Heparin Anti-Xa method is a two-stage chromogenic assay capable 
of measuring for their Anti-Xa activity of homogeneous heparin in plasma or in purified solutions. 
A cumulative release curve was built with experimental data. The standard deviation at each time 
point over 4 samples was also plotted along with the average release values. 
 
5.2.5 Sterilization of grafts 
 
The vascular grafts were frozen in liquid nitrogen (~195˚C), following which they were dried in a 
critical-point drying chamber (Labconco, Kansas City, MO) for approximately 48 hours. Then, the 
grafts were immersed in absolute ethanol (100%) for one hour. Then, the grafts were washed with 
1X DPBS five times to remove any impurities. 
 
5.2.6 Ovine implantation 
 
Two vascular grafts were implanted in a healthy, female sheep in both the Left and Right Carotid 
arteries, subcutaneously (Figure 5.1A). The sheep were premedicated with subcutaneous injections 
of Medetomidin (210 mcg/kg), Midazolam (0.5 mg/kg) and Morphine (1 mg/kg). An intravenous 
catheter was placed in a vein in the ear and propofol (5 to 8 mg/kg) was used to induce anesthesia.  
After intubation, anesthesia was maintained with Isofluran in 100% oxygen. At the time of 
induction, the sheep receive Enrofloxacin at a dose of 5mg/kg. The sheep were placed on dorsal 
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recumbency. The ventral part of the neck was clipped with a # 40 blade and prepared with 
Chlorhexidine soap and alcohol.  After draping the neck with sterile towels and drapes, a ventral 
midline incision was performed to expose both carotid arteries.  Heparin was administered at the 
dose of 200 U/kg intravenously. After exposure of both carotid arteries, a graft was implanted in 
each artery.  One artery at a time was isolated and clamped with vascular clamps.  The artery was 
transected between the two clamps.  A graft was anastomosed in an end to end fashion with 7-0 
propylene suture in a continuous fashion.  The graft was de-aired before completion of the 
anastomosis. Blood flow was re-established and Gelfoam was applied around the sites of 
anastomosis for hemostasis.  The second artery was treated in a similar fashion. Subcutaneous tissue 
and skin were closed in a routine fashion. The sheep received buprenorphine (0.05mg/kg 
subcutaneously twice a day for 3 days) and meloxicam (0.3 mg/kg subcutaneously twice a day for 3 
days). 
 
  
Figure 5.1: (A) Ovine Implantation: Implanted 5.56mm multilayer vascular graft replacing the 
carotid artery of a sheep with anastomosis covered with gauge to stop bleeding. (B) Explanted graft 
fully integrated with the neighboring artery 
 
(A) (B) 
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5.2.7 Ultrasound sonography 
 
Ultrasound images of the grafts, the upstream and downstream neighboring artery, were taken after 
2-Days, 1-week, 2-Weeks, 3-Weeks and 4-Weeks (1-month) of implantation to visualize any 
thrombus formation or narrowing of the graft. Lumen diameter and wall thickness was measured 
using the open-sourced imaging software ImageJ (National Institutes of Health). 
 
5.2.8 Graft explantation 
 
The explantation of the grafts from the sheep was performed four weeks (1-month) after the 
implantation. Grafts were located by feel, and removed with approximately 20 millimeters of 
upstream and downstream neighboring artery for comparison.  
 
5.2.9 Histology 
 
Cross sections of the graft, the neighboring artery, and the site of anastomosis were fixed in 10% 
formaldehyde and cryo-sectioned. Stained specimens were placed on the slide normal to the 
longitudinal axis. The histological sections where then stained with Movat’s pentachrome (MP), and 
hematoxylin and eosin (HE). These stained sections were observed under the light microscope 
(Zeiss Axiovert S100, Carl Zeiss – Advanced Imaging Microscopy, Germany) at 20X magnification. 
Unstained sections were imaged for immunofluorescence (IF) under the light microscope at 20X 
magnification. 
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5.2.10 Data analysis and statistics 
 
Data were statistically analyzed using the one-way ANOVA test. Student’s t test was then used to 
compare the means of each individual group. The level of significance was set at α = 0.05 for 95% 
statistical significance. Error bars on all the histogram charts represent the standard error of the 
mean based on the total number of the samples. 
 
5.3 Results 
 
5.3.1 Heparin release 
 
Figure 5.2 shows the cumulative release percentage of heparin from heparin encapsulated 
unmodified PCL over time in days. Since it is a cumulative curve, each successive time step is a sum 
of all the releases in the previous time steps. Within the first 24 hours, 14.88±5.31% had been 
released and after 30 days a total of 59.16±6.12% heparin was released. 
 
 
Figure 5.2: Heparin Release from PCL fibers expressed as cumulative  
release percentage over time in days 
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5.3.2 No thrombosis, good patency, excellent graft integration & restoration of pulsatile flow  
 
Explantation revealed little complications in the sheep. Grafts had merged with the native artery at 
anastamosa satisfactorily at anastamosa (Figure 5.1B). Grafts were located through manual 
examination of the artery. The biodegradable sutures were absorbed into the system without any 
adverse reactions. The ultrasound images (Figures 5.3A-H) revealed there was no thrombosis or 
stenosis at any cross-section of the graft, the anastamosa or the neighboring artery during any of 
weeks (1, 2, 3 or 4). Thus, the graft, the anastamosa as well as the neighboring artery remained 
patent all through -the study. In all of the 8 images (Figures 5.3A-H), some incongruence at the 
anastamosa can be seen. Additionally turbulent flow is present, especially in the initial weeks (1-2) of 
the study. Images from 3rd (Figure 5.3E-F) and 4th weeks (Figure 5.3G-H), clearly, suggests that 
normal pulsatile flow has been restored in the vessels. The images reveal distinct fluid velocity 
sections with little flow dispersion. In these images from weeks 3 (Figure 5.3E-F) & 4 (Figure 5.3G-
H), some breaks in flow can be observed at the anastamosa toward the neighboring artery.  
  
 
 
  
(A) (B) 
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Figure 5.3: Ultrasound Sonography: (A): 1st Week Image of the graft on Right Carotid Artery; (B): 
1st Week Image of the graft on Left Carotid Artery; (C): 2nd Week Image of the graft on Right 
Carotid Artery; (D): 2nd Week Image of the graft on Left Carotid Artery; (E): 3rd Week Image of 
the graft on Right Carotid Artery; (F): 3rd Week Image of the graft on Left Carotid Artery; (G): 4th 
Week Image of the graft on Right Carotid Artery; (H): 4th Week Image of the graft on Left Carotid 
Artery. (Note: Figures (A) & (B) are on the previous page) 
 
(C) (D) 
(E) (F) 
(G) (H) 
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5.3.3 No change in vascular graft average lumen diameter 
 
The overall lumen diameter (Figure 5.4A) of the grafts, computed from the ultrasound sonography 
images, did not show any statistically significant change throughout the four week duration. The 
lumen diameter of the graft (Figure 5.4B), computed from the ultrasound sonography images, 
showed no significant increase in diameter when normalized to the diameter of an upstream carotid 
artery from week 1. Both the cases did not reveal any overall trend. 
 
  
Figure 5.4: (A): Graft Lumen Diameter during each week after implantation; (B): Graft Lumen 
Diameter Normalized to the 1st Week Neighboring Artery Diameter 
 
5.3.4 Increase in vascular graft average wall thickness 
 
The average graft wall thickness values computed from the ultrasound sonography images are 
indicated in Figure 5.5A. Figure 5.5B illustrates the changes in the average graft wall thickness 
normalized to the thickness of the neighboring artery during the 1st week computed from the 
ultrasound sonography images. Similar results were observed in both cases. There was a significant 
(A) (B) 
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change in the graft wall thickness from the 1st week to each of the other three weeks. There was also 
a significant change in the 3rd and the 4th weeks in comparison to the 2nd week. There were no 
significant changes in between the 3rd and the 4th weeks.  
 
  
Figure 5.5: (A): Graft Average Wall Thickness. † - p<0.05, statistical significance w.r.t. to 1st week 
graft wall thickness; ††- p<0.1, statistical significance w.r.t. to 1st week graft wall thickness; ‡ - 
p<0.05, statistical significance w.r.t. to 2nd week graft wall thickness. (B): Graft Average Wall 
Thickness Normalized to the 1st Week Neighboring Wall Thickness. † - p<0.05, statistical 
significance w.r.t. to 1st week normalized graft wall thickness; ‡ - p<0.05, statistical significance w.r.t. 
to 2nd week normalized graft wall thickness. 
 
5.3.5 No endothelium regeneration 
 
Immunofluorescence for the SMA, DAPI, and PECAM (CD31) were highlighted to indicate SMCs, 
nuclei, and endothelial cells respectively. Figure 5.6 shows the HE staining of the neighboring artery 
(Figure 5.6A) and the graft (Figure 5.6B) and the stain stains the cell cytoplasm red and the nuclei 
blue. These images reveal no endothelialization at the anastomosa even though there is a confluent 
(A) (B) 
140 
 
layer of ECs in the neighbouring artery. This is also confirmed by the immunoflorescence imaging 
(Figure 5.7) and the Movat’s Pentachrome staining (Figure 5.8) of the sections. In Figure 5.7, the EC 
recruting molecule, PECAM (CD31) is also stained green. PECAM (CD31) is clearly present in the 
neighbouring artery (Figure 5.7A) and the anastamosa (Figure 5.7B) but absent in the graft (Figure 
5.7C). Hence, it is clear that there is no endothelium regeneration. 
 
  
Figure 5.6: Hematoxylin and Eosin (H&E) staining of (A) the sectioned neighboring artery and (B) 
the sectioned graft. H&E staining displays cell cytoplasm (red) and nuclei (blue). Scale bar: 100µm. 
 
5.3.6 Intimal hyperplasia at anastamosa 
 
Figure 5.7 shows the immunofluorescence of the neighbouring artery (Figure 5.7A), the anastmosa 
(Figure 5.7B) and the graft (Figure 5.7C). These images reveal the formation of the neointimal 
hyperplasia which is marked with a yellow line. The size of the neointimal hyperplasia near the 
anastamosa is approximately 400µm. Though there is fairly large neointimal hyperplasia formed at 
the anastamosa, its size decreases to zero while moving away from the anastamosa to the center of 
the graft. This is confirmed by Figure 5.8, which has be obtained by merging the red, the green and 
the blue intensity images at the center of the graft. The blue dots in Figure 5.8 are the SMCs which 
141 
 
have migrated from the neighboring artery into the graft. Collagen in the outer shell can be observed 
in red while the PCL in the inner core is observed in green. 
 
 
Figure 5.7: Immunofluorescence of (A) the neighboring artery, (B) the Anastamosa and (C) the graft. 
Pictured are the smooth muscle cells (red), endothelial cells (green), nuclei (blue), and connective 
tissue (autofluorescent). The basal membrane is marked with the yellow arrow. The lumen is marked 
“L”, and the lumen side neointimal hyperplasia is marked by the yellow line.  
Scale Bar for A-B: 100µm & for C: 50µm. 
 
Figure 5.8: Absence of Neointimal Hyperplasia in the Middle of the Graft. Scale Bar: 100µm 
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5.3.7 Migration of SMCs into graft and production of ECM 
 
In the immunofluorescence images of Figure 5.7, the SMCs, the ECs and their nuclei are stained red, 
green and blue, respectively. These histological images show SMC migration and proliferation into 
the graft medial layer. Since there is no endothelium regenerated, the SMCs have, also, migrated on 
to the PCL surface causing the formation of the neointimal hyperplasia. The SMCs are distinctly 
aligned on the neointimal hyperplasia, while the media contains a disorganization of randomly 
aligned fibers and SMCs. Figure 5.9 displays the Movat’s Pentachrome staining of the neighboring 
artery (Figure 5.9A) and the graft (Figure 5.9B). SMCs, elastin, collagen, fibrin and the ground 
substance are stained red, purplish-black, yellowish-green, deep red and bluish-green, respectively. In 
addition, little to no ground substance or elastic fibers can be seen in the medial layer. Finally, 
delamination, seen in all histological images, is a result of the histological sectioning itself.  
  
Figure 5.9: Movat’s Pentachrome staining of the Neighboring Artery (A) and Graft (B). Pictures are 
the smooth muscle tissue (red), elastin (purplish black), collagen (yellowish green), and 
glycosaminoglycans (bluish green). The basal membrane is indicated by the blue arrows. The lumen 
is marked “L”. Scale bar: 100µm 
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5.4 Discussion 
 
This study was performed to study the in vivo properties of a grafting scaffold developed in our 
previous work (Chapter 4). The graft did not reveal any unfavorable immunogenic responses, 
thrombosis or stenosis when implanted inside a sheep model. The graft had fully integrated with the 
neighboring artery at anastamosa. Healing and remodeling at anastamosa was also very satisfactory. 
Image analysis of the images obtained from ultrasound sonography showed minimal changes in the 
diameter and significant changes to the wall thickness of the graft over the 1-month implantation 
due to the formation of the neointimal hyperplasia. Histology of the graft revealed the formation of 
neointimal hyperplasia and the absence of a confluent layer of ECs.  
 
Salacinski et al [23] established a linear relationship between compliance and patency after one 
month of implantation. Based on this relationship, in our previous study, we have established that 
these grafts possess compliance similar to that of the carotid artery and hence will be highly patent at 
the end of 1st month of implantation. Our prediction was confirmed since the graft did not show 
any kind of patency, except for the formation of a neointimal hyperplasia (approximately 
400microns thick), after one month of implantation. This can be attributed to the migration of the 
SMCs from the neighboring artery to the medial layer of the graft through the anastamosa followed 
by their proliferation. Even though SMCs migrated, ECs did not get recruited to form a confluent 
layer adhering to the PCL surface instead a layer of neointimal hyperplasia had formed. Histological 
imaging provides little doubt about the neointimal hyperplasia, though no stenosis was observed in 
the specimens during the implantation through the ultrasound images as well as after the 
explantation using the histological images. This indicates SMCs migrated on to the intima and 
prevented endothelialization. Plausible reasons for the SMC intimal migration include decreased 
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fluid shear at the anastamosa due to incongruence of the graft and vessel intima layers and lack of an 
optimum concentration of EC recruiters such as heparin and PECAM (CD31). The incongruence in 
the graft and vessel can also be witnessed in the fluid flow ultrasound imaging. It is to be clearly 
noted that though endothelialization does not occur, stenosis does not occur either, which is 
possibly due to the low or no compliance mismatch.  
 
Ultrasound images of the grafts in vivo show clearly no signs of stenosis, with no change in lumen 
diameter over the length of the study. In addition, no trend in lumen decrease, when compared to 
the neighboring artery, was seen, which indicates functional similarity between the artery and the 
graft flow areas. Percentage change between the upstream artery and the graft for weeks 2 and 4 are 
significantly different from the upstream artery, showing a decrease in lumen diameter. Because of 
the peak seen in week 3, this decrease in diameter could be resulting from difficulty in differentiating 
the anastomosis from the neighboring artery, as well as differentiating vessel structures in the 
neighboring artery. Ultrasound additionally showed an increase in graft wall thickness, when 
compared to initial values (week 1) and when compared to the upstream artery for each image taken. 
Two reasons which contribute to the increase in the wall thickness are as follow. The increase in the 
wall thickness indicates the advanced integration of the graft into the neighboring artery, with tissue 
growth around graft walls. Additionally, when taken in conjunction with the histological images, the 
increased wall thickness is also due to the formation of the neointimal hyperplasia. 
 
SMCs present in the neointimal hyperplasia are circumferentially aligned, and viable, and could act as 
a functional media layer, which could be a limitation in long-term studies. Improvements to the 
construct should necessitate the formation of a confluent layer of ECs attached to the intima to 
avoid any SMC migration or formation of neointimal hyperplasia. Improved EC migration and 
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attachment could be influenced by fiber alignment or material property changes to the intimal 
construct. In addition, circumferential alignment of SMCs should be achieved through fiber 
alignment in GCC, the outer shell of the multilayer graft. SMC morphology in the medial layer can 
also be seen to have a random orientation, in contrast to the circumferential alignment seen in the 
native blood vessels. Hemodynamic loading of the SMC scaffold is required to align them in the 
direction of highest stress which will also ensure that the ECM production will also be 
circumferential. Without this alignment, vessels may fail under systolic pressures. PCL, a slow-
degrading high-strength polymer, provides a suitable attachment layer for ECs and restricts the 
migration of medial SMCs into the intima. It was assumed that due to its low decay rate, medial 
vessel wall stresses will increase, gradually, leading to the alignment of the ECM and SMCs in a long-
term in vivo. To address the issues which have arisen in this study, a new intimal layer structure could 
be investigated and effect way of communicating with the ECs in vivo should be developed. It has 
also been established in our previous studies (Chapter 4), that the integrity of the graft would be 
dependent on the interface between the intimal and the medial equivalents. Any improvement in the 
attachment of the intimal and the medial equivalents would provide a stronger interface bond 
between intima and media, as well as provide better cell proliferation/migration and attachment. 
Endothelialization would be the most important issue to be answered from the study. With 
improvements in endothelialization, this multilayer layer grafting scaffold, consisting of an 
electrospun intimal equivalent (PCL) and a collagenous medial equivalent (GCC), has the potential 
to serve as a suitable replacement to damaged or diseased small-caliber blood vessels by providing 
the balance between the biomechanical and the physiological requirements to TEBV and well as a 
micro-environment which will promote favorable responses and remodeling in vivo. 
 
146 
 
5.5 Conclusions 
 
This study demonstrated that the graft did not reveal any unfavorable immunogenic responses, 
thrombosis or stenosis when implanted inside a sheep model while fully integrating with the 
neighboring artery. Healing and remodeling at anastamosa after one-month of implantation was also 
very satisfactory. Analysis of the ultrasound sonography images showed no change in the average 
lumen diameter of the graft while there were significant changes to the average wall thickness over 
the 1-month implantation possibly due to the integration of the graft with the neighboring artery as 
well as the formation of the neointimal hyperplasia. Histology of the graft revealed the formation of 
neointimal hyperplasia whose thickness decreased from the anastamosa to the center of the graft. 
Histology also revealed there was no endothelium regenerated in the graft and the structure of the 
extracellular matrix in the medial layer was quite distinct from that of the neighboring artery.  
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CHAPTER 6 
 
6. DISCUSSION AND FUTURE WORK 
 
6.1 Discussion 
 
This Ph. D. dissertation has focused on the design and the development of a multilayer vascular 
graft consisting of an electrospun inner core (intimal equivalent) and a collagenous outer core 
(medial equivalent). The dissertation can broadly be divided into three sections: Material Selection, 
Multilayer Graft and Interface Design, Multilayer Graft in vitro Testing and Multilayer Graft in vivo 
Testing. 
 
6.1.1 Material selection 
 
To explore an alternative approach to design a material a suitable vascular grafting scaffold, the 
material selection process involved the engineering of collagenous scaffolds by the incorporation of 
mimetic components and crosslinking the construct with different crosslinkers. The effects of 
component additives, such as chitosan and elastin, were evaluated in terms of their mechanical and 
biological properties. Results demonstrated that the incorporation of chitosan and/or elastin altered 
stress-strain curves in the low stress loading region, and significantly improved the stretching ratio 
and ultimate stress of modified collagenous scaffolds compared to pure collagen scaffolds. Electron 
microscopy results suggested that the mechanical improvements were plausibly due to 
microstructural modifications by the sheets of chitosan and elastin fibers embedded in the collagen 
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scaffold like an interfibrillar network. The effects of crosslinkers, such as formaldehyde, genipin and 
ethyl-(dimethyl aminopropyl) carbodiimide hydrochloride (EDAC) were also evaluated. Fourier 
transform infrared spectroscopy results demonstrated that formaldehyde, EDAC and genipin 
employed different mechanisms to crosslink the collagenous scaffolds, and use of genipin as a 
scaffold crosslinker improved the elongation and the endothelial cell attachment as compared to 
formaldehyde and EDAC. In addition, extending gelation time increased the elastic modulus but not 
the ultimate strength.  
 
Following this, the biocompatible crosslinker, genipin was, then, used to crosslink collagen-chitosan-
elastin scaffolds, and the effects of genipin concentration on the mechanical properties, smooth 
muscle cell activity and degradation of collagen-chitosan-elastin scaffolds were examined. Results 
revealed that mechanical strength, stiffness and stability of collagen-chitosan-elastin scaffolds 
increased with the concentration of the genipin crosslinker increasing from 1mM to 25mM, but, 
also, significantly inhibited smooth muscle cell contraction of and invasion in the collagen-chitosan-
elastin scaffolds. No smooth muscle cell contraction or invasion was observed in the scaffolds 
crosslinked with genipin at a concentration of 5mM or above. These results were shown to be 
correlated with the chemical characterization results from fourier transform infrared spectroscopy. 
We, also, incorporated several growth factor conditions in the genipin-crosslinked collagen-chitosan-
elastin scaffolds and evaluated their effects on smooth muscle cell activities. These conditions 
included heparin, platelet-derived transforming growth factor, high-concentration fetal bovine serum 
and their combinations. Results showed that the addition of high-concentration fetal bovine serum 
in genipin-crosslinked gels significantly increased smooth muscle cell contraction and invasion, 
platelet-derived transforming growth factor increased smooth muscle cell invasion while heparin 
reduced this platelet-derived transforming growth factor effect, and the synergetic effects of high-
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concentration fetal bovine serum and platelet-derived transforming growth factor stimulated smooth 
muscle cell invasion more significantly than a single factor. Thus, this study suggested that the use of 
combination of high-concentration fetal bovine serum and platelet-derived transforming growth 
factor with low-concentration (1mM) genipin-crosslinked collagen-chitosan-elastin scaffolds might 
potentially achieve a vascular media equivalent with superior performances.  
 
6.1.2 Multilayer graft & interface design with in vitro testing  
 
From our study suggested that designing a suitable engineering equivalent to blood vessels which 
allow immediate implantation and encourage tissue regeneration in vivo should employ an 
appropriate combination of crosslinking condition and soluble biomolecule factors, striking a 
balance between mechanical and biological properties. To keep our multilayer graft design simple, it 
was decided to carry forward the low-concentration genipin-crosslinked collagen-chitosan scaffold. 
The concentration of the genipin crosslinker was fixed at 2.5mM since lower crosslinker 
concentrations did not impart desired shape of the tubular vascular graft. Also, since the low-
concentration genipin-crosslinked collagenous scaffold lacked sufficient strength, a thin layer of 
electrospun scaffold was introduced underneath the collagenous scaffold. In this study, we designed 
a multilayer grafting scaffold from a combination of electrospun poly-ε-caprolactone, as the intimal 
equivalent, and a genipin crosslinked collagen-chitosan scaffold as the medial equivalent. The adhesion 
between the two layers played a critical role in the design of the vascular graft and the improvement of 
the adhesion was done either, physically, by increasing porosity of the top surface or by improving the 
hydrophilicity of the intimal equivalent or chemically by crosslinking the two layers. The grafts used 
for biomechanical testing possessed an inner diameter of 4.76mm, poly-ε-caprolactone layer thickness 
of 120µm and genipin-crosslinked collagen-chitosan scaffold thickness of 1.25mm (approximately).  
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These grafts exhibited burst strengths varying between 644mmHg to 1152mmHg and compliance 
(80-120mmHg range) between 2.6-5.2%. The water permeability of the electrospun poly-ε-
caprolactone scaffold reduced from 2380mL/cm2/min to 551mL/cm2/min due to the addition of 
the genipin-crosslinked collagen-chitosan layer over them. The suture strengths of the single poly-ε-
caprolactone as well as the multilayer scaffolds were 2N and 2.4N, respectively. Both compliance 
and burst strength were found to be dependent on the thickness (120µm & 240µm) of the intimal 
equivalent layer while the genipin concentration (1mM, 2.5mM and 10mM) for crosslinking the 
genipin-crosslinked collagen-chitosan scaffold had no effect on them. As a preliminary study, the 
multilayer graft (inner diameter 3mm) was implanted for short duration of 1-day into rabbits 
replacing the abdominal aorta. These grafts on explantation showed no unfavorable immunogenic or 
inflammatory responses. Our study suggests that designing a suitable engineering equivalent to 
blood vessels which would sustain the physiological conditions and promote appropriate cellular 
activity in vivo would involve the balancing of biomechanical and biochemical properties of fibrous 
scaffolds synthesized by the mimicry of natural blood vessels.  
 
6.1.3 Multilayer graft in vivo testing  
 
Since in our preliminary implantation studies, no unfavorable immunogenic responses or thrombosis 
were seen after a day of implantation, in this study, we replaced the carotid arteries in a sheep with 
two multilayer grafts, with an inner core made of an electrospun intimal equivalent (Poly-ε-
Caprolactone) and an outer shell made of a collagenous medial equivalent (genipin-crosslinked 
collagen-chitosan), for a duration of one month. The endothelial cell chemoattractant, heparin, was 
embedded in the inner core during the process of electrospinning. During the one-month period, 
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ultrasound sonography images were obtained which were used to calculate the changes in the lumen 
diameter and the wall thickness during each week. The graft was explanted after a month after 
implantation. During the explantation, it was observed that the graft had fully integrated with the 
neighboring artery. Sections of the graft, the suture sites and the neighboring artery were then 
subjected to cryo-sectioning for histological staining.  
 
The ultrasound images revealed minimal changes to the graft diameter as well as significant changes 
to the graft wall thickness during the four weeks. The increase in thickness of the graft wall in vivo is 
due to the integration of the graft with the neighboring artery as well as the formation of the 
neointimal hyperplasia. The formation of the neointimal hyperplasia, about 400 microns in 
thickness, is also confirmed by the stained histological sections. There was no recruitment of 
endothelial cells in the intimal possibly due to the recruitment of the smooth muscle cells onto the 
intimal equivalent. The smooth muscle cells and the extracellular matrix were found to have no 
orientation in the medial equivalent while they were aligned circumferentially in the neointimal 
hyperplasia. Additionally, the ultrasound sonography images as well as the histological sections 
confirm that no unfavorable immunogenic response or thrombosis or stenosis occurred in vivo 
during the implantation. With all the superior physiological properties along with some methods to 
develop in vivo endothelialization, this multilayer graft has the potential to serve as a suitable vascular 
graft scaffold providing the right biomechanical properties and the micro-environments suitable to 
promote vascular cell migration and proliferation as well as tissue remodeling. 
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6.2 Suggestions & future work 
 
6.2.1 Interface characterization & adhesion improvement: 
 
Some of the major issue faced during this project was that the interface was very critical in designing 
the multilayer vascular graft. Since two materials with completely different water affinities were 
being combined, it was quite difficult to combine them without a proper interface design. Fair 
degree of success was achieved with the creation of high porosity in the top surface of the inner core 
which subsequently imparted suitable biomechanical properties and integrity to the graft. By the 
oxygen-plasma treatment, even though the adhesion was superior, the biomechanical properties 
were drastically reduced since the treatment rendered the inner core to become very stiff. The 
chemical crosslinking process yielded less success. To improve the adhesion, it is suggested to first 
create the high porous at the top surface and then, bind gelatin to the inner core fiber surface using 
the oxygen-plasma treatment and then crosslink the inner core and the outer shell with low-
concentration genipin. This method has been employed by other researchers for cell attachment 
procedure with a fair degree of success [120, 134]. 
 
6.2.2 Stiffness and thickness of inner core 
 
The inner core thickness was set to 120µm based on the work done by our group member, Walter 
Bonani [118]. Other researchers have used higher thicknesses. Lee et al used a 300 µm [113] while 
McClure et al used thickness varying from 200µm to 500µm [124]. Due this difference, it can be 
clearly seen that their burst strength values were much superior to ours while our compliance values 
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where superior to theirs. In the future, the inner core has to be designed in such a way that the fibers 
are able impart superior burst strength as well as compliance. This can be achieved by 
electrospinning poly-ε-caprolactone with collagen and/or elastin and/or chitosan as done by other 
researchers [113, 124] to the same thickness of 120µm. This will definitely improve the mechanical 
properties of the inner core as well as improve the attachment with the outer shell via crosslinking. 
This will also provide a better surface for endothelial cell attachment. 
 
6.2.3 Endothelialization 
 
Endothelialization is very critical for the performance of the graft in vivo. Our results have suggested 
that there was no endothelialization possibly due to the recruitment of the smooth muscle cell on to 
the inner surface of the intimal equivalent as well as low concentration of the endothelial recruiter. 
First method to solve this problem of no-endothelialization would be to find the optimum level of 
heparin and/or other chemoattractants like PECAM (CD31). This can be done by setting up a flow 
system with circulating endothelial cells. The concentration of the chemotaxant on the inner core 
fiber surface can be varied and the threshold concentration which instigates the attachment of the 
endothelial cells on to the inner core can be determined. The other method would be to seed 
endothelial cells on to the surface of the inner core and then, they are allowed to proliferate to form 
a smooth confluent layer. Then the cell-seeded multilayer graft can be used to study performance in 
vivo. 
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6.2.4 Inclusion of elastin in outer shell scaffold 
 
Elastin plays a critical role in the physiological functioning of any vascular vessel [14, 81]. We have 
been able to show that a collagen scaffold reinforced with chitosan and elastin and crosslinked with 
genipin performs biologically better than a pure collagen or collagen-chitosan scaffold. The next 
level of research will involve the incorporation of soluble elastin [80] in the outer shell scaffold. This 
will not only improve cell activity but will also improve the structural stability of the outer shell. 
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8. APPENDIX A: METHOD FOR FINDING TRANSITION POINT USING MATLAB 
 
8.1 Matlab code for determination of transition point 
 
clc 
close all 
clear all 
  
%% COLLAGEN 
%% Data Import & Storing in Corresponding Matrices 
[Time_COL, Extension_COL, Load_COL, Strain_COL, Stress_COL] = importFile(‘/XXXXX/’); 
%%/XXXXX/ is the Name of the Directory 
 
%% Smooth Curve using a filter 
Sm_COL.Stress = smooth(Strain_COL,Stress_COL,0.25,'rloess'); 
  
% Shifting Curve to origin along y-axis 
if Sm_COL.Stress(1) < 0 
    Smooth_Stress_COL = Sm_COL.Stress(:)+abs(Sm_COL.Stress(1)); 
elseif Sm_COL.Stress(1) > 0 
    Smooth_Stress_COL = Sm_COL.Stress(:)-abs(Sm_COL.Stress(1)); 
end 
  
%% Curve Fitting 
  
syms x 
  
% Fit Type 
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f_COL = fittype('poly5'); 
  
% Fit Curve 
[cfun_COL,gof_COL,output_COL] = fit(Strain_COL,Smooth_Stress_COL,f_COL); 
  
% Recalculate Fitted Stress Matrix 
FitStress_COL = cfun_COL(Strain_COL); 
  
% ReShifting Curve to origin along y-axis 
if FitStress_COL(1) < 0 
    FitStress_COL = FitStress_COL(:)+abs(FitStress_COL(1)); 
elseif FitStress_COL(1) > 0 
    FitStress_COL = FitStress_COL(:)-abs(FitStress_COL(1)); 
end 
  
% Peak Stress 
peakStress_COL = max(FitStress_COL); 
  
% Strain at Break 
n_COL = size(FitStress_COL,1); 
strainAtbreak_COL = Strain_COL(n_COL); 
  
%% Calculating Radius of Curvature 
  
% Initialize Radius of Curvature Vector 
rho_COL = zeros(n_COL,1); 
  
% Calculate 1st and 2nd Derivatives 
[dy_dx_COL, d2y_dx2_COL] = differentiate(cfun_COL,Strain_COL); 
  
% Calculate Curvature 
for i = 1:n_COL 
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    k_COL(i,1) = abs(d2y_dx2_COL(i))/(1+(dy_dx_COL(i)^2))^(3/2); 
end 
  
z_COL = find(k_COL>=0.01*max(k_COL)); 
  
m_COL = size(z_COL,1); 
  
% Find point of transition 
TransitionStrain_COL = Strain_COL(z_COL(1)); 
TransitionStress_COL = FitStress_COL(z_COL(1)); 
  
% Linear Modulus 
LinearModulus_COL = 100*(FitStress_COL(z_COL(m_COL,1))-
FitStress_COL(z_COL(1,1)))/(Strain_COL(z_COL(m_COL,1))-Strain_COL(z_COL(1,1))); 
  
%% COLLAGEN-CHITOSAN 
%% Data Import & Storing in Corresponding Matrices 
[Time_COL_CHI, Extension_COL_CHI, Load_COL_CHI, Strain_COL_CHI, Stress_COL_CHI] 
= importFile(‘/XXXXX/’); 
%%/XXXXX/ is the Name of the Directory 
 
  
%% Smooth Curve using a filter 
Sm_COL_CHI.Stress = smooth(Strain_COL_CHI,Stress_COL_CHI,0.25,'rloess'); 
  
% Shifting Curve to origin along y-axis 
if Sm_COL_CHI.Stress(1) < 0 
    Smooth_Stress_COL_CHI = Sm_COL_CHI.Stress(:)+abs(Sm_COL_CHI.Stress(1)); 
elseif Sm_COL_CHI.Stress(1) > 0 
    Smooth_Stress_COL_CHI = Sm_COL_CHI.Stress(:)-abs(Sm_COL_CHI.Stress(1)); 
end 
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%% Curve Fitting 
  
syms x 
  
% Fit Type 
f_COL_CHI = fittype('poly5'); 
  
% Fit Curve 
[cfun_COL_CHI,gof_COL_CHI,output_COL_CHI] = 
fit(Strain_COL_CHI,Smooth_Stress_COL_CHI,f_COL_CHI); 
  
% Recalculate Fitted Stress Matrix 
FitStress_COL_CHI = cfun_COL_CHI(Strain_COL_CHI); 
  
% ReShifting Curve to origin along y-axis 
if FitStress_COL_CHI(1) < 0 
    FitStress_COL_CHI = FitStress_COL_CHI(:)+abs(FitStress_COL_CHI(1)); 
elseif FitStress_COL_CHI(1) > 0 
    FitStress_COL_CHI = FitStress_COL_CHI(:)-abs(FitStress_COL_CHI(1)); 
end 
  
% Peak Stress 
peakStress_COL_CHI = max(FitStress_COL_CHI); 
  
% Strain at Break 
n_COL_CHI = size(FitStress_COL_CHI,1); 
strainAtbreak_COL_CHI = Strain_COL_CHI(n_COL_CHI); 
  
%% Calculating Radius of Curvature 
  
% Initialize Radius of Curvature Vector 
rho_COL_CHI = zeros(n_COL_CHI,1); 
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% Calculate 1st and 2nd Derivatives 
[dy_dx_COL_CHI, d2y_dx2_COL_CHI] = differentiate(cfun_COL_CHI,Strain_COL_CHI); 
  
% Calculate Curvature 
for i = 1:n_COL_CHI 
    k_COL_CHI(i,1) = abs(d2y_dx2_COL_CHI(i))/(1+(dy_dx_COL_CHI(i)^2))^(3/2); 
end 
  
z_COL_CHI = find(k_COL_CHI>=0.01*max(k_COL_CHI)); 
  
m_COL_CHI = size(z_COL_CHI,1); 
  
% Find point of transition 
TransitionStrain_COL_CHI = Strain_COL_CHI(z_COL_CHI(1)); 
TransitionStress_COL_CHI = FitStress_COL_CHI(z_COL_CHI(1)); 
  
% Linear Modulus 
LinearModulus_COL_CHI = 100*(FitStress_COL_CHI(z_COL_CHI(m_COL_CHI,1))-
FitStress_COL_CHI(z_COL_CHI(1,1)))/(Strain_COL_CHI(z_COL_CHI(m_COL_CHI,1))-
Strain_COL_CHI(z_COL_CHI(1,1))); 
  
%% COLLAGEN-CHITOSAN-ELASTIN 
%% Data Import & Storing in Corresponding Matrices 
[Time_COL_CHI_ELN, Extension_COL_CHI_ELN, Load_COL_CHI_ELN, 
Strain_COL_CHI_ELN, Stress_COL_CHI_ELN] = importFile(‘/XXXXX/’); 
%%/XXXXX/ is the Name of the Directory 
  
%% Smooth Curve using a filter 
Sm_COL_CHI_ELN.Stress = 
smooth(Strain_COL_CHI_ELN,Stress_COL_CHI_ELN,0.25,'rloess'); 
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% Shifting Curve to origin along y-axis 
if Sm_COL_CHI_ELN.Stress(1) < 0 
    Smooth_Stress_COL_CHI_ELN = 
Sm_COL_CHI_ELN.Stress(:)+abs(Sm_COL_CHI_ELN.Stress(1)); 
elseif Sm__COL_CHI_ELN.Stress(1) > 0 
    Smooth_Stress_COL_CHI_ELN = Sm_COL_CHI_ELN.Stress(:)-
abs(Sm_COL_CHI_ELN.Stress(1)); 
end 
  
%% Curve Fitting 
  
syms x 
  
% Fit Type 
f_COL_CHI_ELN = fittype('poly5'); 
  
% Fit Curve 
[cfun_COL_CHI_ELN,gof_COL_CHI_ELN,output_COL_CHI_ELN] = 
fit(Strain_COL_CHI_ELN,Smooth_Stress_COL_CHI_ELN,f_COL_CHI_ELN); 
  
% Recalculate Fitted Stress Matrix 
FitStress_COL_CHI_ELN = cfun_COL_CHI_ELN(Strain_COL_CHI_ELN); 
  
% ReShifting Curve to origin along y-axis 
if FitStress_COL_CHI_ELN(1) < 0 
    FitStress_COL_CHI_ELN = FitStress_COL_CHI_ELN(:)+abs(FitStress_COL_CHI_ELN(1)); 
elseif FitStress_COL_CHI_ELN(1) > 0 
    FitStress_COL_CHI_ELN = FitStress_COL_CHI_ELN(:)-abs(FitStress_COL_CHI_ELN(1)); 
end 
  
% Peak Stress 
peakStress_COL_CHI_ELN = max(FitStress_COL_CHI_ELN); 
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% Strain at Break 
n_COL_CHI_ELN = size(FitStress_COL_CHI_ELN,1); 
strainAtbreak_COL_CHI_ELN = Strain_COL_CHI_ELN(n_COL_CHI_ELN); 
  
%% Calculating Radius of Curvature 
  
% Initialize Radius of Curvature Vector 
rho_COL_CHI_ELN = zeros(n_COL_CHI_ELN,1); 
  
% Calculate 1st and 2nd Derivatives 
[dy_dx_COL_CHI_ELN, d2y_dx2_COL_CHI_ELN] = 
differentiate(cfun_COL_CHI_ELN,Strain_COL_CHI_ELN); 
  
% Calculate Curvature 
for i = 1:n_COL_CHI_ELN 
    k_COL_CHI_ELN(i,1) = 
abs(d2y_dx2_COL_CHI_ELN(i))/(1+(dy_dx_COL_CHI_ELN(i)^2))^(3/2); 
end 
  
z_COL_CHI_ELN = find(k_COL_CHI_ELN>=0.01*max(k_COL_CHI_ELN)); 
  
m_COL_CHI_ELN = size(z_COL_CHI_ELN,1); 
  
% Find point of transition 
TransitionStrain_COL_CHI_ELN = Strain_COL_CHI_ELN(z_COL_CHI_ELN(1)); 
TransitionStress_COL_CHI_ELN = FitStress_COL_CHI_ELN(z_COL_CHI_ELN(1)); 
  
% Linear Modulus 
LinearModulus_COL_CHI_ELN = 
100*(FitStress_COL_CHI_ELN(z_COL_CHI_ELN(m_COL_CHI_ELN,1))-
176 
 
FitStress_COL_CHI_ELN(z_COL_CHI_ELN(1,1)))/(Strain_COL_CHI_ELN(z_COL_CHI_EL
N(m_COL_CHI_ELN,1))-Strain_COL_CHI_ELN(z_COL_CHI_ELN(1,1))); 
  
%% Calculate the Pressure Values 
%Inner Diameter 
a=4.76/1000; %m 
  
%Outer Diamter 
b=8/1000; %m 
  
%Converting Stress in kPa to Pressure in mmHg 
Pressure_COL=7.502*FitStress_COL; 
Pressure_COL_CHI=7.502*FitStress_COL_CHI; 
Pressure_COL_CHI_ELN=7.502*FitStress_COL_CHI_ELN; 
  
%% Plot Stress vs Strain Curve for all Scaffolds 
%% 
figure(1) 
hold on; 
plot(Strain_COL,FitStress_COL,'k','LineWidth',2); 
plot(Strain_COL_CHI,FitStress_COL_CHI,'r','LineWidth',2); 
plot(Strain_COL_CHI_ELN,FitStress_COL_CHI_ELN,'b','LineWidth',2); 
title('Stress-Strain Curves for COL-Based 
Scaffolds','fontname','Garamond','fontsize',12,'fontweight','b') 
xlabel('Strain (%)','fontname','Garamond','fontsize',12,'fontweight','b') 
ylabel('Stress (kPa)','fontname','Garamond','fontsize',12,'fontweight','b') 
hold off 
%% 
  
%% Plot Radius of Curvature-Strain Curve for each of Scaffolds 
%% 
figure(2) 
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hold on 
plot(Strain_COL,max(FitStress_COL)*k_COL/max(k_COL),'b','LineWidth',1); 
plot(Strain_COL_CHI,max(FitStress_COL_CHI)*k_COL_CHI/max(k_COL_CHI),'g','LineWidth',
1); 
plot(Strain_COL_CHI_ELN,max(FitStress_COL_CHI_ELN)*k_COL_CHI_ELN/max(k_COL_C
HI_ELN),'r','LineWidth',1); 
title('Curvature vs Strain for COL-Based 
Scaffolds','fontname','Garamond','fontsize',12,'fontweight','b') 
xlabel('Strain (%)','fontname','Garamond','fontsize',12,'fontweight','b') 
ylabel('Curvature','fontname','Garamond','fontsize',12,'fontweight','b') 
hold off; 
%% 
  
%% Plot Radius of Curvature-Strain & Stress-Strain Curve for COL Scaffolds 
%% 
figure(3) 
hold on 
plot(Strain_COL,FitStress_COL,'b','LineWidth',2); 
plot(Strain_COL,max(FitStress_COL)*k_COL/max(k_COL),'k','LineWidth',1); 
title('Curvature-Strain & Stress-Strain Curves for COL 
Scaffolds','fontname','Garamond','fontsize',12,'fontweight','b') 
hold off 
%% 
  
%% Plot Radius of Curvature-Strain & Stress-Strain Curve for COL-CHI Scaffolds 
%% 
figure(4) 
hold on 
plot(Strain_COL_CHI,FitStress_COL_CHI,'b','LineWidth',2); 
plot(Strain_COL_CHI,max(FitStress_COL_CHI)*k_COL_CHI/max(k_COL_CHI),'k','LineWidth',
1); 
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title('Curvature-Strain & Stress-Strain Curves for COL-CHI 
Scaffolds','fontname','Garamond','fontsize',12,'fontweight','b'); 
hold off 
%% 
  
%% Plot Radius of Curvature-Strain & Stress-Strain Curve for COL-CHI-ELN Scaffolds 
%% 
figure(5) 
hold on 
plot(Strain_COL_CHI_ELN,FitStress_COL_CHI_ELN,'b','LineWidth',2); 
plot(Strain_COL_CHI_ELN,max(FitStress_COL_CHI_ELN)*k_COL_CHI_ELN/max(k_COL_C
HI_ELN),'k','LineWidth',1); 
title('Curvature-Strain & Stress-Strain Curves for COL-CHI-ELN 
Scaffolds','fontname','Garamond','fontsize',12,'fontweight','b') 
hold off 
xlabel('Strain (%)','fontname','Garamond','fontsize',12,'fontweight','b') 
ylabel('Stress (kPa)','fontname','Garamond','fontsize',12,'fontweight','b') 
%% 
  
%% Plotting Stress-Strain & Pressure-Diameter Curves of COL Scaffolds 
%% 
figure(6) 
[AX,H1,H2]=plotyy(Strain_COL,FitStress_COL,Strain_COL,Pressure_COL,'plot'); 
h = legend('Stress (kPa)','Pressure (mmHg)',2); 
set(h,'Interpreter','none') 
set(get(AX(1),'Ylabel'),'String','Stress (kPa)','fontname','Garamond','fontsize',12,'fontweight','b')  
ylimits1 = get(AX(1),'YLim'); 
yinc1 = (ylimits1(2)-ylimits1(1))/10; 
set(AX(1),'YTick',ylimits1(1):yinc1:ylimits1(2)) 
set(AX(1),'XColor','k','YColor','k','fontname','Garamond','fontsize',12,'fontweight','b') 
set(get(AX(2),'Ylabel'),'String','Internal Pressure 
(mmHg)','fontname','Garamond','fontsize',12,'fontweight','b')  
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ylimits2 = get(AX(2),'YLim'); 
yinc2 = (ylimits2(2)-ylimits2(1))/10; 
set(AX(2),'YTick',ylimits2(1):yinc2:ylimits2(2)) 
set(AX(2),'XColor','k','YColor','k','fontname','Garamond','fontsize',12,'fontweight','b') 
xlabel('Change in Diameter (%)','fontname','Garamond','fontsize',12,'fontweight','b') 
title('Stress-Strain & Pressure-Diameter Curves for COL 
Scaffolds','fontname','Garamond','fontsize',14,'fontweight','b') 
%% 
  
%% Plotting Stress-Strain & Pressure-Diameter Curves of COL-CHI Scaffolds 
%% 
figure(7) 
[AX,H1,H2]=plotyy(Strain_COL_CHI,FitStress_COL_CHI,Strain_COL_CHI,Pressure_COL_CHI
,'plot'); 
h = legend('Stress (kPa)','Pressure (mmHg)',2); 
set(h,'Interpreter','none') 
set(get(AX(1),'Ylabel'),'String','Stress (kPa)','fontname','Garamond','fontsize',12,'fontweight','b')  
ylimits1 = get(AX(1),'YLim'); 
yinc1 = (ylimits1(2)-ylimits1(1))/10; 
set(AX(1),'YTick',ylimits1(1):yinc1:ylimits1(2)) 
set(AX(1),'XColor','k','YColor','k','fontname','Garamond','fontsize',12,'fontweight','b') 
set(get(AX(2),'Ylabel'),'String','Internal Pressure 
(mmHg)','fontname','Garamond','fontsize',12,'fontweight','b')  
ylimits2 = get(AX(2),'YLim'); 
yinc2 = (ylimits2(2)-ylimits2(1))/10; 
set(AX(2),'YTick',ylimits2(1):yinc2:ylimits2(2)) 
set(AX(2),'XColor','k','YColor','k','fontname','Garamond','fontsize',12,'fontweight','b') 
xlabel('Change in Diameter (%)','fontname','Garamond','fontsize',12,'fontweight','b') 
title('Stress-Strain & Pressure-Diameter Curves for COL-CHI 
Scaffolds','fontname','Garamond','fontsize',14,'fontweight','b') 
%% 
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%% Plotting Stress-Strain & Pressure-Diameter Curves of COL-CHI-ELN Scaffolds 
%% 
figure(8) 
[AX,H1,H2]=plotyy(Strain_COL_CHI_ELN,FitStress_COL_CHI_ELN,Strain_COL_CHI_ELN,P
ressure_COL_CHI_ELN,'plot'); 
h = legend('Stress (kPa)','Pressure (mmHg)',2); 
set(h,'Interpreter','none') 
set(get(AX(1),'Ylabel'),'String','Stress (kPa)','fontname','Garamond','fontsize',12,'fontweight','b')  
ylimits1 = get(AX(1),'YLim'); 
yinc1 = (ylimits1(2)-ylimits1(1))/10; 
set(AX(1),'YTick',ylimits1(1):yinc1:ylimits1(2)) 
set(AX(1),'XColor','k','YColor','k','fontname','Garamond','fontsize',12,'fontweight','b') 
set(get(AX(2),'Ylabel'),'String','Internal Pressure 
(mmHg)','fontname','Garamond','fontsize',12,'fontweight','b')  
ylimits2 = get(AX(2),'YLim'); 
yinc2 = (ylimits2(2)-ylimits2(1))/10; 
set(AX(2),'YTick',ylimits2(1):yinc2:ylimits2(2)) 
set(AX(2),'XColor','k','YColor','k','fontname','Garamond','fontsize',12,'fontweight','b') 
xlabel('Change in Diameter (%)','fontname','Garamond','fontsize',12,'fontweight','b') 
title('Stress-Strain & Pressure-Diameter Curves for COL-CHI-ELN 
Scaffolds','fontname','Garamond','fontsize',14,'fontweight','b') 
%% 
 
8.2 Discussion 
 
The stress-strain curve plotted to determine peak stress, strain at break and linear elastic modulus is 
first smoothed with the smooth function available in Matlab (R2009b, Mathworks Inc, Natick, MA).  
This curve was then fit with a 5th order polynomial using the fit function in Matlab. With this fit 
181 
 
data, the curvature of the stress-strain (-) curve was plotted against the strain. The curvature was 
calculated using the general curvature formula, 
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where k is the curvature, y is the abscissa (stress - ) and x is the ordinate (strain - ). On the 
curvature-strain curve, the strain value at the largest local maximum was taken to be the transition 
point.  
 
(P.S.: The term largest local maximum mathematically may not physically mean anything. Since there 
was another smaller local maximum been produced because of the fit function, I have used these 
terms to define the transition point. The method to avoid this artifact is to piecewisely fit curves for 
the three regions.) 
 
Using the transition point and peak stress, the toe, the linear and the failure regions were 
determined. The toe region was characterized as the region on the stress-strain curve up to the 
transition point. The linear elastic modulus was slope of the straight line fit in the region between 
transition point and peak stress. Data collected were statistically analyzed using the one-way 
ANOVA test. Student’s t test was then used to compare the means of each individual group. The 
level of significance was set at α = 0.05 for 95% statistical significance. Error bars on all the 
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histogram charts represent the standard error of the mean (SEM) based on the total number of the 
samples. 
 
Figure 8.1: Determination of Transition Point in COL-CHI-ELN 
 
Figure 8.2: Transition Points in COL (Blue), COL-CHI (Green) & COL-CHI-ELN (Red) 
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9. APPENDIX B: SYNTHESIS OF 4.76MM LATEX TUBE 
 
1. A 4.76mm diameter aluminum rod was cleaned with isopropyl alcohol and air dried.  
2. Next, the aluminum rod was dipped into a coagulant, calcium nitrate solution for approximately 
150 seconds.  
3. The rod was then air dried for 30 minutes. 
4. Once, the rod was dry, the rod was dipped into the latex polymer solution for 150 seconds.  
5. The rod was then air dried for 30 minutes once again. 
6. Again, once the latex had dried out completely, the rod was immersed in a water bath preheated 
to 50°C for 6 hours.  
7. It was ensured that the water was being constantly stirred to ensure uniform distribution of heat 
and to dissolve the salts exuded from the surface of latex.  
8. After the lapse of 6 hours, the rod was removed from the water bath and left in an oven 
preheated to 105°C for 3 hours.  
9. The rod was then wiped with a clean cloth to remove any water on the surface. 
10. The latex was removed after applying some corn starch on the surface to avoid sticking of the 
latex to itself. 
11. The thickness of the latex tube obtained from this process was measured to be 0.05mm. 
12. To increase the thickness by increments of 0.05mm, repeat steps 2-6 before immersing in water 
bath. 
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10. APPENDIX C: MATLAB CODE FOR FINDING DIAMETER CHANGE FROM 
MULTILAYER GRAFT CANNULATION EXPERIMENT (COMPLIANCE TEST) 
 
10.1 Code for cropping images 
clear all 
close all 
clc 
%% Get the Directory with All the Tiff Image Files 
sdirectory = ‘/XXXXX/’); %% /XXXXX/ is the Name of the  Directory 
jpegfiles = dir([sdirectory '\*.jpg']); 
%% Get the Total Number of Tiff Image Files in the Directory 
n = length(jpegfiles); 
for k = 1:n 
    %% Get the Directory Image File Name 
    filename1 = [sdirectory '\' jpegfiles(k).name]; 
    %% Read File 
    I1 = imread(filename1); 
   %% Crop Image File to the position [XXX,XXX,XXX,XXX] 
    I2 = imcrop(I1, [XXX,XXX,XXX,XXX]); 
    %% Read File Path, Name & Extension 
    [pathstr, name, ext] = fileparts(filename1); 
    file = [sdirectory '\' name]; 
    filename2 = sprintf('%s.tif',file); 
    %% Save File 
    imwrite(I2,filename2,'tif'); 
end 
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10.2 Code for diameter determination 
clear all 
close all 
clc 
%% Get the Directory with All the Tiff Image Files 
sdirectory = /XXXXX/’); %% /XXXXX/ is the Name of the  Directory 
%% Process the Tiff files to calculate the diameter 
tifffiles = dir([sdirectory '\*.tif']); 
scale = XX.XX; % pixel/mm 
n = length(tifffiles); 
diameter = zeros(n,1);  
file = [sdirectory '\' 'PCL(HP)_GCC_08.txt']; 
fid = fopen(file,'w'); 
v = 0; 
%% Actual Diameter Determination 
for k = 1:n 
    tic 
    filename = [sdirectory '\' tifffiles(k).name]; 
    I1 = imread(filename); 
    E = entropyfilt(I1); 
    Eim = mat2gray(E); 
    I2 = im2bw(Eim,0.5); 
    [r2, c2] = size(I2); 
    for i = 1:r2 
        I2(i,1) = 1; 
        I2(i,c2) = 1; 
    end 
    I3 = imfill(I2, 'holes'); 
    cc = bwconncomp(I3,4); 
    graft_data = regionprops(cc,'all'); 
    graft_area = max(graft_data(1,:).FilledArea)/(scale^2); 
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    I4 = graft_data(1,:).FilledImage; 
    [r4, c4] = size(I4); 
    graft_length = c4/scale; 
    diameter(k,1) = graft_area/graft_length; 
    fprintf(fid, '%s \t %f \r\n',tifffiles(k).name, diameter(k,1)); 
    u = toc; 
    fprintf('File %d Analyzed: Elapsed Time = %6.4gseconds\n',k,u); 
    v = u + v; 
end 
fclose(fid); 
fprintf('Total Analysis Time for %d Files = %6.4g\n',k,v); 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
